{"id": 44033190, "time": "2025-02-28 00:04:25", "headline": "HP, Dell Technologies And 3 Stocks To Watch Heading Into Friday", "summary": " ", "symbols": ["DELL", "GLP", "GTLS", "HPQ", "OMI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/02/44033190/hp-dell-technologies-and-3-stocks-to-watch-heading-into-friday", "tags": []}
{"id": 44033215, "time": "2025-02-28 00:10:36", "headline": "Nasdaq Tumbles Over 500 Points As Nvidia Plunges Post Q4 Results: Investor Sentiment Declines Further, Greed Index Remains In 'Extreme Fear' Zone", "summary": " ", "symbols": ["GLP", "GTLS", "NVDA", "OMI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/02/44033215/nasdaq-tumbles-over-500-points-as-nvidia-plunges-post-q4-results-investor-sentiment-declines-further-greed-index-remains-in-extreme-fear-zone", "tags": ["earnings"]}
{"id": 44033445, "time": "2025-02-28 00:24:51", "headline": "Dogecoin Scooped By Whales In Large Numbers As Memecoin Plunges Further: Analyst Says Rally Toward New Highs On The Cards If DOGE Crosses This Level", "summary": "Large Dogecoin (CRYPTO: DOGE) investors took advantage of the meme coin\u2019s ongoing downturn to increase their stockpile.\u00a0", "symbols": ["DOGEUSD", "PEPEUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44033445/dogecoin-scooped-by-whales-in-large-numbers-as-memecoin-plunges-further-analyst-says-rally-toward-new-highs-on-the-cards-if-doge-crosses-this-level", "tags": []}
{"id": 44033587, "time": "2025-02-28 00:38:12", "headline": "Nvidia Chips Smuggled To China? 3 Men Charged In Singapore Amid US Export Crackdown", "summary": "Three men were charged with fraud in Singapore on Thursday following raids linked to the alleged illegal movement of Nvidia Corp. chips to China, bypassing U.S. export controls.", "symbols": ["NVDA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/02/44033587/nvidia-chips-smuggled-to-china-3-men-charged-in-singapore-amid-us-export-crackdown", "tags": []}
{"id": 44033735, "time": "2025-02-28 00:49:15", "headline": "Reported Earlier, Japan Tokyo Core Consumer Price Index (YoY) For February 2.2% Vs. 2.3% Est.; 2.5% Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44033735/reported-earlier-japan-tokyo-core-consumer-price-index-yoy-for-february-2-2-vs-2-", "tags": []}
{"id": 44033737, "time": "2025-02-28 00:49:38", "headline": "Reported Earlier, Japan Industrial Production (MoM) Preliminary For January -1.1% Vs. -1.0% Est.; -0.2% Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44033737/reported-earlier-japan-industrial-production-mom-preliminary-for-january-1-1-vs-1", "tags": []}
{"id": 44033748, "time": "2025-02-28 00:56:51", "headline": "DeFi Adoption In Emerging Markets Faces User Experience Hurdles, Says Okto Wallet CEO Rohit Jain", "summary": "DeFi adoption in emerging markets like India is hindered by complex processes and regulatory ambiguity, but improvements in user experience and regulations could unlock significant potential.", "symbols": [], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44033748/defi-adoption-in-emerging-markets-faces-user-experience-hurdles-says-okto-wallet-ceo-rohit-jain", "tags": ["management"]}
{"id": 44033962, "time": "2025-02-28 01:08:04", "headline": "State Street Expands Global Custody Footprint With Acquisition Of Mizuho's Global Custody Business; Deal Terms Not Disclosed", "summary": "", "symbols": ["MFG", "STT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44033962/state-street-expands-global-custody-footprint-with-acquisition-of-mizuhos-global-custody-business-de", "tags": ["contract"]}
{"id": 44033972, "time": "2025-02-28 01:10:45", "headline": "Reported Earlier, Nokia To Modernize Maxis' Data Centers With Next-Gen Automation And Scalable Connectivity", "summary": "", "symbols": ["NOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44033972/reported-earlier-nokia-to-modernize-maxis-data-centers-with-next-gen-automation-and-scalable-connect", "tags": []}
{"id": 44033974, "time": "2025-02-28 01:12:48", "headline": "Reported Earlier, Ingredion Invests $50M To Expand Industrial Starch Production In Cedar Rapids", "summary": "", "symbols": ["INGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44033974/reported-earlier-ingredion-invests-50m-to-expand-industrial-starch-production-in-cedar-rapids", "tags": []}
{"id": 44034101, "time": "2025-02-28 01:17:13", "headline": "Elon Musk's SpaceX Receives FAA Approval For Starship's 8th Flight Test: Here's When It Is Scheduled", "summary": "The FAA gave SpaceX the green light on Wednesday to launch its Starship for its next test flight from Starbase in Boca Chica, Texas.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/general/space/25/02/44034101/elon-musks-spacex-receives-faa-approval-for-starships-8th-flight-test-heres-when-it-is-scheduled", "tags": []}
{"id": 44034111, "time": "2025-02-28 01:19:49", "headline": "Reported Earlier, CCC Intelligent Solutions Prices Secondary Offering Of 42M Shares By Advent International, Plans To Repurchase 7M Shares", "summary": "", "symbols": ["CCCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44034111/reported-earlier-ccc-intelligent-solutions-prices-secondary-offering-of-42m-shares-by-advent-interna", "tags": ["offering", "buyback"]}
{"id": 44034215, "time": "2025-02-28 01:39:23", "headline": "Rocket Lab Unveils 'Flatellite:' Low-Cost, Mass-Producible Satellite To Target Large Constellations Amid Weak Q1 Guidance", "summary": "Rocket Lab USA introduced &#34;Flatellite,&#34; during its earnings call amid a weak guidance and in-line fourth quarter earnings report.", "symbols": ["ONEQ", "RKLB"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/space/25/02/44034215/rocket-lab-unveils-flatellite-low-cost-mass-producible-satellite-to-target-large-constellations-amid-weak-q1-guidance", "tags": ["earnings", "guidance"]}
{"id": 44034352, "time": "2025-02-28 01:48:01", "headline": "Reported Earlier, Ferrovial 2024 Revenue $9.895B Up From $9.21B YoY, Net Profit $3.50B Up From $682M YoY", "summary": "", "symbols": ["FER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44034352/reported-earlier-ferrovial-2024-revenue-9-895b-up-from-9-21b-yoy-net-profit-3-50b-up-from-682m-yoy", "tags": ["earnings"]}
{"id": 44034353, "time": "2025-02-28 01:49:49", "headline": "Reported Earlier, Faraday Future Ships FX 6 Prototype Mules From Shanghai To Los Angeles For Testing & Validation", "summary": "", "symbols": ["FFIE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44034353/reported-earlier-faraday-future-ships-fx-6-prototype-mules-from-shanghai-to-los-angeles-for-testing", "tags": []}
{"id": 44034362, "time": "2025-02-28 01:57:37", "headline": "Reported Earlier, WeRide Launches First Fully Driverless Commercial Robobus Service In Europe With Beti, Renault, And Macif", "summary": "", "symbols": ["WRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44034362/reported-earlier-weride-launches-first-fully-driverless-commercial-robobus-service-in-europe-with-be", "tags": []}
{"id": 44034368, "time": "2025-02-28 02:00:25", "headline": "Infinera Q4 2024 Adj EPS $0.03 Misses $0.11 Estimate, Sales $414.40M Beat $409.07M Estimate", "summary": "", "symbols": ["INFN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44034368/infinera-q4-2024-adj-eps-0-03-misses-0-11-estimate-sales-414-40m-beat-409-07m-estimate", "tags": ["earnings"]}
{"id": 44034438, "time": "2025-02-28 02:01:26", "headline": "U.K. Nationwide HPI (MoM) For February 0.4% Vs. 0.2% Est.; 0.1% Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44034438/u-k-nationwide-hpi-mom-for-february-0-4-vs-0-2-est-0-1-prior", "tags": []}
{"id": 44034439, "time": "2025-02-28 02:01:44", "headline": "U.K. Nationwide HPI (YoY) For February 3.9% Vs. 3.4% Est.; 4.1% Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44034439/u-k-nationwide-hpi-yoy-for-february-3-9-vs-3-4-est-4-1-prior", "tags": []}
{"id": 44034440, "time": "2025-02-28 02:02:06", "headline": "Germany Retail Sales (MoM) For January 0.2% Vs. 0.4% Est.; -1.6% Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44034440/germany-retail-sales-mom-for-january-0-2-vs-0-4-est-1-6-prior", "tags": []}
{"id": 44034455, "time": "2025-02-28 02:08:04", "headline": "Frontline Q4 2024 Adj EPS $0.20 Misses $0.36 Estimate, Sales $443.49M Beat $300.67M Estimate", "summary": "", "symbols": ["FRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44034455/frontline-q4-2024-adj-eps-0-20-misses-0-36-estimate-sales-443-49m-beat-300-67m-estimate", "tags": ["earnings"]}
{"id": 44034474, "time": "2025-02-28 02:11:12", "headline": "AbbVie's RINVOQ Gains CHMP Backing For Giant Cell Arteritis, EU Decision Expected In H1 2025", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44034474/abbvies-rinvoq-gains-chmp-backing-for-giant-cell-arteritis-eu-decision-expected-in-h1-2025", "tags": []}
{"id": 44034579, "time": "2025-02-28 02:14:50", "headline": "Trump Plans 'Big Deals' To Offset China's Belt And Road Initiative: US Wants To 'Reverse All Of That', Says Rubio", "summary": "In an attempt to counter China&#39;s Belt and Road Initiative, President Donald Trump is reportedly planning to strike &#39;big deals&#39;, as per\u00a0Marco Rubio, the U.S. Secretary of State.", "symbols": [], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/02/44034579/trump-plans-big-deals-to-offset-chinas-belt-and-road-initiative-the-us-wants-to-reverse-all-of-that-says-rubio", "tags": []}
{"id": 44034685, "time": "2025-02-28 02:17:22", "headline": "Pearson 2024 Adj. EPS 62.1p Up From 58.2p YoY, Revenue \u00a33.552B Down From \u00a33.674B YoY", "summary": "", "symbols": ["PSO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44034685/pearson-2024-adj-eps-62-1p-up-from-58-2p-yoy-revenue-3-552b-down-from-3-674b-yoy", "tags": ["earnings"]}
{"id": 44034690, "time": "2025-02-28 02:19:50", "headline": "Pearson And AWS Expand Partnership To Revolutionize AI-Powered Personalized Learning Worldwide", "summary": "", "symbols": ["AMZN", "PSO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44034690/pearson-and-aws-expand-partnership-to-revolutionize-ai-powered-personalized-learning-worldwide", "tags": ["contract"]}
{"id": 44034695, "time": "2025-02-28 02:24:29", "headline": "Reported Earlier, Nxera Pharma Assigns Cenerimod Rights In Japan And APAC (ex-China) To Viatris In Strategic Deal", "summary": "", "symbols": ["SOLTF", "VTRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44034695/reported-earlier-nxera-pharma-assigns-cenerimod-rights-in-japan-and-apac-ex-china-to-viatris-in-stra", "tags": ["contract"]}
{"id": 44034701, "time": "2025-02-28 02:27:34", "headline": "Reported Earlier, Seacoast Banking Acquires Heartland Bancshares In $110M Deal, Expanding Florida Market Presence", "summary": "", "symbols": ["SBCF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44034701/reported-earlier-seacoast-banking-acquires-heartland-bancshares-in-110m-deal-expanding-florida-marke", "tags": ["merger", "contract"]}
{"id": 44034821, "time": "2025-02-28 02:32:28", "headline": "Reported Earlier, Ashford Trust Reduces Board Size And Cuts Executive Compensation By 50% As Part Of 'GRO AHT' Strategy", "summary": "", "symbols": ["AHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44034821/reported-earlier-ashford-trust-reduces-board-size-and-cuts-executive-compensation-by-50-as-part-of-g", "tags": []}
{"id": 44034826, "time": "2025-02-28 02:36:15", "headline": "FTAI Infrastructure Q4 2024 GAAP EPS $(1.24) Misses $(0.37) Estimate, Sales $80.76M Miss $94.83M Estimate", "summary": "", "symbols": ["FIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44034826/ftai-infrastructure-q4-2024-gaap-eps-1-24-misses-0-37-estimate-sales-80-76m-miss-94-83m-estimate", "tags": ["earnings"]}
{"id": 44034837, "time": "2025-02-28 02:40:08", "headline": "SoundHound AI Says Polaris Speech Recognition Model Outperforms Google, OpenAI: Company Forays Into Energy Sector With 7-Figure Deal", "summary": "SoundHound AI&#39;s speech recognition model &#34;outperformed&#34; Google and OpenAI during Q4 as it announced a new seven-figure energy sector deal.", "symbols": ["AI", "GOOG", "GOOGL", "MSFT", "ONEQ", "SOUN"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/25/02/44034837/soundhound-ais-polaris-outperforms-google-and-openai-forays-in-energy-sector-with-seven-figure-deal-amid-q4-beat", "tags": ["contract"]}
{"id": 44034855, "time": "2025-02-28 02:44:10", "headline": "'This Is As Good As It Gets For Nvidia:' Analyst Says Jensen Huang-Led Chipmaker's Explosive Growth May Have Peaked As NVDA Stock Falls 13% This Year", "summary": "DA Davidson&#39;s tech analyst,\u00a0Gil Luria, anticipates a deceleration in growth for\u00a0Nvidia Corporation\u00a0(NASDAQ: NVDA) despite the company&#39;s impressive performance.", "symbols": ["GOOG", "GOOGL", "META", "MSFT", "NVDA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/02/44034855/this-is-as-good-as-it-gets-for-nvidia-says-this-analyst-as-he-predicts-a-slowdown-for-the-chipmaker", "tags": []}
{"id": 44035056, "time": "2025-02-28 02:47:42", "headline": "Reported Earlier, Fifth Era Acquisition Corp I Prices $200M Initial Public Offering Of 20M Units At $10/Unit", "summary": "", "symbols": ["FERA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44035056/reported-earlier-fifth-era-acquisition-corp-i-prices-200m-initial-public-offering-of-20m-units-at-10", "tags": ["offering"]}
{"id": 44035075, "time": "2025-02-28 02:52:16", "headline": "France Consumer Spending (MoM) For January -0.5% Vs. -0.6% Est.; 0.7% Prior", "summary": "", "symbols": ["EWQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44035075/france-consumer-spending-mom-for-january-0-5-vs-0-6-est-0-7-prior", "tags": []}
{"id": 44035077, "time": "2025-02-28 02:52:52", "headline": "France Consumer Price Index (MoM) Preliminary For February 0.0% Vs. 0.5% Est.; 0.2% Prior", "summary": "", "symbols": ["EWQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44035077/france-consumer-price-index-mom-preliminary-for-february-0-0-vs-0-5-est-0-2-prior", "tags": []}
{"id": 44035078, "time": "2025-02-28 02:53:10", "headline": "France Gross Domestic Product (QoQ) For Q4 -0.1% Vs. -0.1% Est.; 0.4% Prior", "summary": "", "symbols": ["EWQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44035078/france-gross-domestic-product-qoq-for-q4-0-1-vs-0-1-est-0-4-prior", "tags": []}
{"id": 44035079, "time": "2025-02-28 02:53:28", "headline": "France Gross Domestic Product (YoY) For Q4 0.6% Vs. 0.7% Est.; 1.2% Prior", "summary": "", "symbols": ["EWQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44035079/france-gross-domestic-product-yoy-for-q4-0-6-vs-0-7-est-1-2-prior", "tags": []}
{"id": 44035080, "time": "2025-02-28 02:53:48", "headline": "France Harmonised Index of Consumer Prices (MoM) Preliminary For February 0.0% Vs. 0.3% Est.; -0.2% Prior", "summary": "", "symbols": ["EWQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44035080/france-harmonised-index-of-consumer-prices-mom-preliminary-for-february-0-0-vs-0-", "tags": []}
{"id": 44035087, "time": "2025-02-28 02:59:04", "headline": "Activist Investor ValueAct, Once Linked To Steve Ballmer's Microsoft Exit, Bought Meta, Visa, Sold Spotify In Q3: A Smart Bet?", "summary": "Activist investor ValueAct Holdings, L.P., known for its role in Microsoft Corp. leadership changes a decade ago, disclosed significant portfolio adjustments in its third-quarter 13F filing with the Securities and Exchange Commission.", "symbols": ["AMZN", "META", "MSFT", "SPOT", "V"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/02/44035087/activist-investor-valueact-once-linked-to-steve-ballmers-microsoft-exit-bought-meta-visa-sold-spotify-in-q3-a-smart-bet", "tags": []}
{"id": 44035209, "time": "2025-02-28 03:03:14", "headline": "Waymo Offering 200,000 Robotaxi Rides Per Week, Says Alphabet CEO Sundar Pichai: '20x Growth In Less Than 2 Years'", "summary": "Waymo is now serving over 200,000 paid trips in its robotaxis each week, Alphabet Inc CEO Sundar Pichai said on Thursday.", "symbols": ["GOOG", "GOOGL", "TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/25/02/44035209/waymo-offering-200000-robotaxi-rides-per-week-says-alphabet-ceo-sundar-pichai", "tags": ["offering", "management"]}
{"id": 44035516, "time": "2025-02-28 03:32:09", "headline": "Earnings Scheduled For February 28, 2025", "summary": " ", "symbols": ["AMR", "AMRX", "ANIP", "APLS", "BFLY", "BLX", "BTCM", "CLMT", "DCBO", "DIBS", "FLGT", "FLNT", "FRO", "FUBO", "GLP", "GTLS", "IAS", "LB", "LGVN", "MRCC", "MSEX", "NAT", "NRP", "NWN", "OMI", "OXSQ", "PAR", "RPID", "RXRX", "WULF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/02/44035516/earnings-scheduled-for-february-28-2025", "tags": ["earnings"]}
{"id": 44035545, "time": "2025-02-28 03:37:06", "headline": "Tesla Rival Xiaomi Slashes Luxury EV Price By 35% To Challenge Model S, Porsche In China", "summary": "Xiaomi cut the price of its luxury electric sedan SU7 Ultra by 35% to 529,900 yuan ($72,932) from 814,900 yuan ($111,842).", "symbols": ["TSLA", "XIACY"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/02/44035545/tesla-rival-xiaomi-slashes-luxury-ev-price-by-35-to-challenge-model-s-porsche-in-china", "tags": []}
{"id": 44035798, "time": "2025-02-28 03:53:59", "headline": "Dell Technologies Projects $15 Billion AI Server Revenue For FY26, Raises Dividend By 18% Amid A Mixed Quarter", "summary": "Dell Technologies announced an 18% dividend increase and expects the AI server business to grow by at least $15 billion in FY26.", "symbols": ["DELL", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/25/02/44035798/dell-technologies-projects-15-billion-ai-server-revenue-for-fy26-raises-dividend-18-amid-a-mixed-quarter", "tags": ["earnings", "dividend"]}
{"id": 44035813, "time": "2025-02-28 03:58:38", "headline": "Microsoft Urges Trump To Avoid This Critical Mistake In Global AI Race, Cautions It Will 'Give China A Strategic Advantage'", "summary": "Microsoft Corporation\u00a0(NASDAQ: MSFT) has cautioned the Trump administration that the Biden-era &#39;AI Diffusion Rule&#39;, might inadvertently strengthen China&#39;s rapidly expanding AI sector.", "symbols": ["MSFT"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/02/44035813/microsoft-urges-trump-to-avoid-this-critical-mistake-in-the-global-ai-race-cautions-it-will-give-china-a-strategic-advantage", "tags": []}
{"id": 44035845, "time": "2025-02-28 04:03:30", "headline": "Gravity Game Hub Launches New Game Ragnarok Idle Adventure Plus Globally", "summary": "", "symbols": ["GRVY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/entertainment/25/02/44035845/gravity-game-hub-launches-new-game-ragnarok-idle-adventure-plus-globally", "tags": []}
{"id": 44035850, "time": "2025-02-28 04:05:54", "headline": "Germany Unemployment Change For February 5K Vs. 14K Est.; 11K Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44035850/germany-unemployment-change-for-february-5k-vs-14k-est-11k-prior", "tags": []}
{"id": 44035862, "time": "2025-02-28 04:08:20", "headline": "Germany Unemployment Rate For February Unchanged At 6.2% Vs. 6.2% Est.", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44035862/germany-unemployment-rate-for-february-unchanged-at-6-2-vs-6-2-est", "tags": []}
{"id": 44036079, "time": "2025-02-28 04:21:48", "headline": "Tim Cook's Apple Is Developing New Technology To Help Social Media Apps Determine If Users Are Under 16", "summary": "Apple is working on an API to help social media apps identify users under 16 with parental consent, for concerns over under-aged users.", "symbols": ["AAPL"], "source": "benzinga", "author": "Rounak Jain", "url": "https://www.benzinga.com/25/02/44036079/apples-new-declared-age-range-api-could-reshape-social-media-age-restrictions", "tags": []}
{"id": 44036156, "time": "2025-02-28 04:40:18", "headline": "Galaxy Payroll And Euler Number Partner To Revolutionize HR And Payroll With AI & Big Data", "summary": "", "symbols": ["GLXG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44036156/galaxy-payroll-and-euler-number-partner-to-revolutionize-hr-and-payroll-with-ai-big-data", "tags": []}
{"id": 44036158, "time": "2025-02-28 04:42:09", "headline": "Elon Musk Calls On Retired Employees To Return To Work At FAA: 'There Is A Shortage Of Top Notch Air Traffic Controllers'", "summary": "Billionaire and Department of Government Efficiency lead Elon Musk on Thursday called on retired air traffic controllers to return to work.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/news/25/02/44036158/elon-musk-calls-on-retired-employees-to-return-to-work-at-faa-there-is-a-shortage-of-top-notch-air-traffic-controllers", "tags": []}
{"id": 44036422, "time": "2025-02-28 05:07:18", "headline": "Robert Reich Slams $880 Billion Medicaid Cuts: 'Trump's Tyranny Is Undeniable'", "summary": "Former U.S. Secretary of Labor, Robert Reich recently expressed his concerns over the governance style and policy decisions of the Trump administration, highlighting a stark contrast between the current state of affairs and his own experiences in the cabinet room.", "symbols": [], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/news/25/02/44036422/robert-reich-slams-880-billion-medicaid-cuts-trumps-tyranny-is-undeniable", "tags": []}
{"id": 44036485, "time": "2025-02-28 05:13:20", "headline": "Needham Maintains Buy on Dentsply Sirona, Lowers Price Target to $23", "summary": "", "symbols": ["XRAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44036485/needham-maintains-buy-on-dentsply-sirona-lowers-price-target-to-23", "tags": ["analyst_other", "price_target_down"]}
{"id": 44036489, "time": "2025-02-28 05:14:59", "headline": "Needham Reiterates Buy on Heron Therapeutics, Maintains $4 Price Target", "summary": "", "symbols": ["HRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44036489/needham-reiterates-buy-on-heron-therapeutics-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 44036687, "time": "2025-02-28 05:18:08", "headline": "Needham Maintains Buy on Privia Health Gr, Raises Price Target to $30", "summary": "", "symbols": ["PRVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44036687/needham-maintains-buy-on-privia-health-gr-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 44036688, "time": "2025-02-28 05:18:08", "headline": "Lixiang Education Regains Nasdaq Minimum Market Value Requirement Compliance", "summary": "", "symbols": ["LXEH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44036688/lixiang-education-regains-nasdaq-minimum-market-value-requirement-compliance", "tags": []}
{"id": 44036699, "time": "2025-02-28 05:20:11", "headline": "Needham Maintains Buy on Adtran Holdings, Raises Price Target to $14", "summary": "", "symbols": ["ADTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44036699/needham-maintains-buy-on-adtran-holdings-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 44036700, "time": "2025-02-28 05:22:19", "headline": "Needham Maintains Buy on NCR Voyix, Lowers Price Target to $15", "summary": "", "symbols": ["VYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44036700/needham-maintains-buy-on-ncr-voyix-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 44036732, "time": "2025-02-28 05:31:35", "headline": "India Gross Domestic Product Quarterly (YoY) For Q3 6.2% Vs. 6.3% Est.; 5.4% Prior", "summary": "", "symbols": ["INDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44036732/india-gross-domestic-product-quarterly-yoy-for-q3-6-2-vs-6-3-est-5-4-prior", "tags": []}
{"id": 44036750, "time": "2025-02-28 05:39:15", "headline": "Nordic American Tankers Q4 2024 GAAP EPS $0.01 Misses $0.04 Estimate, Sales $46.39M Miss $51.38M Estimate", "summary": "", "symbols": ["NAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44036750/nordic-american-tankers-q4-2024-gaap-eps-0-01-misses-0-04-estimate-sales-46-39m-miss-51-38m-estimat", "tags": ["earnings"]}
{"id": 44036765, "time": "2025-02-28 05:40:32", "headline": "Nordic American Tankers Q4 Average Time Charter Equivalent (TCE) For Its Fleet Came In At $26,416 Per Day Per Ship", "summary": "", "symbols": ["NAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44036765/nordic-american-tankers-q4-average-time-charter-equivalent-tce-for-its-fleet-came-in-at-26-416-per-", "tags": []}
{"id": 44036914, "time": "2025-02-28 05:45:25", "headline": "Alkami Technology Beats Q4 Estimates, Strengthens Digital Banking Platform With $400 Million FinTech Acquisition", "summary": "Alkami Technology reported Q4 results, with adjusted EPS beating consensus. They also announced a deal to acquire FinTech for $400M.", "symbols": ["ALKT"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/25/02/44036914/alkami-technology-beats-q4-estimates-strengthens-digital-banking-platform-with-400-million-fintech-acquisition", "tags": ["earnings", "merger", "contract"]}
{"id": 44037023, "time": "2025-02-28 05:46:33", "headline": "Tesla Cybertruck Inventory Swells Despite Discounts, Falling Short of Elon Musk's Vision", "summary": "Tesla&#39;s Cybertruck vehicles are reportedly piling outside the company&#39;s gigafactory in Texas and collecting dust.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/25/02/44037023/tesla-cybertruck-inventory-swells-despite-discounts-falling-short-of-elon-musks-vision", "tags": []}
{"id": 44037042, "time": "2025-02-28 05:54:07", "headline": "MSTR Stock Falls Over 3% In Friday Pre-Market: What's Going On?", "summary": "In Friday\u2019s pre-market trading,\u00a0Strategy\u00a0(NASDAQ:MSTR) saw a 3.18% dip in its stock, following a 7% decrease in Bitcoin\u2018s (CRYPTO: BTC) value over the past day, according to\u00a0", "symbols": ["BTC", "BTCUSD", "MSTR"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/equities/25/02/44037042/mstr-stock-falls-over-3-in-friday-pre-market-whats-going-on", "tags": ["why_moving"]}
{"id": 44037056, "time": "2025-02-28 05:55:49", "headline": "Telsey Advisory Group Maintains Market Perform on J.Jill, Maintains $31 Price Target", "summary": "", "symbols": ["JILL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037056/telsey-advisory-group-maintains-market-perform-on-j-jill-maintains-31-price-target", "tags": ["analyst_other"]}
{"id": 44037059, "time": "2025-02-28 05:58:43", "headline": "Telsey Advisory Group Maintains Market Perform on Gap, Maintains $26 Price Target", "summary": "", "symbols": ["GAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037059/telsey-advisory-group-maintains-market-perform-on-gap-maintains-26-price-target", "tags": ["analyst_other"]}
{"id": 44037061, "time": "2025-02-28 06:00:01", "headline": "US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections", "summary": "U.S. stock futures rose on Friday following Thursday&#39;s sell-off. Futures advanced except the small-cap gauge Russell 2000.", "symbols": ["DELL", "GTLS", "HPQ", "IAS", "NVDA", "OMI", "PMAX", "QQQ", "RKLB", "RPID", "SOUN", "SPY", "VRPX"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/25/02/44037061/us-stocks-likely-to-open-higher-following-a-sell-off-this-choppy-start-to-2025-isnt-abnormal-dont-panic-says-expert-highlighting-seasonal-weakness-in-the-first-quarter-after-elections", "tags": []}
{"id": 44037081, "time": "2025-02-28 06:00:12", "headline": "Intl Cons Airlines Group Q4 Adj EPS $0.28 Beats $0.17 Estimate, Sales $8.59B Beat $7.65B Estimate", "summary": "", "symbols": ["ICAGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44037081/intl-cons-airlines-group-q4-adj-eps-0-28-beats-0-17-estimate-sales-8-59b-beat-7-65b-estimate", "tags": ["earnings"]}
{"id": 44037093, "time": "2025-02-28 06:01:05", "headline": "Amneal Pharmaceuticals Q4 2024 Adj EPS $0.12 Misses $0.15 Estimate, Sales $730.52M Beat $707.55M Estimate", "summary": "", "symbols": ["AMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44037093/amneal-pharmaceuticals-q4-2024-adj-eps-0-12-misses-0-15-estimate-sales-730-52m-beat-707-55m-estimat", "tags": ["earnings"]}
{"id": 44037100, "time": "2025-02-28 06:01:52", "headline": "Northwest Natural Hldg Q4 2024 Adj EPS $1.41 Beats $1.37 Estimate, Sales $370.88M Miss $395.05M Estimate", "summary": "", "symbols": ["NWN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44037100/northwest-natural-hldg-q4-2024-adj-eps-1-41-beats-1-37-estimate-sales-370-88m-miss-395-05m-estimate", "tags": ["earnings"]}
{"id": 44037103, "time": "2025-02-28 06:02:13", "headline": "Amneal Expects 2025 Revenues Of $3B-$3.1B And Adjusted EPS Of $0.65-$0.70 Versus Consensus Of $2.896B And $0.71, Respectively", "summary": "", "symbols": ["AMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44037103/amneal-expects-2025-revenues-of-3b-3-1b-and-adjusted-eps-of-0-65-0-70-versus-consensus-of-2-896b-an", "tags": ["earnings"]}
{"id": 44037105, "time": "2025-02-28 06:02:57", "headline": "AES Q4 2024 Adj EPS $0.54 Beats $0.34 Estimate, Sales $2.96B Miss $3.07B Estimate", "summary": "", "symbols": ["AES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44037105/aes-q4-2024-adj-eps-0-54-beats-0-34-estimate-sales-2-96b-miss-3-07b-estimate", "tags": ["earnings"]}
{"id": 44037112, "time": "2025-02-28 06:03:18", "headline": "Telsey Advisory Group Maintains Market Perform on FIGS, Maintains $7 Price Target", "summary": "", "symbols": ["FIGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037112/telsey-advisory-group-maintains-market-perform-on-figs-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 44037130, "time": "2025-02-28 06:05:12", "headline": "AES Initiates 2025 Guidance For Adjusted EPS Of $2.10 - $2.26", "summary": "", "symbols": ["AES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037130/aes-initiates-2025-guidance-for-adjusted-eps-of-2-10-2-26", "tags": ["earnings", "guidance"]}
{"id": 44037131, "time": "2025-02-28 06:05:40", "headline": "Northwest Natural Gas Sees FY25 Adjusted EPS Of $2.75-$2.95 Vs $2.88 Est.", "summary": "", "symbols": ["NWN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037131/northwest-natural-gas-sees-fy25-adjusted-eps-of-2-75-2-95-vs-2-88-est", "tags": ["earnings"]}
{"id": 44037149, "time": "2025-02-28 06:07:33", "headline": "Telsey Advisory Group Maintains Outperform on Traeger, Maintains $4 Price Target", "summary": "", "symbols": ["COOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037149/telsey-advisory-group-maintains-outperform-on-traeger-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 44037160, "time": "2025-02-28 06:07:44", "headline": "Docebo Q4 2024 Adj. EPS $0.28 Beats $0.16 Estimate, Sales $57.041M Beat $56.211M Estimate", "summary": "", "symbols": ["DCBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44037160/docebo-q4-2024-adj-eps-0-28-beats-0-16-estimate-sales-57-041m-beat-56-211m-estimate", "tags": ["earnings"]}
{"id": 44037232, "time": "2025-02-28 06:09:48", "headline": "NextDecade Says Overall Project Completion Percentage For Trains 1 And 2 And The Common Facilities Of The Rio Grande LNG Facility Was 38.1%", "summary": "", "symbols": ["NEXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037232/nextdecade-says-overall-project-completion-percentage-for-trains-1-and-2-and-the-common-facilities-o", "tags": []}
{"id": 44037233, "time": "2025-02-28 06:09:54", "headline": "Telsey Advisory Group Maintains Outperform on Vital Farms, Maintains $52 Price Target", "summary": "", "symbols": ["VITL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037233/telsey-advisory-group-maintains-outperform-on-vital-farms-maintains-52-price-target", "tags": ["analyst_other"]}
{"id": 44037234, "time": "2025-02-28 06:09:55", "headline": "Docebo Expects Q1 Revenue Of $57.0M-$57.2M Vs $58.43M Est", "summary": "", "symbols": ["DCBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037234/docebo-expects-q1-revenue-of-57-0m-57-2m-vs-58-43m-est", "tags": ["earnings"]}
{"id": 44037259, "time": "2025-02-28 06:10:58", "headline": "AES Initiates 2025 Guidance For Adjusted EBITDA Of $2.65B - $2.85B; Reaffirms Annualized Growth Target Of 5% To 7% Through 2027, Off Base Of 2023 Guidance", "summary": "", "symbols": ["AES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037259/aes-initiates-2025-guidance-for-adjusted-ebitda-of-2-65b-2-85b-reaffirms-annualized-growth-target-of", "tags": ["guidance"]}
{"id": 44037286, "time": "2025-02-28 06:11:37", "headline": "Docebo Expects FY25 Revenue Growth Of 11.0%-12.0% Vs $246.22M Est And Adj Revenue Growth Of 12.5%-13.5%", "summary": "", "symbols": ["DCBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037286/docebo-expects-fy25-revenue-growth-of-11-0-12-0-vs-246-22m-est-and-adj-revenue-growth-of-12-5-13-5", "tags": ["earnings"]}
{"id": 44037321, "time": "2025-02-28 06:12:15", "headline": "Telsey Advisory Group Maintains Outperform on Bath & Body Works, Maintains $43 Price Target", "summary": "", "symbols": ["BBWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037321/telsey-advisory-group-maintains-outperform-on-bath-body-works-maintains-43-price-target", "tags": ["analyst_other"]}
{"id": 44037455, "time": "2025-02-28 06:14:56", "headline": "Telsey Advisory Group Maintains Market Perform on a.k.a. Brands Holding, Maintains $22 Price Target", "summary": "", "symbols": ["AKA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037455/telsey-advisory-group-maintains-market-perform-on-a-k-a-brands-holding-maintains-22-price-target", "tags": ["analyst_other"]}
{"id": 44037703, "time": "2025-02-28 06:18:14", "headline": "Reported Earlier, International Paper Names Lance Loeffler As Senior Vice President And CFO", "summary": "", "symbols": ["IP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037703/reported-earlier-international-paper-names-lance-loeffler-as-senior-vice-president-and-cfo", "tags": ["management"]}
{"id": 44037709, "time": "2025-02-28 06:19:01", "headline": "Telsey Advisory Group Maintains Outperform on Warby Parker, Raises Price Target to $30", "summary": "", "symbols": ["WRBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037709/telsey-advisory-group-maintains-outperform-on-warby-parker-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 44037737, "time": "2025-02-28 06:20:31", "headline": "Simpple Named Gary Goh Yean Seng CFO", "summary": "", "symbols": ["SPPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037737/simpple-named-gary-goh-yean-seng-cfo", "tags": ["management"]}
{"id": 44037774, "time": "2025-02-28 06:22:02", "headline": "BGM Group Named Chen Xin As Chairman", "summary": "", "symbols": ["BGM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037774/bgm-group-named-chen-xin-as-chairman", "tags": []}
{"id": 44037842, "time": "2025-02-28 06:23:42", "headline": "DA Davidson Maintains Buy on Cars.com, Lowers Price Target to $14.5", "summary": "", "symbols": ["CARS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037842/da-davidson-maintains-buy-on-cars-com-lowers-price-target-to-14-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44037872, "time": "2025-02-28 06:24:34", "headline": "HC Wainwright & Co. Reiterates Buy on NPK International, Maintains $12 Price Target", "summary": "", "symbols": ["NPKI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037872/hc-wainwright-co-reiterates-buy-on-npk-international-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 44037927, "time": "2025-02-28 06:26:40", "headline": "HC Wainwright & Co. Reiterates Buy on Archer Aviation, Maintains $12.5 Price Target", "summary": "", "symbols": ["ACHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44037927/hc-wainwright-co-reiterates-buy-on-archer-aviation-maintains-12-5-price-target", "tags": ["analyst_other"]}
{"id": 44038042, "time": "2025-02-28 06:30:28", "headline": "Bybit's Mega Ethereum Hack Sparks Hard Fork Divide\u2014A Choice Between Preventing Kim Jong Un's Nuclear Ambitions And Blockchain Immutability?", "summary": "The $1.4 billion Ethereum (CRYPTO: ETH) theft from cryptocurrency exchange Bybit has not only sent shockwaves through the market but also revived a long-standing contentious debate\u2014implementing a hard fork to recover hacked funds.", "symbols": ["ETCUSD", "ETH", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44038042/bybits-mega-ethereum-hack-sparks-hard-fork-divide-a-choice-between-preventing-kim-jong-uns-nuclear-ambitions-and-blockchain-immutability", "tags": []}
{"id": 44038049, "time": "2025-02-28 06:30:37", "headline": "HC Wainwright & Co. Maintains Buy on GoldMining, Lowers Price Target to $3.25", "summary": "", "symbols": ["GLDG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038049/hc-wainwright-co-maintains-buy-on-goldmining-lowers-price-target-to-3-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 44038118, "time": "2025-02-28 06:31:42", "headline": "Butterfly Network Q4 2024 Adj EPS $(0.05) Beats $(0.10) Estimate, Sales $22.35M Beat $21.97M Estimate", "summary": "", "symbols": ["BFLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038118/butterfly-network-q4-2024-adj-eps-0-05-beats-0-10-estimate-sales-22-35m-beat-21-97m-estimate", "tags": ["earnings"]}
{"id": 44038124, "time": "2025-02-28 06:31:49", "headline": "Asia Markets Slide, Europe Extends Losses; Oil Drops On Tariff Concerns - Global Markets Today While US Slept", "summary": "U.S. markets closed red on 2/27 due to Nvidia&#39;s disappointing forecast, slowing AI demand, and economic data indicating a cooling economy.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/forex/25/02/44038124/asia-markets-slide-europe-extends-losses-oil-drops-on-tariff-concerns-global-markets-today-while-us-slept", "tags": ["guidance"]}
{"id": 44038154, "time": "2025-02-28 06:32:10", "headline": "Owens & Minor Q4 2024 Adj EPS $0.55 Beats $0.52 Estimate, Sales $2.70B Beat $2.69B Estimate", "summary": "", "symbols": ["OMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038154/owens-minor-q4-2024-adj-eps-0-55-beats-0-52-estimate-sales-2-70b-beat-2-69b-estimate", "tags": ["earnings"]}
{"id": 44038172, "time": "2025-02-28 06:32:20", "headline": "HC Wainwright & Co. Maintains Buy on Energy Fuels, Lowers Price Target to $10.75", "summary": "", "symbols": ["UUUU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038172/hc-wainwright-co-maintains-buy-on-energy-fuels-lowers-price-target-to-10-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 44038214, "time": "2025-02-28 06:33:09", "headline": "Owens & Minor Authorizes Share Repurchase Program of Up to $100M", "summary": "", "symbols": ["OMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/large-cap/25/02/44038214/owens-minor-authorizes-share-repurchase-program-of-up-to-100m", "tags": ["buyback"]}
{"id": 44038215, "time": "2025-02-28 06:33:13", "headline": "Butterfly Network Expects FY25 Revenue Of $96M - $100M Or Approximately 20% Growth (Est $97.80M)", "summary": "", "symbols": ["BFLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038215/butterfly-network-expects-fy25-revenue-of-96m-100m-or-approximately-20-growth-est-97-80m", "tags": ["earnings"]}
{"id": 44038223, "time": "2025-02-28 06:33:50", "headline": "Recursion Pharmaceuticals Q4 EPS $(0.53) Misses $(0.46) Estimate, Sales $4.55M Miss $19.04M Estimate", "summary": "", "symbols": ["RXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038223/recursion-pharmaceuticals-q4-eps-0-53-misses-0-46-estimate-sales-4-55m-miss-19-04m-estimate", "tags": ["earnings"]}
{"id": 44038225, "time": "2025-02-28 06:34:38", "headline": "Wedbush Reiterates Outperform on Papa John's International, Maintains $60 Price Target", "summary": "", "symbols": ["PZZA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038225/wedbush-reiterates-outperform-on-papa-johns-international-maintains-60-price-target", "tags": ["analyst_other"]}
{"id": 44038227, "time": "2025-02-28 06:34:54", "headline": "Owens & Minor Expects 2025 Revenues Of $10.85B-$11.15B And Adjusted EPS Of $1.60-$1.85 Versus Consensus Of $10.97B And $1.79, Respectively", "summary": "", "symbols": ["OMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038227/owens-minor-expects-2025-revenues-of-10-85b-11-15b-and-adjusted-eps-of-1-60-1-85-versus-consensus-o", "tags": ["earnings"]}
{"id": 44038228, "time": "2025-02-28 06:35:02", "headline": "Octava Funds Reported Acquisition Of 30.55% Stake In Ryde Group From DLG Ventures In 13D Filing", "summary": "", "symbols": ["RYDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44038228/octava-funds-reported-acquisition-of-30-55-stake-in-ryde-group-from-dlg-ventures-in-13d-filing", "tags": []}
{"id": 44038229, "time": "2025-02-28 06:35:05", "headline": "Chart Industries Q4 2024 Adj EPS $2.66 Misses $3.09 Estimate, Sales $1.11B Miss $1.17B Estimate", "summary": "", "symbols": ["GTLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038229/chart-industries-q4-2024-adj-eps-2-66-misses-3-09-estimate-sales-1-11b-miss-1-17b-estimate", "tags": ["earnings"]}
{"id": 44038230, "time": "2025-02-28 06:35:31", "headline": "Owens & Minor Says Active Discussions Well Underway Regarding Potential Sale of Products & Healthcare Services Segment", "summary": "", "symbols": ["OMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/large-cap/25/02/44038230/owens-minor-says-active-discussions-well-underway-regarding-potential-sale-of-products-healthcare-", "tags": []}
{"id": 44038232, "time": "2025-02-28 06:36:42", "headline": "Wedbush Downgrades Dine Brands Global to Neutral, Lowers Price Target to $28", "summary": "", "symbols": ["DIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038232/wedbush-downgrades-dine-brands-global-to-neutral-lowers-price-target-to-28", "tags": ["analyst_down", "price_target_down"]}
{"id": 44038243, "time": "2025-02-28 06:37:23", "headline": "Rapid Micro Biosystems Q4 EPS $(0.22) Beats $(0.23) Estimate, Sales $8.22M Beat $7.80M Estimate", "summary": "", "symbols": ["RPID"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038243/rapid-micro-biosystems-q4-eps-0-22-beats-0-23-estimate-sales-8-22m-beat-7-80m-estimate", "tags": ["earnings"]}
{"id": 44038252, "time": "2025-02-28 06:38:05", "headline": "Laurentian Bank of Canada Q1 Adj $0.78 Beats $0.76 Estimate, Sales $249.64M Beat $245.21M Estimate", "summary": "", "symbols": ["TSX:LB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038252/laurentian-bank-of-canada-q1-adj-0-78-beats-0-76-estimate-sales-249-64m-beat-245-21m-estimate", "tags": []}
{"id": 44038253, "time": "2025-02-28 06:38:18", "headline": "Chart Industries Reiterates Its 2025 Outlook: Sees Sales Of $4.65B-$4.85B Vs. $4.689B Est., Adj. EPS Of $12.00-$13.00 Vs. $12.14 Est.", "summary": "", "symbols": ["GTLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038253/chart-industries-reiterates-its-2025-outlook-sees-sales-of-4-65b-4-85b-vs-4-689b-est-adj-eps-of-12-", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 44038254, "time": "2025-02-28 06:38:19", "headline": "Rapid Micro Biosystems Sees FY2025 Sales $32.000M vs $32.90M Est", "summary": "", "symbols": ["RPID"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038254/rapid-micro-biosystems-sees-fy2025-sales-32-000m-vs-32-90m-est", "tags": []}
{"id": 44038255, "time": "2025-02-28 06:38:37", "headline": "HC Wainwright & Co. Reiterates Buy on Cullinan Therapeutics, Maintains $33 Price Target", "summary": "", "symbols": ["CGEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038255/hc-wainwright-co-reiterates-buy-on-cullinan-therapeutics-maintains-33-price-target", "tags": ["analyst_other"]}
{"id": 44038260, "time": "2025-02-28 06:40:10", "headline": "Canaccord Genuity Downgrades ICF International to Hold, Lowers Price Target to $100", "summary": "", "symbols": ["ICFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038260/canaccord-genuity-downgrades-icf-international-to-hold-lowers-price-target-to-100", "tags": ["analyst_down", "price_target_down"]}
{"id": 44038261, "time": "2025-02-28 06:40:14", "headline": "HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target", "summary": "", "symbols": ["PBYI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038261/hc-wainwright-co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 44038268, "time": "2025-02-28 06:42:03", "headline": "HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $120 Price Target", "summary": "", "symbols": ["CYTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038268/hc-wainwright-co-reiterates-buy-on-cytokinetics-maintains-120-price-target", "tags": ["analyst_other"]}
{"id": 44038303, "time": "2025-02-28 06:43:47", "headline": "HC Wainwright & Co. Reiterates Buy on Celldex Therapeutics, Maintains $80 Price Target", "summary": "", "symbols": ["CLDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038303/hc-wainwright-co-reiterates-buy-on-celldex-therapeutics-maintains-80-price-target", "tags": ["analyst_other"]}
{"id": 44038412, "time": "2025-02-28 06:46:03", "headline": "Panama Explores 'Novel Ideas' For Its Shuttered Cornerstone Mining Asset", "summary": "Panama inching closer to resolution on largest mining asset, considering novel ideas to resolve dispute with First Quantum Minerals over Cobre Panama copper mine.", "symbols": ["FQVLF"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/25/02/44038412/panama-explores-novel-ideas-for-its-shuttered-cornerstone-mining-asset", "tags": []}
{"id": 44038520, "time": "2025-02-28 06:46:59", "headline": "Life Time Group Prices Previously Announced Secondary Offering Of 23M Shares By Certain Selling Stockholders Resulting In Total Gross Proceeds Of $699.2M", "summary": "", "symbols": ["LTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038520/life-time-group-prices-previously-announced-secondary-offering-of-23m-shares-by-certain-selling-stoc", "tags": ["offering"]}
{"id": 44038522, "time": "2025-02-28 06:47:17", "headline": "JP Morgan Upgrades Li Auto to Overweight, Raises Price Target to $40", "summary": "", "symbols": ["LI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038522/jp-morgan-upgrades-li-auto-to-overweight-raises-price-target-to-40", "tags": ["analyst_up", "price_target_up"]}
{"id": 44038539, "time": "2025-02-28 06:50:06", "headline": "Castellum 2024 Sales $44.8M Down From $45.2M YoY", "summary": "", "symbols": ["CTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038539/castellum-2024-sales-44-8m-down-from-45-2m-yoy", "tags": []}
{"id": 44038543, "time": "2025-02-28 06:50:33", "headline": "Comstock Enters Into An Agreement With Marathon Petroleum For The Purchase Of Comstock Fuels Equity Worth $14M", "summary": "", "symbols": ["LODE", "MPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038543/comstock-enters-into-an-agreement-with-marathon-petroleum-for-the-purchase-of-comstock-fuels-equity", "tags": ["contract"]}
{"id": 44038545, "time": "2025-02-28 06:50:52", "headline": "JP Morgan Downgrades Intellia Therapeutics to Neutral, Lowers Price Target to $13", "summary": "", "symbols": ["NTLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038545/jp-morgan-downgrades-intellia-therapeutics-to-neutral-lowers-price-target-to-13", "tags": ["analyst_down", "price_target_down"]}
{"id": 44038546, "time": "2025-02-28 06:51:44", "headline": "ANI Pharmaceuticals Q4 2024 Adj EPS $1.63 Beats $1.44 Estimate, Sales $190.57M Beat $175.37M Estimate", "summary": "", "symbols": ["ANIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038546/ani-pharmaceuticals-q4-2024-adj-eps-1-63-beats-1-44-estimate-sales-190-57m-beat-175-37m-estimate", "tags": ["earnings"]}
{"id": 44038547, "time": "2025-02-28 06:51:49", "headline": "HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price Target", "summary": "", "symbols": ["IOVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038547/hc-wainwright-co-reiterates-buy-on-iovance-biotherapeutics-maintains-32-price-target", "tags": ["analyst_other"]}
{"id": 44038550, "time": "2025-02-28 06:52:01", "headline": "Erajaya Active Lifestyle Announced Official Launch of XPENG in Indonesia", "summary": "", "symbols": ["XPEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038550/erajaya-active-lifestyle-announced-official-launch-of-xpeng-in-indonesia", "tags": []}
{"id": 44038566, "time": "2025-02-28 06:53:48", "headline": "HC Wainwright & Co. Reiterates Buy on Vericel, Maintains $60 Price Target", "summary": "", "symbols": ["VCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038566/hc-wainwright-co-reiterates-buy-on-vericel-maintains-60-price-target", "tags": ["analyst_other"]}
{"id": 44038585, "time": "2025-02-28 06:55:47", "headline": "HC Wainwright & Co. Reiterates Buy on Personalis, Maintains $8 Price Target", "summary": "", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038585/hc-wainwright-co-reiterates-buy-on-personalis-maintains-8-price-target", "tags": ["analyst_other"]}
{"id": 44038586, "time": "2025-02-28 06:56:42", "headline": "MPLX Signs Definitive Deal With Affiliates Of WhiteWater And Diamondback Energy To Acquire Remaining 55% Interest In BANGL, LLC For $715M", "summary": "", "symbols": ["MPLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44038586/mplx-signs-definitive-deal-with-affiliates-of-whitewater-and-diamondback-energy-to-acquire-remaining", "tags": ["merger", "contract"]}
{"id": 44038587, "time": "2025-02-28 06:56:44", "headline": "Natural Resources Q4 2024 GAAP EPS $3.15 Down From $4.31 YoY, Sales $65.73M Down From $93.16M YoY", "summary": "", "symbols": ["NRP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038587/natural-resources-q4-2024-gaap-eps-3-15-down-from-4-31-yoy-sales-65-73m-down-from-93-16m-yoy", "tags": ["earnings"]}
{"id": 44038588, "time": "2025-02-28 06:57:02", "headline": "Barclays Downgrades WPP to Equal-Weight", "summary": "", "symbols": ["WPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038588/barclays-downgrades-wpp-to-equal-weight", "tags": ["analyst_down"]}
{"id": 44038590, "time": "2025-02-28 06:57:38", "headline": "Needham Reiterates Buy on Outbrain, Maintains $9 Price Target", "summary": "", "symbols": ["OB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038590/needham-reiterates-buy-on-outbrain-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 44038591, "time": "2025-02-28 06:58:27", "headline": "ANI Pharmaceuticals Expects 2025 Revenues Of $756M-$776M Versus Prior Guidance Of $739M-$759M And Consensus Of $724.71M, With Adjusted EBITDA Of $190M-$200M Compared To Prior Guidance Of $182M-$192M", "summary": "", "symbols": ["ANIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038591/ani-pharmaceuticals-expects-2025-revenues-of-756m-776m-versus-prior-guidance-of-739m-759m-and-conse", "tags": ["guidance"]}
{"id": 44038593, "time": "2025-02-28 06:59:16", "headline": "ANI Pharmaceuticals Expects 2025 Adjusted EPS Of $6.12-$6.49 Versus Consensus Of $5.56", "summary": "", "symbols": ["ANIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038593/ani-pharmaceuticals-expects-2025-adjusted-eps-of-6-12-6-49-versus-consensus-of-5-56", "tags": ["earnings"]}
{"id": 44038642, "time": "2025-02-28 07:00:14", "headline": "Demystifying Adtran Holdings: Insights From 5 Analyst Reviews", "summary": " ", "symbols": ["ADTN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44038642/demystifying-adtran-holdings-insights-from-5-analyst-reviews", "tags": []}
{"id": 44038644, "time": "2025-02-28 07:00:23", "headline": "Assessing Cars.com: Insights From 4 Financial Analysts", "summary": " ", "symbols": ["CARS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44038644/assessing-cars-com-insights-from-4-financial-analysts", "tags": []}
{"id": 44038648, "time": "2025-02-28 07:00:30", "headline": "A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts", "summary": " ", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44038648/a-glimpse-into-the-expert-outlook-on-personalis-through-7-analysts", "tags": ["guidance"]}
{"id": 44038654, "time": "2025-02-28 07:00:48", "headline": "What Analysts Are Saying About Intellia Therapeutics Stock", "summary": " ", "symbols": ["NTLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44038654/what-analysts-are-saying-about-intellia-therapeutics-stock", "tags": []}
{"id": 44038660, "time": "2025-02-28 07:00:57", "headline": "Expert Outlook: Dentsply Sirona Through The Eyes Of 9 Analysts", "summary": " ", "symbols": ["XRAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44038660/expert-outlook-dentsply-sirona-through-the-eyes-of-9-analysts", "tags": ["guidance"]}
{"id": 44038665, "time": "2025-02-28 07:01:07", "headline": "Forecasting The Future: 6 Analyst Projections For Celldex Therapeutics", "summary": " ", "symbols": ["CLDX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44038665/forecasting-the-future-6-analyst-projections-for-celldex-therapeutics", "tags": []}
{"id": 44038672, "time": "2025-02-28 07:01:11", "headline": "Citigroup Upgrades Bath & Body Works to Buy, Raises Price Target to $48", "summary": "", "symbols": ["BBWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038672/citigroup-upgrades-bath-body-works-to-buy-raises-price-target-to-48", "tags": ["analyst_up", "price_target_up"]}
{"id": 44038677, "time": "2025-02-28 07:01:25", "headline": "1stdibs.com Q4 2024 GAAP EPS $(0.14) Beats $(0.17) Estimate, Sales $22.770M Beat $21.523M Estimate", "summary": "", "symbols": ["DIBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038677/1stdibs-com-q4-2024-gaap-eps-0-14-beats-0-17-estimate-sales-22-770m-beat-21-523m-estimate", "tags": ["earnings"]}
{"id": 44038680, "time": "2025-02-28 07:01:32", "headline": "Polestar Secures 12-Month Term Facility Of Up To $450M And Renews \u20ac480M Green Trade Finance Facility", "summary": "", "symbols": ["PSNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038680/polestar-secures-12-month-term-facility-of-up-to-450m-and-renews-480m-green-trade-finance-facility", "tags": []}
{"id": 44038681, "time": "2025-02-28 07:01:42", "headline": "Plug Power Reveals Adoption Of Executive Compensation Program That Enables Eligible Executives To Receive Up To 75% Of Compensation In  Form Of Stock", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038681/plug-power-reveals-adoption-of-executive-compensation-program-that-enables-eligible-executives-to-re", "tags": []}
{"id": 44038688, "time": "2025-02-28 07:01:52", "headline": "Fulgent Genetics Q4 Adj $0.04 Beats $(0.12) Estimate, Sales $76.21M Beat $75.39M Estimate", "summary": "", "symbols": ["FLGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038688/fulgent-genetics-q4-adj-0-04-beats-0-12-estimate-sales-76-21m-beat-75-39m-estimate", "tags": []}
{"id": 44038707, "time": "2025-02-28 07:02:14", "headline": "1stdibs.com Sees Q1 Sales $21.700M-$22.800M vs $23.28M Est", "summary": "", "symbols": ["DIBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038707/1stdibs-com-sees-q1-sales-21-700m-22-800m-vs-23-28m-est", "tags": []}
{"id": 44038741, "time": "2025-02-28 07:03:21", "headline": "Regeneron Says EMA's CHMP Adopted Positive Opinion Recommending Conditional Marketing Authorization Of Linvoseltamab In Relapsed/Refractory Multiple Myeloma", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038741/regeneron-says-emas-chmp-adopted-positive-opinion-recommending-conditional-marketing-authorization-o", "tags": []}
{"id": 44038749, "time": "2025-02-28 07:03:49", "headline": "Regeneron Says EMA CHMP Adopted Positive Opinion Recommending Conditional Marketing Authorization Of Linvoseltamab To Treat Adults With Relapsed And Refractory Multiple Myeloma", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038749/regeneron-says-ema-chmp-adopted-positive-opinion-recommending-conditional-marketing-authorization-of", "tags": []}
{"id": 44038750, "time": "2025-02-28 07:03:50", "headline": "Calumet Streamlines Specialties Business With $110M Sale Of Royal Purple Industrial Line, Retains Texas Production Facility", "summary": "", "symbols": ["CLMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44038750/calumet-streamlines-specialties-business-with-110m-sale-of-royal-purple-industrial-line-retains-texa", "tags": []}
{"id": 44038755, "time": "2025-02-28 07:04:06", "headline": "Fulgent Genetics Sees FY25 Revenue Of $310M Vs. $324.21M Est; Adj EPS Of ($0.65) Vs. ($0.46) Est.", "summary": "", "symbols": ["FLGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038755/fulgent-genetics-sees-fy25-revenue-of-310m-vs-324-21m-est-adj-eps-of-0-65-vs-0-46-est", "tags": ["earnings"]}
{"id": 44038756, "time": "2025-02-28 07:04:11", "headline": "Needham Reiterates Hold on Warner Bros. Discoveryto Hold", "summary": "", "symbols": ["WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038756/needham-reiterates-hold-on-warner-bros-discoveryto-hold", "tags": ["analyst_other"]}
{"id": 44038759, "time": "2025-02-28 07:04:19", "headline": "William Blair Initiates Coverage On Bioage Labs with Market Perform Rating", "summary": "", "symbols": ["BIOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038759/william-blair-initiates-coverage-on-bioage-labs-with-market-perform-rating", "tags": ["analyst_init"]}
{"id": 44038760, "time": "2025-02-28 07:04:20", "headline": "TeraWulf FY 2024 GAAP EPS $(0.21) Misses $(0.16) Estimate, Sales $140.051M Miss $143.071M Estimate", "summary": "", "symbols": ["WULF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038760/terawulf-fy-2024-gaap-eps-0-21-misses-0-16-estimate-sales-140-051m-miss-143-071m-estimate", "tags": ["earnings"]}
{"id": 44038763, "time": "2025-02-28 07:04:37", "headline": "Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule", "summary": "", "symbols": ["TRAW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/25/02/44038763/traws-pharma-regains-compliance-with-nasdaq-equity-listing-rule", "tags": []}
{"id": 44038794, "time": "2025-02-28 07:05:07", "headline": "Achilles Therapeutics Announces Voluntary Nasdaq Delisting And SEC Deregistration", "summary": "", "symbols": ["ACHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/sec/25/02/44038794/achilles-therapeutics-announces-voluntary-nasdaq-delisting-and-sec-deregistration", "tags": []}
{"id": 44038797, "time": "2025-02-28 07:05:26", "headline": "Siyata Mobile Provides Additional Details Related To Key Term Of Its Definitive Merger Agreement With Core Gaming", "summary": "", "symbols": ["SYTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038797/siyata-mobile-provides-additional-details-related-to-key-term-of-its-definitive-merger-agreement-wit", "tags": ["merger", "contract"]}
{"id": 44038800, "time": "2025-02-28 07:06:06", "headline": "BioXcel Therapeutics Regains Nasdaq Listing Compliance, Overcomes Bid Price Challenge", "summary": "", "symbols": ["BTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038800/bioxcel-therapeutics-regains-nasdaq-listing-compliance-overcomes-bid-price-challenge", "tags": []}
{"id": 44038801, "time": "2025-02-28 07:06:07", "headline": "TeraWulf Board Approved $200M Share Buyback Plan", "summary": "", "symbols": ["WULF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038801/terawulf-board-approved-200m-share-buyback-plan", "tags": ["buyback"]}
{"id": 44038802, "time": "2025-02-28 07:06:20", "headline": "NewGen Regains Compliance With Nasdaq Minimum Bid Price Requirement, Announces Listing Transfer To Nasdaq Capital Market", "summary": "", "symbols": ["NIVF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/25/02/44038802/newgen-regains-compliance-with-nasdaq-minimum-bid-price-requirement-announces-listing-transfer-to-na", "tags": []}
{"id": 44038804, "time": "2025-02-28 07:06:20", "headline": "William Blair Initiates Coverage On Structure Therapeutics with Outperform Rating", "summary": "", "symbols": ["GPCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038804/william-blair-initiates-coverage-on-structure-therapeutics-with-outperform-rating", "tags": ["analyst_init"]}
{"id": 44038808, "time": "2025-02-28 07:06:39", "headline": "HC Wainwright & Co. Maintains Buy on argenx, Raises Price Target to $720", "summary": "", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038808/hc-wainwright-co-maintains-buy-on-argenx-raises-price-target-to-720", "tags": ["analyst_other", "price_target_up"]}
{"id": 44038841, "time": "2025-02-28 07:08:51", "headline": "Needham Maintains Buy on Personalis, Lowers Price Target to $7", "summary": "", "symbols": ["PSNL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038841/needham-maintains-buy-on-personalis-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 44038842, "time": "2025-02-28 07:08:56", "headline": "Calumet Specialty Prods Q4 2024 GAAP EPS $(0.47) Beats $(0.73) Estimate, Sales $949.50M Beat $921.76M Estimate", "summary": "", "symbols": ["CLMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038842/calumet-specialty-prods-q4-2024-gaap-eps-0-47-beats-0-73-estimate-sales-949-50m-beat-921-76m-estima", "tags": ["earnings"]}
{"id": 44038843, "time": "2025-02-28 07:08:59", "headline": "William Blair Initiates Coverage On Terns Pharma with Market Perform Rating", "summary": "", "symbols": ["TERN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038843/william-blair-initiates-coverage-on-terns-pharma-with-market-perform-rating", "tags": ["analyst_init"]}
{"id": 44038850, "time": "2025-02-28 07:10:07", "headline": "Apellis Pharmaceuticals Q4 2024 GAAP EPS $(0.29) Beats $(0.37) Estimate, Sales $212.53M Beat $198.35M Estimate", "summary": "", "symbols": ["APLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44038850/apellis-pharmaceuticals-q4-2024-gaap-eps-0-29-beats-0-37-estimate-sales-212-53m-beat-198-35m-estima", "tags": ["earnings"]}
{"id": 44038852, "time": "2025-02-28 07:10:53", "headline": "Best Buy Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["BBY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/02/44038852/best-buy-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 44038861, "time": "2025-02-28 07:11:19", "headline": "PAR Technology Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["PAR"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/02/44038861/par-technology-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 44038873, "time": "2025-02-28 07:11:57", "headline": "HC Wainwright & Co. Maintains Buy on Pacira BioSciences, Raises Price Target to $70", "summary": "", "symbols": ["PCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038873/hc-wainwright-co-maintains-buy-on-pacira-biosciences-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 44038874, "time": "2025-02-28 07:12:11", "headline": "Nvidia Wipes $375 Billion Of Investor Wealth In 2025: 'Margin Of Error Razor Thin,' Says Analyst Reiterating 'Buy On Dips' Call", "summary": "While some analysts say Nvidia&#39;s fall could be because of the outlook on &#34;gross margins,&#34; others believe that these concerns are &#34;misplaced&#34;.", "symbols": ["NVDA", "QQQ"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/news/earnings/25/02/44038874/nvidia-wipes-375-billion-of-investor-wealth-in-2025-margin-of-error-razor-thin-says-analyst-reiterating-buy-on-dips-call", "tags": ["guidance"]}
{"id": 44038875, "time": "2025-02-28 07:12:18", "headline": "Apellis Pharmaceuticals' Cash And Cash Equivalents Of $411.3M As Of December 31, 2024; Projected Revenues And Cash Expected To Be Sufficient To Fund Operations To Profitability", "summary": "", "symbols": ["APLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44038875/apellis-pharmaceuticals-cash-and-cash-equivalents-of-411-3m-as-of-december-31-2024-projected-reve", "tags": []}
{"id": 44038909, "time": "2025-02-28 07:14:04", "headline": "LiveOne Says It Surpassed A Milestone Of Over 1M Subscribers, Including Tesla", "summary": "", "symbols": ["LVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038909/liveone-says-it-surpassed-a-milestone-of-over-1m-subscribers-including-tesla", "tags": []}
{"id": 44038912, "time": "2025-02-28 07:14:30", "headline": "William Blair Initiates Coverage On Altimmune with Market Perform Rating", "summary": "", "symbols": ["ALT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44038912/william-blair-initiates-coverage-on-altimmune-with-market-perform-rating", "tags": ["analyst_init"]}
{"id": 44039090, "time": "2025-02-28 07:16:11", "headline": "HC Wainwright & Co. Reiterates Buy on Opthea, Maintains $12 Price Target", "summary": "", "symbols": ["OPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039090/hc-wainwright-co-reiterates-buy-on-opthea-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 44039213, "time": "2025-02-28 07:17:10", "headline": "William Blair Initiates Coverage On Skye Bioscience with Outperform Rating", "summary": "", "symbols": ["SKYE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039213/william-blair-initiates-coverage-on-skye-bioscience-with-outperform-rating", "tags": ["analyst_init"]}
{"id": 44039244, "time": "2025-02-28 07:18:01", "headline": "Needham Maintains Buy on PENN Entertainment, Lowers Price Target to $25", "summary": "", "symbols": ["PENN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039244/needham-maintains-buy-on-penn-entertainment-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 44039281, "time": "2025-02-28 07:18:51", "headline": "Perrigo Co Expects FY25 Sales Growth Of 1%-3% Vs $4.79B Est, Adj EPS Of $2.90-$3.10 Vs $3.36 Est", "summary": "", "symbols": ["PRGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039281/perrigo-co-expects-fy25-sales-growth-of-1-3-vs-4-79b-est-adj-eps-of-2-90-3-10-vs-3-36-est", "tags": ["earnings"]}
{"id": 44039282, "time": "2025-02-28 07:18:53", "headline": "Market-Moving News for February 28th", "summary": "", "symbols": ["DV", "ESTC", "RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/25/02/44039282/market-moving-news-for-february-28th", "tags": []}
{"id": 44039319, "time": "2025-02-28 07:19:29", "headline": "Trading Halt: Halted at 7:19:25 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["HLXB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44039319/trading-halt-halted-at-7-19-25-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44039321, "time": "2025-02-28 07:19:47", "headline": "Fading Nvidia For The Win (Again)", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "David Pinsen", "url": "https://www.benzinga.com/markets/equities/25/02/44039321/fading-nvidia-for-the-win-again", "tags": []}
{"id": 44039325, "time": "2025-02-28 07:19:56", "headline": "SINOVAC Says Determined To Maintain Transparency And Uphold High Standards Of Corporate Governance Under Leadership Of New Board", "summary": "", "symbols": ["SVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039325/sinovac-says-determined-to-maintain-transparency-and-uphold-high-standards-of-corporate-governance-u", "tags": []}
{"id": 44039326, "time": "2025-02-28 07:19:59", "headline": "Needham Maintains Buy on Merus, Lowers Price Target to $83", "summary": "", "symbols": ["MRUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039326/needham-maintains-buy-on-merus-lowers-price-target-to-83", "tags": ["analyst_other", "price_target_down"]}
{"id": 44039337, "time": "2025-02-28 07:20:19", "headline": "Perrigo Co Projected FY25-FY27 Organic Net Sales CAGR Of 2.5%-4.5%, Adj EPS CAGR Of High-Single To Low-Double Digit Percentage", "summary": "", "symbols": ["PRGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039337/perrigo-co-projected-fy25-fy27-organic-net-sales-cagr-of-2-5-4-5-adj-eps-cagr-of-high-single-to-low", "tags": ["earnings"]}
{"id": 44039381, "time": "2025-02-28 07:22:04", "headline": "Tuya Smart Integrates DeepSeek Large Language Model Into Its AIoT Platform", "summary": "", "symbols": ["TUYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039381/tuya-smart-integrates-deepseek-large-language-model-into-its-aiot-platform", "tags": []}
{"id": 44039386, "time": "2025-02-28 07:23:22", "headline": "William Blair Initiates Coverage On Corbus Pharmaceuticals with Outperform Rating", "summary": "", "symbols": ["CRBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039386/william-blair-initiates-coverage-on-corbus-pharmaceuticals-with-outperform-rating", "tags": ["analyst_init"]}
{"id": 44039391, "time": "2025-02-28 07:24:25", "headline": "HC Wainwright & Co. Maintains Buy on Verona Pharma, Raises Price Target to $75", "summary": "", "symbols": ["VRNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039391/hc-wainwright-co-maintains-buy-on-verona-pharma-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 44039414, "time": "2025-02-28 07:25:22", "headline": "Microsoft Regarding UK's Probe Into Cloud Computing Market Says CMA Fundamentally Misjudges AI Technology Driving Competitive Dynamic In Cloud Computing", "summary": "", "symbols": ["EWU", "MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039414/microsoft-regarding-uks-probe-into-cloud-computing-market-says-cma-fundamentally-misjudges-ai-techno", "tags": []}
{"id": 44039416, "time": "2025-02-28 07:26:08", "headline": "Needham Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $42", "summary": "", "symbols": ["RCKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039416/needham-maintains-buy-on-rocket-pharmaceuticals-lowers-price-target-to-42", "tags": ["analyst_other", "price_target_down"]}
{"id": 44039417, "time": "2025-02-28 07:26:29", "headline": "Bladex Plans To Continue Executing Its Strategic Plan; Increases Dividend By 25% From $0.50 To $0.625 Per Share", "summary": "", "symbols": ["BLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039417/bladex-plans-to-continue-executing-its-strategic-plan-increases-dividend-by-25-from-0-50-to-0-625-pe", "tags": ["dividend"]}
{"id": 44039429, "time": "2025-02-28 07:28:31", "headline": "HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Raises Price Target to $17", "summary": "", "symbols": ["CRDF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039429/hc-wainwright-co-maintains-buy-on-cardiff-oncology-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 44039431, "time": "2025-02-28 07:29:47", "headline": "Bitcoin Plummets Below $80,000, Ethereum, XRP, Dogecoin Get Hammered As Crypto Crash Continues", "summary": "Bitcoin (CRYPTO: BTC) continues to tumble, falling as low as $78,433 in early Friday morning hours amid a record streak of spot Bitcoin ETF outflows.", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "IBIT", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44039431/bitcoin-plummets-below-80000-ethereum-xrp-dogecoin-get-hammered-as-crypto-crash-continues", "tags": []}
{"id": 44039456, "time": "2025-02-28 07:30:16", "headline": "HC Wainwright & Co. Maintains Buy on Verve Therapeutics, Raises Price Target to $15", "summary": "", "symbols": ["VERV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039456/hc-wainwright-co-maintains-buy-on-verve-therapeutics-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 44039528, "time": "2025-02-28 07:31:29", "headline": "Piper Sandler Maintains Overweight on Duolingo, Raises Price Target to $390", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039528/piper-sandler-maintains-overweight-on-duolingo-raises-price-target-to-390", "tags": ["analyst_other", "price_target_up"]}
{"id": 44039530, "time": "2025-02-28 07:31:36", "headline": "Integral Ad Science Q4 2024 GAAP EPS $0.09 Misses $0.10 Estimate, Sales $153.04M Beat $148.82M Estimate", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44039530/integral-ad-science-q4-2024-gaap-eps-0-09-misses-0-10-estimate-sales-153-04m-beat-148-82m-estimate", "tags": ["earnings"]}
{"id": 44039532, "time": "2025-02-28 07:31:52", "headline": "FuboTV Q4 Sales $443.277M Miss $445.798M Estimate", "summary": "", "symbols": ["FUBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44039532/fubotv-q4-sales-443-277m-miss-445-798m-estimate", "tags": []}
{"id": 44039534, "time": "2025-02-28 07:32:38", "headline": "AGM Group Holdings Announces Partnership Agreement With HashBeaver; Companies Agree To Harvest AGM's Mining Resources In Canada To Support Bitcoin Mining Initiatives", "summary": "", "symbols": ["AGMH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44039534/agm-group-holdings-announces-partnership-agreement-with-hashbeaver-companies-agree-to-harv", "tags": ["contract"]}
{"id": 44039535, "time": "2025-02-28 07:32:47", "headline": "Chardan Capital Maintains Buy on Avidity Biosciences, Maintains $65 Price Target", "summary": "", "symbols": ["RNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039535/chardan-capital-maintains-buy-on-avidity-biosciences-maintains-65-price-target", "tags": ["analyst_other"]}
{"id": 44039536, "time": "2025-02-28 07:32:52", "headline": "Piper Sandler Maintains Neutral on AvidXchange Holdings, Lowers Price Target to $8", "summary": "", "symbols": ["AVDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039536/piper-sandler-maintains-neutral-on-avidxchange-holdings-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 44039537, "time": "2025-02-28 07:32:54", "headline": "Alpha Metallurgical Q4 2024 GAAP EPS $(0.16), Inline, Sales $617.35M Miss $658.20M Estimate", "summary": "", "symbols": ["AMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44039537/alpha-metallurgical-q4-2024-gaap-eps-0-16-inline-sales-617-35m-miss-658-20m-estimate", "tags": ["earnings"]}
{"id": 44039538, "time": "2025-02-28 07:32:56", "headline": "Integral Ad Science Expects To Deliver Profitable, Double-digit Revenue Growth In 2025", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039538/integral-ad-science-expects-to-deliver-profitable-double-digit-revenue-growth-in-2025", "tags": ["earnings"]}
{"id": 44039539, "time": "2025-02-28 07:32:57", "headline": "FuboTV Q4 2024 Adj. EPS $(0.02) Beats $(0.18) Estimate", "summary": "", "symbols": ["FUBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44039539/fubotv-q4-2024-adj-eps-0-02-beats-0-18-estimate", "tags": ["earnings"]}
{"id": 44039545, "time": "2025-02-28 07:33:23", "headline": "China's Tiangong Space Station To Host First Non-Chinese Astronaut In Coming Years, Pakistan Selected: Report", "summary": "A Pakistani astronaut will fly to the Chinese space station in the coming years, making them the first foreign national to visit the station.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/general/space/25/02/44039545/chinas-tiangong-space-station-to-host-first-non-chinese-astronaut-in-coming-years-pakistan-selected-report", "tags": []}
{"id": 44039547, "time": "2025-02-28 07:33:35", "headline": "Aehr Completes  Shipment Of Its First FOX-XP Wafer-Level Burn-In System For Advanced AI Processors", "summary": "", "symbols": ["AEHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039547/aehr-completes-shipment-of-its-first-fox-xp-wafer-level-burn-in-system-for-advanced-ai-processors", "tags": []}
{"id": 44039553, "time": "2025-02-28 07:33:39", "headline": "Bowman Secures Multi-Year, $6M Engineering Services Contract To Support Montebello's Infrastructure Growth", "summary": "", "symbols": ["BWMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039553/bowman-secures-multi-year-6m-engineering-services-contract-to-support-montebellos-infrastructure-gro", "tags": ["contract"]}
{"id": 44039556, "time": "2025-02-28 07:34:05", "headline": "Alpha Metallurgical Resources Reported Tons Of Coal Sold In Q4 Of 4.1M", "summary": "", "symbols": ["AMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44039556/alpha-metallurgical-resources-reported-tons-of-coal-sold-in-q4-of-4-1m", "tags": []}
{"id": 44039557, "time": "2025-02-28 07:34:22", "headline": "PAR Technology Q4 Sales $105.00M Beat $99.10M Estimate", "summary": "", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44039557/par-technology-q4-sales-105-00m-beat-99-10m-estimate", "tags": []}
{"id": 44039564, "time": "2025-02-28 07:35:19", "headline": "Mizuho Maintains Outperform on Hilton Grand Vacations, Raises Price Target to $60", "summary": "", "symbols": ["HGV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039564/mizuho-maintains-outperform-on-hilton-grand-vacations-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 44039565, "time": "2025-02-28 07:35:20", "headline": "Integral Ad Science Expects Total Revenue Of $128M - $131M For Q1 (Est $126.847M), $588M - $600M For 2025 (Est $588.409M)", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039565/integral-ad-science-expects-total-revenue-of-128m-131m-for-q1-est-126-847m-588m-600m-for-2025-est-58", "tags": ["earnings"]}
{"id": 44039566, "time": "2025-02-28 07:35:21", "headline": "fuboTV Expects Q1 North America Revenue Of $400M-$410M And ROW Revenue Of $7.5M-$8.5M  Vs $440.24M Est", "summary": "", "symbols": ["FUBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039566/fubotv-expects-q1-north-america-revenue-of-400m-410m-and-row-revenue-of-7-5m-8-5m-vs-440-24m-est", "tags": ["earnings"]}
{"id": 44039570, "time": "2025-02-28 07:35:55", "headline": "Alpha Metallurgical Lowered Guidance For Total Coal Shipment To 14.5M-15.5M Tons From 15.0M-16.0M In FY25", "summary": "", "symbols": ["AMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039570/alpha-metallurgical-lowered-guidance-for-total-coal-shipment-to-14-5m-15-5m-tons-from-15-0m-16-0m-in", "tags": ["guidance"]}
{"id": 44039578, "time": "2025-02-28 07:36:07", "headline": "Barrington Research Maintains Outperform on Standex International, Maintains $220 Price Target", "summary": "", "symbols": ["SXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039578/barrington-research-maintains-outperform-on-standex-international-maintains-220-price-target", "tags": ["analyst_other"]}
{"id": 44039604, "time": "2025-02-28 07:36:48", "headline": "Opthea Half-Year Adjusted Non-IFRS Net Income $(69.8)M, Up From $(84.3)M YoY", "summary": "", "symbols": ["OPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44039604/opthea-half-year-adjusted-non-ifrs-net-income-69-8-m-up-from-84-3-m-yoy", "tags": []}
{"id": 44039630, "time": "2025-02-28 07:37:38", "headline": "Alpha Metallurgical Revised FY25 Coal Sales Guidance To $103.00-$110.00 Per Ton From $103.00 to $108.00 Per Ton", "summary": "", "symbols": ["AMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039630/alpha-metallurgical-revised-fy25-coal-sales-guidance-to-103-00-110-00-per-ton-from-103-00-to-108-00", "tags": ["guidance"]}
{"id": 44039642, "time": "2025-02-28 07:38:51", "headline": "HC Wainwright & Co. Maintains Buy on Denali Therapeutics, Raises Price Target to $87", "summary": "", "symbols": ["DNLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039642/hc-wainwright-co-maintains-buy-on-denali-therapeutics-raises-price-target-to-87", "tags": ["analyst_other", "price_target_up"]}
{"id": 44039645, "time": "2025-02-28 07:39:28", "headline": "Mizuho Maintains Outperform on Marriott Vacations, Lowers Price Target to $112", "summary": "", "symbols": ["VAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039645/mizuho-maintains-outperform-on-marriott-vacations-lowers-price-target-to-112", "tags": ["analyst_other", "price_target_down"]}
{"id": 44039656, "time": "2025-02-28 07:40:24", "headline": "Lanvin Group FY24 Revenue Decline 23% YoY; Says Remains Committed To Its Long-term Vision In 2025, Despite Challenging Macroeconomic Environment", "summary": "", "symbols": ["LANV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44039656/lanvin-group-fy24-revenue-decline-23-yoy-says-remains-committed-to-its-long-term-vision-in-2025-des", "tags": ["earnings"]}
{"id": 44039670, "time": "2025-02-28 07:41:24", "headline": "Baird Downgrades Alamo Group to Neutral, Lowers Price Target to $177", "summary": "", "symbols": ["ALG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039670/baird-downgrades-alamo-group-to-neutral-lowers-price-target-to-177", "tags": ["analyst_down", "price_target_down"]}
{"id": 44039671, "time": "2025-02-28 07:41:32", "headline": "Krystal Biotech Secures Positive CHMP Opinion For VYJUVEK For Treatment Of Dystrophic Epidermolysis Bullosa", "summary": "", "symbols": ["KRYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039671/krystal-biotech-secures-positive-chmp-opinion-for-vyjuvek-for-treatment-of-dystrophic-epidermolysis", "tags": []}
{"id": 44039676, "time": "2025-02-28 07:42:14", "headline": "Olin Intends To Offer $600M Of Senior Notes Due 2033", "summary": "", "symbols": ["OLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039676/olin-intends-to-offer-600m-of-senior-notes-due-2033", "tags": []}
{"id": 44039678, "time": "2025-02-28 07:42:32", "headline": "Baird Downgrades Playtika Holding to Neutral, Lowers Price Target to $6", "summary": "", "symbols": ["PLTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039678/baird-downgrades-playtika-holding-to-neutral-lowers-price-target-to-6", "tags": ["analyst_down", "price_target_down"]}
{"id": 44039693, "time": "2025-02-28 07:43:19", "headline": "HC Wainwright & Co. Maintains Buy on Kymera Therapeutics, Raises Price Target to $60", "summary": "", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039693/hc-wainwright-co-maintains-buy-on-kymera-therapeutics-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 44039701, "time": "2025-02-28 07:43:46", "headline": "Arcos Dorados Announces Intent To Redeem All Of Its Outstanding 5.875% Senior Notes Due 2027", "summary": "", "symbols": ["ARCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039701/arcos-dorados-announces-intent-to-redeem-all-of-its-outstanding-5-875-senior-notes-due-2027", "tags": []}
{"id": 44039704, "time": "2025-02-28 07:43:51", "headline": "Barrington Research Downgrades LeMaitre Vascular to Market Perform", "summary": "", "symbols": ["LMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039704/barrington-research-downgrades-lemaitre-vascular-to-market-perform", "tags": ["analyst_down"]}
{"id": 44039705, "time": "2025-02-28 07:44:08", "headline": "B of A Securities Downgrades Logitech International to Underperform, Lowers Price Target to $90", "summary": "", "symbols": ["LOGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039705/b-of-a-securities-downgrades-logitech-international-to-underperform-lowers-price-target-to-90", "tags": ["analyst_down", "price_target_down"]}
{"id": 44039738, "time": "2025-02-28 07:45:22", "headline": "HC Wainwright & Co. Maintains Buy on Dyne Therapeutics, Lowers Price Target to $46", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039738/hc-wainwright-co-maintains-buy-on-dyne-therapeutics-lowers-price-target-to-46", "tags": ["analyst_other", "price_target_down"]}
{"id": 44039856, "time": "2025-02-28 07:46:37", "headline": "Nvidia Stock Is A 'Buy On The Pullback, Says Top Analyst, Considers Earnings As 'Great But Not Extraordinary'", "summary": "Deepwater&#39;s\u00a0Gene Munster, shared his views on Nvidia Corporation\u00a0(NASDAQ: NVDA) recent performance, suggesting it was solid but fell short of extraordinary expectations. However, he remains upbeat on the stock.", "symbols": ["NVDA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/02/44039856/nvidia-stock-is-a-buy-on-the-pullback-says-top-analyst-considers-earnings-as-great-but-not-extraordinary", "tags": ["earnings"]}
{"id": 44039966, "time": "2025-02-28 07:46:56", "headline": "Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $98", "summary": "", "symbols": ["USPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039966/barrington-research-maintains-outperform-on-us-physical-therapy-lowers-price-target-to-98", "tags": ["analyst_other", "price_target_down"]}
{"id": 44039970, "time": "2025-02-28 07:46:58", "headline": "B of A Securities Maintains Underperform on Viatris, Lowers Price Target to $10", "summary": "", "symbols": ["VTRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039970/b-of-a-securities-maintains-underperform-on-viatris-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 44039977, "time": "2025-02-28 07:47:08", "headline": "Juniper Networks, IBM Plan To Expand Collaboration Around Joint Sales, Marketing And Product Integration Efforts", "summary": "", "symbols": ["IBM", "JNPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039977/juniper-networks-ibm-plan-to-expand-collaboration-around-joint-sales-marketing-and-product-integrati", "tags": []}
{"id": 44039990, "time": "2025-02-28 07:48:06", "headline": "B of A Securities Maintains Buy on Acadia Healthcare Co, Lowers Price Target to $44.5", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44039990/b-of-a-securities-maintains-buy-on-acadia-healthcare-co-lowers-price-target-to-44-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44040003, "time": "2025-02-28 07:49:27", "headline": "Alibaba Expands AI Intern Workforce While DeepSeek Slashes Model Prices in Market Battle", "summary": "Alibaba Group offers 3,000 internships, over half in AI. Plans to invest $52.2B in AI and cloud computing. Stock down 4.61%.", "symbols": ["BABA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/25/02/44040003/alibaba-expands-ai-workforce-while-deepseek-slashes-model-prices-in-market-battle", "tags": []}
{"id": 44040011, "time": "2025-02-28 07:49:47", "headline": "Craig-Hallum Initiates Coverage On MediWound with Buy Rating, Announces Price Target of $39", "summary": "", "symbols": ["MDWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040011/craig-hallum-initiates-coverage-on-mediwound-with-buy-rating-announces-price-target-of-39", "tags": ["analyst_init"]}
{"id": 44040029, "time": "2025-02-28 07:51:04", "headline": "Deutsche Bank Initiates Coverage On CoStar Group with Buy Rating, Announces Price Target of $89", "summary": "", "symbols": ["CSGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040029/deutsche-bank-initiates-coverage-on-costar-group-with-buy-rating-announces-price-target-of-89", "tags": ["analyst_init"]}
{"id": 44040032, "time": "2025-02-28 07:51:35", "headline": "HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $72", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040032/hc-wainwright-co-maintains-buy-on-mirum-pharmaceuticals-raises-price-target-to-72", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040034, "time": "2025-02-28 07:51:44", "headline": "Barrington Research Maintains Outperform on Carriage Servs, Maintains $50 Price Target", "summary": "", "symbols": ["CSV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040034/barrington-research-maintains-outperform-on-carriage-servs-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 44040037, "time": "2025-02-28 07:52:56", "headline": "BridgeBio Oncology Therapeutics, Helix Acquisition Corp. II Enter Business Combination Agreement", "summary": "", "symbols": ["HLXB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44040037/bridgebio-oncology-therapeutics-helix-acquisition-corp-ii-enter-business-combination-agreement", "tags": ["contract"]}
{"id": 44040038, "time": "2025-02-28 07:53:02", "headline": "Generic Drugmaker Amneal Clocks Mixed Q4 Earnings, Plans Expansion In High-Growth Areas Like Weight Loss Products, Biosimilars", "summary": "Amneal Pharmaceuticals&#39; Q4 sales rose 18% to $730.52M, surpassing estimates, while adjusted EPS missed. The company forecasts up to $3.1B in 2025 revenue.", "symbols": ["AMRX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/25/02/44040038/generic-drugmaker-amneal-clocks-mixed-q4-earnings-plans-expansion-in-high-growth-areas-like-weight-loss-products-biosimilars", "tags": ["earnings"]}
{"id": 44040050, "time": "2025-02-28 07:53:57", "headline": "Needham Maintains Buy on Archer Aviation, Raises Price Target to $13", "summary": "", "symbols": ["ACHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040050/needham-maintains-buy-on-archer-aviation-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040051, "time": "2025-02-28 07:54:06", "headline": "Deutsche Bank Maintains Buy on Monster Beverage, Raises Price Target to $61", "summary": "", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040051/deutsche-bank-maintains-buy-on-monster-beverage-raises-price-target-to-61", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040074, "time": "2025-02-28 07:55:04", "headline": "Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["PRAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44040074/trading-halt-halted-at-7-55-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44040097, "time": "2025-02-28 07:55:21", "headline": "Rosenblatt Maintains Buy on Autodesk, Raises Price Target to $340", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040097/rosenblatt-maintains-buy-on-autodesk-raises-price-target-to-340", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040100, "time": "2025-02-28 07:55:40", "headline": "Needham Maintains Buy on Duolingo, Raises Price Target to $400", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040100/needham-maintains-buy-on-duolingo-raises-price-target-to-400", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040111, "time": "2025-02-28 07:55:59", "headline": "Deutsche Bank Maintains Buy on Primo Brands, Raises Price Target to $40", "summary": "", "symbols": ["PRMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040111/deutsche-bank-maintains-buy-on-primo-brands-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040127, "time": "2025-02-28 07:57:30", "headline": "Deutsche Bank Downgrades Walgreens Boots Alliance to Sell, Lowers Price Target to $9", "summary": "", "symbols": ["WBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040127/deutsche-bank-downgrades-walgreens-boots-alliance-to-sell-lowers-price-target-to-9", "tags": ["analyst_down", "price_target_down"]}
{"id": 44040163, "time": "2025-02-28 07:58:39", "headline": "Needham Maintains Buy on Pacira BioSciences, Raises Price Target to $32", "summary": "", "symbols": ["PCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040163/needham-maintains-buy-on-pacira-biosciences-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040164, "time": "2025-02-28 07:58:46", "headline": "Erste Group Bank Q4 EPS $0.71 Misses $1.52 Estimate, Sales $2.07B Miss $2.77B Estimate", "summary": "", "symbols": ["EBKDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44040164/erste-group-bank-q4-eps-0-71-misses-1-52-estimate-sales-2-07b-miss-2-77b-estimate", "tags": ["earnings"]}
{"id": 44040167, "time": "2025-02-28 07:59:07", "headline": "Nayax Reveals Acquisition Of UPPay For Purchase Price Equating To An Enterprise Value Of $5.3M", "summary": "", "symbols": ["NYAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44040167/nayax-reveals-acquisition-of-uppay-for-purchase-price-equating-to-an-enterprise-value-of-5-3m", "tags": []}
{"id": 44040243, "time": "2025-02-28 08:00:21", "headline": "Beyond The Numbers: 6 Analysts Discuss Acadia Healthcare Co Stock", "summary": " ", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44040243/beyond-the-numbers-6-analysts-discuss-acadia-healthcare-co-stock", "tags": []}
{"id": 44040250, "time": "2025-02-28 08:00:40", "headline": "Needham Maintains Buy on DocGo, Lowers Price Target to $4", "summary": "", "symbols": ["DCGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040250/needham-maintains-buy-on-docgo-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 44040251, "time": "2025-02-28 08:00:45", "headline": "Breaking Down Walgreens Boots Alliance: 7 Analysts Share Their Views", "summary": " ", "symbols": ["WBA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44040251/breaking-down-walgreens-boots-alliance-7-analysts-share-their-views", "tags": []}
{"id": 44040260, "time": "2025-02-28 08:00:56", "headline": "Avidity Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["RNA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44040260/avidity-biosciences-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 44040262, "time": "2025-02-28 08:00:57", "headline": "How Is The Market Feeling About CRH?", "summary": " ", "symbols": ["CRH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44040262/how-is-the-market-feeling-about-crh", "tags": []}
{"id": 44040292, "time": "2025-02-28 08:01:03", "headline": "Peering Into Affirm Holdings's Recent Short Interest", "summary": " ", "symbols": ["AFRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44040292/peering-into-affirm-holdingss-recent-short-interest", "tags": []}
{"id": 44040294, "time": "2025-02-28 08:01:09", "headline": "Is Rocket Lab USA Gaining or Losing Market Support?", "summary": " ", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44040294/is-rocket-lab-usa-gaining-or-losing-market-support", "tags": []}
{"id": 44040295, "time": "2025-02-28 08:01:09", "headline": "Goldman Sachs Maintains Buy on Armstrong World Indus, Raises Price Target to $180", "summary": "", "symbols": ["AWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040295/goldman-sachs-maintains-buy-on-armstrong-world-indus-raises-price-target-to-180", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040296, "time": "2025-02-28 08:01:10", "headline": "What Analysts Are Saying About US Physical Therapy Stock", "summary": " ", "symbols": ["USPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44040296/what-analysts-are-saying-about-us-physical-therapy-stock", "tags": []}
{"id": 44040314, "time": "2025-02-28 08:01:18", "headline": "Nano Labs Receives $4.9M Equivalent In Bitcoin And USDT From Previously Announced Private Placement", "summary": "", "symbols": ["NA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44040314/nano-labs-receives-4-9m-equivalent-in-bitcoin-and-usdt-from-previously-announced-private-p", "tags": ["offering"]}
{"id": 44040321, "time": "2025-02-28 08:01:29", "headline": "Where Vericel Stands With Analysts", "summary": " ", "symbols": ["VCEL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44040321/where-vericel-stands-with-analysts", "tags": []}
{"id": 44040325, "time": "2025-02-28 08:01:42", "headline": "Demystifying Kymera Therapeutics: Insights From 6 Analyst Reviews", "summary": " ", "symbols": ["KYMR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44040325/demystifying-kymera-therapeutics-insights-from-6-analyst-reviews", "tags": []}
{"id": 44040335, "time": "2025-02-28 08:02:04", "headline": "Global Partners Q4 2024 GAAP EPS $0.52 Beats $0.24 Estimate, Sales $4.19B Miss $5.80B Estimate", "summary": "", "symbols": ["GLP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44040335/global-partners-q4-2024-gaap-eps-0-52-beats-0-24-estimate-sales-4-19b-miss-5-80b-estimate", "tags": ["earnings"]}
{"id": 44040369, "time": "2025-02-28 08:02:53", "headline": "Fluent Q4 Adj $(0.18) Beats $(0.27) Estimate, Sales $65.41M Miss $68.06M Estimate", "summary": "", "symbols": ["FLNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44040369/fluent-q4-adj-0-18-beats-0-27-estimate-sales-65-41m-miss-68-06m-estimate", "tags": []}
{"id": 44040373, "time": "2025-02-28 08:03:03", "headline": "AMD Launches AMD Radeon RX 9070 XT And RX 9070 Graphics Cards", "summary": "", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040373/amd-launches-amd-radeon-rx-9070-xt-and-rx-9070-graphics-cards", "tags": []}
{"id": 44040396, "time": "2025-02-28 08:03:15", "headline": "Goldman Sachs Downgrades Bentley Systems to Sell, Lowers Price Target to $42", "summary": "", "symbols": ["BSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040396/goldman-sachs-downgrades-bentley-systems-to-sell-lowers-price-target-to-42", "tags": ["analyst_down", "price_target_down"]}
{"id": 44040405, "time": "2025-02-28 08:03:50", "headline": "Green Dot Corporation And Marqeta Enteres Into New Relationship Enabling Marqeta To Provide Customers With Convenient And Affordable Cash Services, Enables Convenient Access To Deposit Cash To Bank Accounts At More Than 95,000 Locations Nationwide.", "summary": "", "symbols": ["GDOT", "MQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040405/green-dot-corporation-and-marqeta-enteres-into-new-relationship-enabling-marqeta-to-provide-customer", "tags": []}
{"id": 44040412, "time": "2025-02-28 08:04:02", "headline": "Jasper Therapeutics To Present At American Academy of Dermatology Annual Meeting Mar. 8", "summary": "", "symbols": ["JSPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44040412/jasper-therapeutics-to-present-at-american-academy-of-dermatology-annual-meeting-mar-8", "tags": []}
{"id": 44040421, "time": "2025-02-28 08:04:22", "headline": "Rosenblatt Maintains Buy on Elastic, Raises Price Target to $140", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040421/rosenblatt-maintains-buy-on-elastic-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040425, "time": "2025-02-28 08:04:31", "headline": "Twin Vee PowerCats Launches BoatsForSale.com", "summary": "", "symbols": ["VEEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040425/twin-vee-powercats-launches-boatsforsale-com", "tags": []}
{"id": 44040426, "time": "2025-02-28 08:04:36", "headline": "Goldman Sachs Initiates Coverage On Summit Therapeutics with Buy Rating, Announces Price Target of $42", "summary": "", "symbols": ["SMMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040426/goldman-sachs-initiates-coverage-on-summit-therapeutics-with-buy-rating-announces-price-target-of-42", "tags": ["analyst_init"]}
{"id": 44040465, "time": "2025-02-28 08:05:53", "headline": "Prime Medicine FY 2024 GAAP EPS $(1.65) Beats $(1.66) Estimate, Sales $2.983M Beats $929.100K Estimate", "summary": "", "symbols": ["PRME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44040465/prime-medicine-fy-2024-gaap-eps-1-65-beats-1-66-estimate-sales-2-983m-beats-929-100k-estimate", "tags": ["earnings"]}
{"id": 44040466, "time": "2025-02-28 08:05:55", "headline": "Goldman Sachs Downgrades DoubleVerify Hldgs to Neutral, Lowers Price Target to $20", "summary": "", "symbols": ["DV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040466/goldman-sachs-downgrades-doubleverify-hldgs-to-neutral-lowers-price-target-to-20", "tags": ["analyst_down", "price_target_down"]}
{"id": 44040467, "time": "2025-02-28 08:06:02", "headline": "Oxford Square Cap Q4 Net investment income per share $0.09 Beats $0.06 Estimate, Total investment income $10.22M Beat $9.90M Estimate", "summary": "", "symbols": ["OXSQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44040467/oxford-square-cap-q4-net-investment-income-per-share-0-09-beats-0-06-estimate-total-investment-inco", "tags": []}
{"id": 44040469, "time": "2025-02-28 08:06:19", "headline": "Outlook Therapeutics Re-Submits Its Biologics License Application For ONS-5010 In Wet AMD To The FDA", "summary": "", "symbols": ["OTLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44040469/outlook-therapeutics-re-submits-its-biologics-license-application-for-ons-5010-in-wet-amd-to-the-", "tags": ["guidance", "fda"]}
{"id": 44040470, "time": "2025-02-28 08:06:25", "headline": "Rosenblatt Maintains Buy on Stagwell, Raises Price Target to $10", "summary": "", "symbols": ["STGW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040470/rosenblatt-maintains-buy-on-stagwell-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040491, "time": "2025-02-28 08:07:16", "headline": "Praxis Precision Medicines Provides Update On Interim Analysis For Study 1 Of Essential3 Program; Independent Data Monitoring Committee Recommended Study Be Stopped For Futility Due To Results Being Unlikely To Meet Endpoint", "summary": "", "symbols": ["PRAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44040491/praxis-precision-medicines-provides-update-on-interim-analysis-for-study-1-of-essential3-program-", "tags": []}
{"id": 44040507, "time": "2025-02-28 08:07:31", "headline": "Safe & Green Holdings Regains Compliance With Nasdaq Continued Listing Requirements", "summary": "", "symbols": ["SGBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/25/02/44040507/safe-green-holdings-regains-compliance-with-nasdaq-continued-listing-requirements", "tags": []}
{"id": 44040518, "time": "2025-02-28 08:08:07", "headline": "enVVeno Medical FY 2024 GAAP EPS $(1.27) Beats $(1.32) Estimate", "summary": "", "symbols": ["NVNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44040518/envveno-medical-fy-2024-gaap-eps-1-27-beats-1-32-estimate", "tags": ["earnings"]}
{"id": 44040520, "time": "2025-02-28 08:08:19", "headline": "Morgan Stanley Upgrades Voya Financial to Overweight, Raises Price Target to $87", "summary": "", "symbols": ["VOYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040520/morgan-stanley-upgrades-voya-financial-to-overweight-raises-price-target-to-87", "tags": ["analyst_up", "price_target_up"]}
{"id": 44040537, "time": "2025-02-28 08:09:38", "headline": "TikTok Invests $8.8 Billion in Thailand Data Centers, Bypassing US-China Tech Tensions", "summary": "ByteDance&#39;s TikTok commits $8.8B for data centers in Thailand over 5 years, joining other tech giants like Amazon, Google, and Microsoft in investing in the country&#39;s growing AI infrastructure.", "symbols": ["AMZN", "GOOG", "GOOGL", "MSFT", "NVDA", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/markets/emerging-markets/25/02/44040537/tiktok-invests-8-8-billion-in-thailand-data-centers-bypassing-us-china-tech-tensions", "tags": []}
{"id": 44040546, "time": "2025-02-28 08:09:57", "headline": "Morgan Stanley Upgrades Corebridge Financial to Overweight, Raises Price Target to $43", "summary": "", "symbols": ["CRBG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040546/morgan-stanley-upgrades-corebridge-financial-to-overweight-raises-price-target-to-43", "tags": ["analyst_up", "price_target_up"]}
{"id": 44040549, "time": "2025-02-28 08:10:07", "headline": "Leading And Lagging Sectors For February 28, 2025", "summary": " ", "symbols": ["XLB", "XLC", "XLE", "XLF", "XLI", "XLK", "XLP", "XLRE", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/25/02/44040549/leading-and-lagging-sectors-for-february-28-2025", "tags": []}
{"id": 44040553, "time": "2025-02-28 08:10:25", "headline": "WestPark Capital Reiterates Buy on Okta, Maintains $140 Price Target", "summary": "", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040553/westpark-capital-reiterates-buy-on-okta-maintains-140-price-target", "tags": ["analyst_other"]}
{"id": 44040571, "time": "2025-02-28 08:10:53", "headline": "Rosenblatt Maintains Buy on Adeia, Maintains $20 Price Target", "summary": "", "symbols": ["ADEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040571/rosenblatt-maintains-buy-on-adeia-maintains-20-price-target", "tags": ["analyst_other"]}
{"id": 44040577, "time": "2025-02-28 08:11:35", "headline": "Morgan Stanley Downgrades DLocal to Equal-Weight, Lowers Price Target to $10", "summary": "", "symbols": ["DLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040577/morgan-stanley-downgrades-dlocal-to-equal-weight-lowers-price-target-to-10", "tags": ["analyst_down", "price_target_down"]}
{"id": 44040578, "time": "2025-02-28 08:12:31", "headline": "Frontline Q4 Earnings: Revenue Beats, But EPS Sinks\u2014CEO Cites 'Unusually Soft' Market", "summary": "Frontline Plc reported 6.9% revenue growth in Q4 2024, with net income and operating cash flow declining. Board declared $0.20 dividend per share.", "symbols": ["FRO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/02/44040578/frontline-sees-softer-q4-as-oil-exports-slow-eyes-2025-sanctions-impact-on-tanker-market", "tags": ["earnings", "management", "dividend"]}
{"id": 44040579, "time": "2025-02-28 08:12:32", "headline": "Morgan Stanley Maintains Overweight on Autodesk, Raises Price Target to $385", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040579/morgan-stanley-maintains-overweight-on-autodesk-raises-price-target-to-385", "tags": ["analyst_other", "price_target_up"]}
{"id": 44040601, "time": "2025-02-28 08:13:26", "headline": "Small Cap Consumer Research Reiterates Buy on Betterware de Mexico SAPI, Maintains $22.5 Price Target", "summary": "", "symbols": ["BWMX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040601/small-cap-consumer-research-reiterates-buy-on-betterware-de-mexico-sapi-maintains-22-5-price-target", "tags": ["analyst_other"]}
{"id": 44040603, "time": "2025-02-28 08:13:50", "headline": "Morgan Stanley Maintains Equal-Weight on HP, Lowers Price Target to $35", "summary": "", "symbols": ["HPQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040603/morgan-stanley-maintains-equal-weight-on-hp-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 44040617, "time": "2025-02-28 08:14:19", "headline": "Rosenblatt Maintains Buy on Adtran Holdings, Maintains $15 Price Target", "summary": "", "symbols": ["ADTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040617/rosenblatt-maintains-buy-on-adtran-holdings-maintains-15-price-target", "tags": ["analyst_other"]}
{"id": 44040631, "time": "2025-02-28 08:15:04", "headline": "Trading Halt: Halt status updated at 8:15:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["HLXB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44040631/trading-halt-halt-status-updated-at-8-15-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 44040632, "time": "2025-02-28 08:15:12", "headline": "IonQ CEO Fires Back At Nvidia's Jensen Huang: 'We Remain The 800 Pound Guerrilla'", "summary": "IonQ CEO Niccolo De Masi is confident that quantum computing will soon be the third leg of computing. With major partnerships and predicted GAAP revenue, IonQ is poised to be a leader in the industry.", "symbols": ["AZN", "GD", "IONQ", "MSFT", "NVDA"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/long-ideas/25/02/44040632/ionq-ceo-fires-back-at-nvidias-jensen-huang-we-remain-the-800-pound-guerrilla", "tags": ["earnings", "management"]}
{"id": 44040634, "time": "2025-02-28 08:15:19", "headline": "Peering Into JPMorgan Chase's Recent Short Interest", "summary": " ", "symbols": ["JPM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44040634/peering-into-jpmorgan-chases-recent-short-interest", "tags": []}
{"id": 44040635, "time": "2025-02-28 08:15:25", "headline": "Is the Market Bullish or Bearish on Webster Finl?", "summary": " ", "symbols": ["WBS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44040635/is-the-market-bullish-or-bearish-on-webster-finl", "tags": []}
{"id": 44040638, "time": "2025-02-28 08:15:29", "headline": "Is the Market Bullish or Bearish on Bio-Techne?", "summary": " ", "symbols": ["TECH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44040638/is-the-market-bullish-or-bearish-on-bio-techne", "tags": []}
{"id": 44040771, "time": "2025-02-28 08:16:36", "headline": "Lilly's Jaypirca Recommended By CHMP For Approval In The EU For Adults With Relapsed Or Refractory Chronic Lymphocytic Leukemia Previously Treated With A BTK Inhibitor", "summary": "", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44040771/lillys-jaypirca-recommended-by-chmp-for-approval-in-the-eu-for-adults-with-relapsed-or-refractory", "tags": []}
{"id": 44040878, "time": "2025-02-28 08:18:01", "headline": "Trump Media Stock Craters 70% From Highs: Is There Any Floor Left?", "summary": "Trump Media &amp; Technology stock has been in a free fall, trading at a staggering 70% discount from its 52-week high of $79.38.", "symbols": ["DJT"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/25/02/44040878/trump-media-stock-craters-70-from-highs-is-there-any-floor-left", "tags": []}
{"id": 44040922, "time": "2025-02-28 08:19:28", "headline": "Piper Sandler Upgrades Cava Group to Overweight, Lowers Price Target to $115", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040922/piper-sandler-upgrades-cava-group-to-overweight-lowers-price-target-to-115", "tags": ["analyst_up", "price_target_down"]}
{"id": 44040957, "time": "2025-02-28 08:20:24", "headline": "Liquidia Litigation Against FDA Over Tyvaso DPI Exclusivity Denied; United Therapeutics' Cross Claim Remains Pending; Exclusivity Expires May 23, 2025", "summary": "", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44040957/liquidia-litigation-against-fda-over-tyvaso-dpi-exclusivity-denied-united-therapeutics-cross-clai", "tags": ["fda"]}
{"id": 44040990, "time": "2025-02-28 08:22:08", "headline": "Piper Sandler Downgrades Teleflex to Neutral, Lowers Price Target to $140", "summary": "", "symbols": ["TFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44040990/piper-sandler-downgrades-teleflex-to-neutral-lowers-price-target-to-140", "tags": ["analyst_down", "price_target_down"]}
{"id": 44041011, "time": "2025-02-28 08:22:56", "headline": "Pearson Reports Mixed FY24, Expands Partnership With Amazon", "summary": "Pearson and Amazon expand partnership to leverage cloud and AI for personalized learning, aiming to optimize education worldwide.", "symbols": ["PSO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/02/44041011/pearson-reports-mixed-fy24-expands-partnership-with-amazon-more", "tags": ["contract"]}
{"id": 44041025, "time": "2025-02-28 08:23:41", "headline": "Piper Sandler Initiates Coverage On Avalo Therapeutics with Overweight Rating, Announces Price Target of $48", "summary": "", "symbols": ["AVTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041025/piper-sandler-initiates-coverage-on-avalo-therapeutics-with-overweight-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 44041038, "time": "2025-02-28 08:23:58", "headline": "The CHMP Reaffirms Positive Opinion For Lecanemab In Early Alzheimer's Disease", "summary": "", "symbols": ["BIIB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44041038/the-chmp-reaffirms-positive-opinion-for-lecanemab-in-early-alzheimers-disease", "tags": []}
{"id": 44041080, "time": "2025-02-28 08:25:08", "headline": "Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["PRAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44041080/trading-halt-halt-status-updated-at-8-25-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 44041097, "time": "2025-02-28 08:26:17", "headline": "Piper Sandler Maintains Neutral on Solventum, Raises Price Target to $84", "summary": "", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041097/piper-sandler-maintains-neutral-on-solventum-raises-price-target-to-84", "tags": ["analyst_other", "price_target_up"]}
{"id": 44041104, "time": "2025-02-28 08:27:19", "headline": "How To Earn $500 A Month From Target Stock Ahead Of Q4 Earnings", "summary": " ", "symbols": ["TGT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/02/44041104/how-to-earn-500-a-month-from-target-stock-ahead-of-q4-earnings", "tags": ["earnings"]}
{"id": 44041113, "time": "2025-02-28 08:27:41", "headline": "Piper Sandler Maintains Overweight on Privia Health Gr, Raises Price Target to $40", "summary": "", "symbols": ["PRVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041113/piper-sandler-maintains-overweight-on-privia-health-gr-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 44041144, "time": "2025-02-28 08:28:42", "headline": "Piper Sandler Maintains Neutral on Iovance Biotherapeutics, Lowers Price Target to $6", "summary": "", "symbols": ["IOVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041144/piper-sandler-maintains-neutral-on-iovance-biotherapeutics-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 44041147, "time": "2025-02-28 08:30:02", "headline": "Piper Sandler Maintains Overweight on Dyne Therapeutics, Lowers Price Target to $48", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041147/piper-sandler-maintains-overweight-on-dyne-therapeutics-lowers-price-target-to-48", "tags": ["analyst_other", "price_target_down"]}
{"id": 44041186, "time": "2025-02-28 08:30:16", "headline": "USA Core PCE Price Index (MoM) For Jan. 0.3% Vs 0.3% Est. Vs 0.2% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44041186/usa-core-pce-price-index-mom-for-jan-0-3-vs-0-3-est-vs-0-2-prior", "tags": []}
{"id": 44041188, "time": "2025-02-28 08:30:20", "headline": "USA Core PCE Price Index (YoY) For January 2.6% Vs 2.6% Est.; 2.9% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44041188/usa-core-pce-price-index-yoy-for-january-2-6-vs-2-6-est-2-9-prior", "tags": []}
{"id": 44041190, "time": "2025-02-28 08:30:24", "headline": "PCE price index (MoM) (Jan) +0.3% vs +0.3% Est.; Prior +0.3%", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44041190/pce-price-index-mom-jan-0-3-vs-0-3-est-prior-0-3", "tags": []}
{"id": 44041191, "time": "2025-02-28 08:30:34", "headline": "USA PCE Price Index (YoY) For January 2.5% Vs 2.5% Est.; 2.6% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44041191/usa-pce-price-index-yoy-for-january-2-5-vs-2-5-est-2-6-prior", "tags": []}
{"id": 44041192, "time": "2025-02-28 08:30:36", "headline": "USA Personal Spending (MoM) For January -0.2% Vs 0.2% Est.; 0.8% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44041192/usa-personal-spending-mom-for-january-0-2-vs-0-2-est-0-8-prior", "tags": []}
{"id": 44041201, "time": "2025-02-28 08:31:07", "headline": "Adagio Medical Announces Strategic Restructuring To Accelerate IDE Trial And Product Innovation", "summary": "", "symbols": ["ADGM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44041201/adagio-medical-announces-strategic-restructuring-to-accelerate-ide-trial-and-product-innovation", "tags": ["fda"]}
{"id": 44041232, "time": "2025-02-28 08:31:44", "headline": "Trinity Biotech Announces Additional $4M Funding", "summary": "", "symbols": ["TRIB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041232/trinity-biotech-announces-additional-4m-funding", "tags": []}
{"id": 44041233, "time": "2025-02-28 08:31:47", "headline": "Nexalin Technology To Begin Patient Recruitment For UCSD's TBI & PTSD Clinical Study", "summary": "", "symbols": ["NXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44041233/nexalin-technology-to-begin-patient-recruitment-for-ucsds-tbi-ptsd-clinical-study", "tags": ["fda"]}
{"id": 44041237, "time": "2025-02-28 08:32:17", "headline": "D. Boral Capital Maintains Buy on ImmunityBio, Maintains $30 Price Target", "summary": "", "symbols": ["IBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041237/d-boral-capital-maintains-buy-on-immunitybio-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 44041238, "time": "2025-02-28 08:32:36", "headline": "Cibus President And COO Appointed As Interim CEO; Succeeds Rory Riggs", "summary": "", "symbols": ["CBUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041238/cibus-president-and-coo-appointed-as-interim-ceo-succeeds-rory-riggs", "tags": ["management"]}
{"id": 44041268, "time": "2025-02-28 08:33:12", "headline": "Piper Sandler Maintains Overweight on SITE Centers, Lowers Price Target to $19", "summary": "", "symbols": ["SITC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041268/piper-sandler-maintains-overweight-on-site-centers-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 44041269, "time": "2025-02-28 08:33:27", "headline": "Nuvve Awarded $400M Contract For New Mexico's ZEV And Renewable Energy Goals", "summary": "", "symbols": ["NVVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041269/nuvve-awarded-400m-contract-for-new-mexicos-zev-and-renewable-energy-goals", "tags": ["contract"]}
{"id": 44041271, "time": "2025-02-28 08:34:03", "headline": "New Jersey Opens Door To Cannabis Lounges, Setting Stage For Industry Expansion", "summary": "New Jersey launches licensing process for cannabis consumption lounges in 2025. Market surpasses $1B in sales. Benzinga event to address growth.", "symbols": [], "source": "benzinga", "author": "Abbey Higginbotham", "url": "https://www.benzinga.com/news/events/25/02/44041271/new-jersey-opens-door-to-cannabis-lounges-setting-stage-for-industry-expansion", "tags": []}
{"id": 44041280, "time": "2025-02-28 08:34:21", "headline": "Piper Sandler Maintains Underweight on Macerich, Lowers Price Target to $16", "summary": "", "symbols": ["MAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041280/piper-sandler-maintains-underweight-on-macerich-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 44041348, "time": "2025-02-28 08:37:18", "headline": "WeRide's Robobus Rolls Out In France With Renault & Beti Backing: Details", "summary": "WeRide expands its global reach with the launch of its fully autonomous Robobus service in Dr\u00f4me, France. In collaboration with beti, Renault Group, and Macif, the L4-level shuttle service offers eco-friendly transportation on a 3.3 km route. ", "symbols": ["WRD"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/markets/equities/25/02/44041348/werides-robobus-rolls-out-in-france-with-renault-beti-backing-details", "tags": []}
{"id": 44041389, "time": "2025-02-28 08:38:09", "headline": "Bitcoin Will Still Hit $500,000 Before Trump Leaves Office, Standard Chartered Analyst Maintains", "summary": "Geoff Kendrick, Standard Chartered\u2019s Head of Digital Assets Research, offers a cautiously optimistic outlook for cryptocurrencies amid recent market turbulence.", "symbols": ["BTCUSD", "IBIT"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44041389/bitcoin-will-still-hit-500000-before-trump-leaves-office-standard-chartered-analyst-maintains", "tags": ["analyst_other", "guidance"]}
{"id": 44041012, "time": "2025-02-28 08:22:54", "headline": "How To Trade Nvidia Today?", "summary": "Nvidia shares closed Thursday&#39;s regular trading session down 8%, despite offering better-than-expected outlook. How to trade Nvidia today?", "symbols": [], "source": "benzinga", "author": "RIPS", "url": "https://www.benzinga.com/markets/equities/25/02/44041012/how-to-trade-nvidia-today", "tags": ["guidance", "offering"]}
{"id": 44041392, "time": "2025-02-28 08:38:20", "headline": "Legendary Investor Warns US Stocks Are Reaching Dangerous Levels, Sounds Alarm On 'Super Bubble'\u2014Is A Market Correction Coming?", "summary": "Long-term investment strategist and co-founder of GMO Investment and Asset Management, Jeremy Grantham, issued a warning about a potential \u201csuper bubble\u201d in the U.S. stock market.  ", "symbols": ["BTC", "BTCUSD", "QQQ", "SPY"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/02/44041392/super-bubble-looming-in-us-markets-cautions-this-legendary-investor", "tags": []}
{"id": 44041404, "time": "2025-02-28 08:38:44", "headline": "Piper Sandler Maintains Overweight on Alexander & Baldwin, Raises Price Target to $24", "summary": "", "symbols": ["ALEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041404/piper-sandler-maintains-overweight-on-alexander-baldwin-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 44041406, "time": "2025-02-28 08:39:01", "headline": "Flight Or Fright? Poll Reveals Whether Plane Mishaps Hurt Air Travel In 2025", "summary": "A Benzinga poll reveals that some passengers may feel uneasy about getting on planes in 2025 after several recent flight mishaps.", "symbols": ["AAL", "DAL", "JETS"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/travel/25/02/44041406/flight-or-fright-poll-reveals-whether-plane-mishaps-hurt-air-travel-in-2025", "tags": []}
{"id": 44041449, "time": "2025-02-28 08:40:32", "headline": "Piper Sandler Maintains Overweight on TechnipFMC, Raises Price Target to $40", "summary": "", "symbols": ["FTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041449/piper-sandler-maintains-overweight-on-technipfmc-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 44041471, "time": "2025-02-28 08:42:04", "headline": "Piper Sandler Maintains Overweight on Bloom Energy, Lowers Price Target to $31", "summary": "", "symbols": ["BE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041471/piper-sandler-maintains-overweight-on-bloom-energy-lowers-price-target-to-31", "tags": ["analyst_other", "price_target_down"]}
{"id": 44041500, "time": "2025-02-28 08:44:14", "headline": "Piper Sandler Maintains Overweight on Coca-Cola, Raises Price Target to $80", "summary": "", "symbols": ["KO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041500/piper-sandler-maintains-overweight-on-coca-cola-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 44041516, "time": "2025-02-28 08:44:42", "headline": "New Jersey Governor's Cannabis Tax Hike Sparks Debate", "summary": "Gov. Murphy&#39;s proposal to raise New Jersey&#39;s cannabis excise tax from $2.50 to $15 per ounce has ignited a fierce debate.", "symbols": [], "source": "benzinga", "author": "Abbey Higginbotham", "url": "https://www.benzinga.com/news/events/25/02/44041516/new-jersey-governors-cannabis-tax-hike-sparks-debate", "tags": []}
{"id": 44041634, "time": "2025-02-28 08:46:11", "headline": "Piper Sandler Maintains Overweight on Elastic, Raises Price Target to $135", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041634/piper-sandler-maintains-overweight-on-elastic-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 44041748, "time": "2025-02-28 08:48:15", "headline": "HUB Cyber Security Secures Continued Nasdaq Listing", "summary": "", "symbols": ["HUBC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041748/hub-cyber-security-secures-continued-nasdaq-listing", "tags": []}
{"id": 44041750, "time": "2025-02-28 08:48:23", "headline": "Truist Securities Initiates Coverage On Infinity with Buy Rating, Announces Price Target of $26", "summary": "", "symbols": ["INR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041750/truist-securities-initiates-coverage-on-infinity-with-buy-rating-announces-price-target-of-26", "tags": ["analyst_init"]}
{"id": 44041837, "time": "2025-02-28 08:53:10", "headline": "Sigenergy Charges Into IPO Just Two Years After Inception", "summary": " ", "symbols": [], "source": "benzinga", "author": "The Bamboo Works", "url": "https://www.benzinga.com/markets/asia/25/02/44041837/sigenergy-charges-into-ipo-just-two-years-after-inception", "tags": []}
{"id": 44041861, "time": "2025-02-28 08:54:04", "headline": "Stifel Downgrades Vertex to Hold, Lowers Price Target to $31", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041861/stifel-downgrades-vertex-to-hold-lowers-price-target-to-31", "tags": ["analyst_down", "price_target_down"]}
{"id": 44040521, "time": "2025-02-28 08:08:19", "headline": "China's Dalu International Files For US IPO, Seeking Rich Valuations", "summary": "China&#39;s Dalu International has filed for a Nasdaq IPO that would value it at about $100 million and give it a higher P/E ratio vs. most peers.", "symbols": [], "source": "benzinga", "author": "The Bamboo Works", "url": "https://www.benzinga.com/markets/asia/25/02/44040521/chinas-dalu-international-files-for-us-ipo-seeking-rich-valuations", "tags": []}
{"id": 44041883, "time": "2025-02-28 08:55:15", "headline": "Stifel Upgrades Vital Farms to Buy, Maintains Price Target to $44", "summary": "", "symbols": ["VITL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041883/stifel-upgrades-vital-farms-to-buy-maintains-price-target-to-44", "tags": ["analyst_up", "analyst_other"]}
{"id": 44041898, "time": "2025-02-28 08:56:39", "headline": "Stifel Maintains Buy on AbCellera Biologics, Lowers Price Target to $10", "summary": "", "symbols": ["ABCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041898/stifel-maintains-buy-on-abcellera-biologics-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 44041895, "time": "2025-02-28 08:56:27", "headline": "fuboTV Reported 1.68M Subscribers For North America In FY24, Up By 4% YoY", "summary": "", "symbols": ["FUBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041895/fubotv-reported-1-68m-subscribers-in-fy24-up-by-4-yoy", "tags": []}
{"id": 44041917, "time": "2025-02-28 08:58:36", "headline": "Stifel Maintains Buy on Dutch Bros, Raises Price Target to $85", "summary": "", "symbols": ["BROS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041917/stifel-maintains-buy-on-dutch-bros-raises-price-target-to-85", "tags": ["analyst_other", "price_target_up"]}
{"id": 44041956, "time": "2025-02-28 09:00:05", "headline": "Stifel Maintains Hold on Planet Fitness, Lowers Price Target to $82", "summary": "", "symbols": ["PLNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44041956/stifel-maintains-hold-on-planet-fitness-lowers-price-target-to-82", "tags": ["analyst_other", "price_target_down"]}
{"id": 44041965, "time": "2025-02-28 09:00:08", "headline": "ARM's Big Bet On Malaysia: Can The Nation Meet The Challenge?", "summary": "ARM Holdings plans to set up base in Malaysia, backed by SoftBank, to capitalize on the country&#39;s appeal as a semiconductor hub. Challenges lie in developing a skilled workforce.", "symbols": ["ARM", "SFTBF"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/25/02/44041965/arms-big-bet-on-malaysia-can-the-nation-keep-up", "tags": []}
{"id": 44042015, "time": "2025-02-28 09:00:21", "headline": "What 5 Analyst Ratings Have To Say About Hilton Grand Vacations", "summary": " ", "symbols": ["HGV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44042015/what-5-analyst-ratings-have-to-say-about-hilton-grand-vacations", "tags": []}
{"id": 44042030, "time": "2025-02-28 09:00:30", "headline": "A Glimpse Into The Expert Outlook On Pacira BioSciences Through 7 Analysts", "summary": " ", "symbols": ["PCRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44042030/a-glimpse-into-the-expert-outlook-on-pacira-biosciences-through-7-analysts", "tags": ["guidance"]}
{"id": 44042035, "time": "2025-02-28 09:00:40", "headline": "Here's How Much $1000 Invested In Packaging Corp of America 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["PKG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44042035/heres-how-much-1000-invested-in-packaging-corp-of-america-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44042038, "time": "2025-02-28 09:00:41", "headline": "Demystifying Outbrain: Insights From 6 Analyst Reviews", "summary": " ", "symbols": ["OB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44042038/demystifying-outbrain-insights-from-6-analyst-reviews", "tags": []}
{"id": 44042048, "time": "2025-02-28 09:01:01", "headline": "A Glimpse Into The Expert Outlook On Bloom Energy Through 10 Analysts", "summary": " ", "symbols": ["BE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44042048/a-glimpse-into-the-expert-outlook-on-bloom-energy-through-10-analysts", "tags": ["guidance"]}
{"id": 44042053, "time": "2025-02-28 09:01:12", "headline": "Demystifying Macerich: Insights From 6 Analyst Reviews", "summary": " ", "symbols": ["MAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44042053/demystifying-macerich-insights-from-6-analyst-reviews", "tags": []}
{"id": 44042055, "time": "2025-02-28 09:01:13", "headline": "Stifel Maintains Buy on Portillos, Raises Price Target to $17", "summary": "", "symbols": ["PTLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042055/stifel-maintains-buy-on-portillos-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 44042057, "time": "2025-02-28 09:01:19", "headline": "Where DoubleVerify Hldgs Stands With Analysts", "summary": " ", "symbols": ["DV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44042057/where-doubleverify-hldgs-stands-with-analysts", "tags": []}
{"id": 44042084, "time": "2025-02-28 09:01:43", "headline": "MacKenzie Realty Capital Prices $4.8 Million Registered Direct Offering Of 2,826,299 Shares", "summary": "", "symbols": ["MKZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042084/mackenzie-realty-capital-prices-4-8-million-registered-direct-offering-of-2-826-299-shares", "tags": ["offering"]}
{"id": 44042085, "time": "2025-02-28 09:01:45", "headline": "WORK Medical Technology Group LTD Enters Strategic Partnership With Shanghai Chartwell Medical Device Co", "summary": "", "symbols": ["WOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042085/work-medical-technology-group-ltd-enters-strategic-partnership-with-shanghai-chartwell-medical-devic", "tags": ["contract"]}
{"id": 44042095, "time": "2025-02-28 09:02:12", "headline": "Castellum Awarded $103.3M Contract To GTMR Subsidiary", "summary": "", "symbols": ["CTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042095/castellum-awarded-103-3m-contract-to-gtmr-subsidiary", "tags": ["contract"]}
{"id": 44042127, "time": "2025-02-28 09:02:35", "headline": "Acme United Q4 EPS $0.41 Misses $0.48 Estimate, Sales $45.94M Beat $42.08M Estimate", "summary": "", "symbols": ["ACU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44042127/acme-united-q4-eps-0-41-misses-0-48-estimate-sales-45-94m-beat-42-08m-estimate", "tags": ["earnings"]}
{"id": 44042134, "time": "2025-02-28 09:02:47", "headline": "Stifel Maintains Buy on Wingstop, Lowers Price Target to $350", "summary": "", "symbols": ["WING"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042134/stifel-maintains-buy-on-wingstop-lowers-price-target-to-350", "tags": ["analyst_other", "price_target_down"]}
{"id": 44042142, "time": "2025-02-28 09:02:59", "headline": "Arcutis To Present At 83rd American Academy Of Dermatology Annual Meeting", "summary": "", "symbols": ["ARQT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44042142/arcutis-to-present-at-83rd-american-academy-of-dermatology-annual-meeting", "tags": []}
{"id": 44042183, "time": "2025-02-28 09:04:11", "headline": "Steakholder Foods Announces $1.25M Private Placement Of 985,028 ADS At $1.269/ADS; Establishes $8M Equity Line Of Credit Funding Mechanism", "summary": "", "symbols": ["STKH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042183/steakholder-foods-announces-1-25m-private-placement-of-985-028-ads-at-1-269ads-establishes-8m-equity", "tags": ["offering"]}
{"id": 44042184, "time": "2025-02-28 09:04:11", "headline": "JetBlue Vacations Expands Cruise Offerings Adding More Rewards, More Partners, And More Ways To Earn Status", "summary": "", "symbols": ["JBLU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042184/jetblue-vacations-expands-cruise-offerings-adding-more-rewards-more-partners-and-more-ways-to-earn-s", "tags": []}
{"id": 44042191, "time": "2025-02-28 09:04:52", "headline": "Stifel Maintains Hold on Yum Brands, Raises Price Target to $148", "summary": "", "symbols": ["YUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042191/stifel-maintains-hold-on-yum-brands-raises-price-target-to-148", "tags": ["analyst_other", "price_target_up"]}
{"id": 44042207, "time": "2025-02-28 09:05:35", "headline": "Novartis Announces Presentation Of 17 Abstracts At 2025 AAAAI/WAO And AAD Meetings, Featuring Phase III REMIX-1/2 Data On Remibrutinib For Chronic Urticaria, Long-Term Cosentyx Data In Hidradenitis Suppurativa, And Phase II Patient Outcomes For Remibrutinib In HS", "summary": "", "symbols": ["NVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44042207/novartis-announces-presentation-of-17-abstracts-at-2025-aaaaiwao-and-aad-meetings-featuring-phase", "tags": ["fda"]}
{"id": 44042222, "time": "2025-02-28 09:06:34", "headline": "NextNav Submitted Study To FCC Confirming 5G Operations Coexist With Unlicensed Devices In Lower 900 MHz Band", "summary": "", "symbols": ["NN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042222/nextnav-submitted-study-to-fcc-confirming-5g-operations-coexist-with-unlicensed-devices-in-lower-900", "tags": []}
{"id": 44042233, "time": "2025-02-28 09:07:22", "headline": "American Financial Group Declares A Special Cash Dividend Of $2.00 Per Share of American Financial Group Common Stock. The Dividend Is Payable On March 28, 2025, To Shareholders Of Record On March 17, 2025", "summary": "", "symbols": ["AFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042233/american-financial-group-declares-a-special-cash-dividend-of-2-00-per-share-of-american-financial-gr", "tags": ["dividend"]}
{"id": 44042270, "time": "2025-02-28 09:08:26", "headline": "For Q1, FuboTV Expects North American Subscribers Of 1.43M-$1.46M (4% YoY Decline at Midpoint) and Rest of World (ROW) Subscribers Of 0.33M-0.34M (16% YoY Decline at Midpoint)", "summary": "", "symbols": ["FUBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042270/for-q1-fubotv-expects-north-american-subscribers-of-1-43m-1-46m-4-yoy-decline-at-midpoint-and-rest-o", "tags": []}
{"id": 44042276, "time": "2025-02-28 09:09:21", "headline": "Bitdeer Announces New $20M Share Repurchase Program", "summary": "", "symbols": ["BTDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042276/bitdeer-announces-new-20m-share-repurchase-program", "tags": ["buyback"]}
{"id": 44042278, "time": "2025-02-28 09:09:23", "headline": "Q32 Bio Announces Results From SIGNAL-AA Part A Clinical Trial Of Bempikibart In Alopecia Areata At 2025 American Academy Of Dermatology Annual Meeting", "summary": "", "symbols": ["QTTB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44042278/q32-bio-announces-results-from-signal-aa-part-a-clinical-trial-of-bempikibart-in-alopecia-areata-", "tags": ["fda"]}
{"id": 44042281, "time": "2025-02-28 09:09:41", "headline": "Baird Maintains Outperform on Bath & Body Works, Raises Price Target to $47", "summary": "", "symbols": ["BBWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042281/baird-maintains-outperform-on-bath-body-works-raises-price-target-to-47", "tags": ["analyst_other", "price_target_up"]}
{"id": 44042301, "time": "2025-02-28 09:10:34", "headline": "FuboTV Projects Subscriber Fall In Q1 After Q4 Topline Growth, Stock Tumbles", "summary": "FuboTV (NYSE: FUBO) gained on Friday after reporting fourth quarter 2024 results with sales of $443.277 million, adjusted EPS loss of 2 cents, and plans to launch a new Sports &amp; Broadcasting service.", "symbols": ["DIS", "FUBO"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/25/02/44042301/fubotv-projects-subscriber-fall-in-q1-after-q4-topline-growth-stock-tumbles", "tags": ["earnings"]}
{"id": 44042316, "time": "2025-02-28 09:11:16", "headline": "Baird Maintains Neutral on Fox Factory Hldg, Lowers Price Target to $32", "summary": "", "symbols": ["FOXF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042316/baird-maintains-neutral-on-fox-factory-hldg-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 44042318, "time": "2025-02-28 09:11:47", "headline": "Alumis Announces Four Phase 2 Data Presentations On ESK-001 TYK2 Inhibitor For Psoriasis At 2025 AAD Meeting; Phase 3 Topline Data Expected In Q1 2026", "summary": "", "symbols": ["ALMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44042318/alumis-announces-four-phase-2-data-presentations-on-esk-001-tyk2-inhibitor-for-psoriasis-at-2025-", "tags": ["fda"]}
{"id": 44042320, "time": "2025-02-28 09:11:58", "headline": "Duolingo Mixed Q4: Paid Subscriber Base Grows 43%, But AI-Driven Costs Hit Margins", "summary": "DUO shares are down premarket as Duolingo reported mixed Q4 results, with a 39% revenue increase and higher subscription bookings and users.", "symbols": ["DUOL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/02/44042320/duolingo-mixed-q4-subscriber-base-grows-43-but-ai-driven-costs-hit-profitability", "tags": ["earnings"]}
{"id": 44042330, "time": "2025-02-28 09:12:34", "headline": "Baird Maintains Outperform on Warby Parker, Raises Price Target to $32", "summary": "", "symbols": ["WRBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042330/baird-maintains-outperform-on-warby-parker-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 44042351, "time": "2025-02-28 09:13:49", "headline": "Baird Maintains Outperform on Castle Biosciences, Raises Price Target to $37", "summary": "", "symbols": ["CSTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042351/baird-maintains-outperform-on-castle-biosciences-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 44042353, "time": "2025-02-28 09:13:55", "headline": "Top 10 Trending Stocks On WallStreetBets As Of February 28, 2025 (Via Swaggy Stocks)", "summary": "", "symbols": ["AMD", "BTCUSD", "CORN", "LUNR", "MSTR", "NVDA", "PLTR", "RKLB", "SMCI", "TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/02/44042353/top-10-trending-stocks-on-wallstreetbets-as-of-february-28-2025-via-swaggy-stocks", "tags": []}
{"id": 44042407, "time": "2025-02-28 09:15:06", "headline": "Baird Maintains Outperform on Iovance Biotherapeutics, Lowers Price Target to $20", "summary": "", "symbols": ["IOVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042407/baird-maintains-outperform-on-iovance-biotherapeutics-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 44042418, "time": "2025-02-28 09:15:23", "headline": "P/E Ratio Insights for Amphenol", "summary": " ", "symbols": ["APH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44042418/pe-ratio-insights-for-amphenol", "tags": []}
{"id": 44042421, "time": "2025-02-28 09:15:35", "headline": "If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["OR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44042421/if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 44042694, "time": "2025-02-28 09:18:46", "headline": "Baird Maintains Outperform on Natera, Raises Price Target to $188", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042694/baird-maintains-outperform-on-natera-raises-price-target-to-188", "tags": ["analyst_other", "price_target_up"]}
{"id": 43982604, "time": "2025-02-28 09:19:41", "headline": "Eli Lilly Doubles Capital Spending On US Drug Manufacturing With $50 Billion Target (CORRECTED)", "summary": "Eli Lilly is investing over $50 billion in U.S. manufacturing, adding four new sites to boost domestic medicine production and create thousands of jobs.", "symbols": ["LLY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/02/43982604/eli-lilly-doubles-capital-spending-on-us-drug-manufacturing-with-50-billion-target", "tags": []}
{"id": 44041803, "time": "2025-02-28 09:20:02", "headline": "Federal Reserve's Preferred Inflation Gauge Marks First Slowdown In 4 Months (UPDATED)", "summary": "The Federal Reserve&#39;s key inflation measure came in in-line with expectations on Friday, with headline PCE inflation marking its first slowdown in four months.", "symbols": ["GLD", "SPY"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/econ-s/25/02/44041803/federal-reserves-preferred-inflation-gauge-marks-first-slowdown-in-4-months", "tags": []}
{"id": 44042729, "time": "2025-02-28 09:20:07", "headline": "Baird Maintains Neutral on Dentsply Sirona, Lowers Price Target to $20", "summary": "", "symbols": ["XRAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042729/baird-maintains-neutral-on-dentsply-sirona-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 44042730, "time": "2025-02-28 09:20:21", "headline": "Eason Technology To Call Upon Up To $150,000 To Purchase Bitcoin", "summary": "", "symbols": ["DXF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44042730/eason-technology-to-call-upon-up-to-150-000-to-purchase-bitcoin", "tags": []}
{"id": 44042755, "time": "2025-02-28 09:22:11", "headline": "HC Wainwright & Co. Reiterates Buy on Catalyst Pharmaceuticals, Maintains $35 Price Target", "summary": "", "symbols": ["CPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042755/hc-wainwright-co-reiterates-buy-on-catalyst-pharmaceuticals-maintains-35-price-target", "tags": ["analyst_other"]}
{"id": 44042761, "time": "2025-02-28 09:24:14", "headline": "HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $221 Price Target", "summary": "", "symbols": ["KRYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042761/hc-wainwright-co-reiterates-buy-on-krystal-biotech-maintains-221-price-target", "tags": ["analyst_other"]}
{"id": 44042800, "time": "2025-02-28 09:26:07", "headline": "Plug Power's High-Stakes Move: Executives Can Take Up To 75% Of Pay In Company Stock", "summary": "Plug Power launches a new executive compensation plan, allowing leaders to choose up to 75% of their pay in company stock. This strategy aims to align leadership incentives with long-term shareholder value.", "symbols": ["PLUG"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/02/44042800/plug-power-ties-executive-compensation-plan-to-stock-performance", "tags": []}
{"id": 44042815, "time": "2025-02-28 09:26:42", "headline": "HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $25 Price Target", "summary": "", "symbols": ["MIST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042815/hc-wainwright-co-reiterates-buy-on-milestone-pharmaceuticals-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 44042818, "time": "2025-02-28 09:26:49", "headline": "Microsoft To Shut Down Skype In May -XDA Report", "summary": "", "symbols": ["MSFT", "ZM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042818/microsoft-to-shut-down-skype-in-may-xda-report", "tags": []}
{"id": 44042869, "time": "2025-02-28 09:29:35", "headline": "HC Wainwright & Co. Reiterates Buy on Beam Therapeutics, Maintains $80 Price Target", "summary": "", "symbols": ["BEAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042869/hc-wainwright-co-reiterates-buy-on-beam-therapeutics-maintains-80-price-target", "tags": ["analyst_other"]}
{"id": 44042906, "time": "2025-02-28 09:30:15", "headline": "U.S. District Court For District Of Delaware Grants PureCycle Preliminary Court Approval Of Shareholder Derivative Settlement", "summary": "", "symbols": ["PCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44042906/u-s-district-court-for-district-of-delaware-grants-purecycle-preliminary-court-approval-of-sharehold", "tags": ["legal"]}
{"id": 44042911, "time": "2025-02-28 09:30:37", "headline": "Is the Market Bullish or Bearish on TransMedics Gr?", "summary": " ", "symbols": ["TMDX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44042911/is-the-market-bullish-or-bearish-on-transmedics-gr", "tags": []}
{"id": 44042913, "time": "2025-02-28 09:30:41", "headline": "Peering Into F5's Recent Short Interest", "summary": " ", "symbols": ["FFIV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44042913/peering-into-f5s-recent-short-interest", "tags": []}
{"id": 44042916, "time": "2025-02-28 09:30:47", "headline": "What Does the Market Think About Taylor Morrison Home?", "summary": " ", "symbols": ["TMHC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44042916/what-does-the-market-think-about-taylor-morrison-home", "tags": []}
{"id": 44043021, "time": "2025-02-28 09:35:06", "headline": "Tesla: The Only Magnificent Seven Stock In Freefall - Can It Reverse Course?", "summary": "Tesla Inc (TSLA) is the worst-performing stock among the Magnificent Seven, down 25.66% YTD. It has dropped over 30% in the past month and has a high forward P/E ratio of 95.24, signaling bearish momentum and market cap woes.", "symbols": ["AAPL", "AMZN", "GOOG", "GOOGL", "MSFT", "NVDA", "TSLA"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/25/02/44043021/tesla-the-only-magnificent-seven-stock-in-freefall-can-it-reverse-course", "tags": []}
{"id": 44043242, "time": "2025-02-28 09:38:26", "headline": "Baird Maintains Outperform on Albany Intl, Lowers Price Target to $92", "summary": "", "symbols": ["AIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043242/baird-maintains-outperform-on-albany-intl-lowers-price-target-to-92", "tags": ["analyst_other", "price_target_down"]}
{"id": 44043253, "time": "2025-02-28 09:38:40", "headline": "MPLX Seals $715 Million Deal For Full Control Of BANGL Pipeline: Details", "summary": "MPLX LP to acquire remaining 55% interest in BANGL, LLC for $715 million and may make additional payments based on financial targets. Transaction expected to close in July 2025 and will improve growth platform.", "symbols": ["AMLP", "AMZA", "FANG", "MPLX"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/25/02/44043253/mplx-seals-715-million-deal-for-full-control-of-bangl-pipeline-details", "tags": ["merger", "contract"]}
{"id": 44043255, "time": "2025-02-28 09:38:41", "headline": "HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target", "summary": "", "symbols": ["IMCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043255/hc-wainwright-co-reiterates-buy-on-immunocore-holdings-maintains-100-price-target", "tags": ["analyst_other"]}
{"id": 44043305, "time": "2025-02-28 09:39:49", "headline": "Baird Maintains Outperform on Ameresco, Lowers Price Target to $25", "summary": "", "symbols": ["AMRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043305/baird-maintains-outperform-on-ameresco-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 44043386, "time": "2025-02-28 09:40:58", "headline": "Baird Maintains Outperform on Beacon Roofing Supply, Raises Price Target to $124", "summary": "", "symbols": ["BECN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043386/baird-maintains-outperform-on-beacon-roofing-supply-raises-price-target-to-124", "tags": ["analyst_other", "price_target_up"]}
{"id": 44043419, "time": "2025-02-28 09:41:39", "headline": "Needham Reiterates Hold on Monster Beverageto Hold", "summary": "", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043419/needham-reiterates-hold-on-monster-beverageto-hold", "tags": ["analyst_other"]}
{"id": 44043429, "time": "2025-02-28 09:41:57", "headline": "Baird Maintains Neutral on Greif, Lowers Price Target to $68", "summary": "", "symbols": ["GEF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043429/baird-maintains-neutral-on-greif-lowers-price-target-to-68", "tags": ["analyst_other", "price_target_down"]}
{"id": 44043473, "time": "2025-02-28 09:43:09", "headline": "Baird Maintains Neutral on Hayward Holdings, Raises Price Target to $18", "summary": "", "symbols": ["HAYW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043473/baird-maintains-neutral-on-hayward-holdings-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 44043515, "time": "2025-02-28 09:44:18", "headline": "Baird Maintains Outperform on Autodesk, Lowers Price Target to $336", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043515/baird-maintains-outperform-on-autodesk-lowers-price-target-to-336", "tags": ["analyst_other", "price_target_down"]}
{"id": 44043596, "time": "2025-02-28 09:45:11", "headline": "Seaport Global Downgrades Array Technologies to Neutral", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043596/seaport-global-downgrades-array-technologies-to-neutral", "tags": ["analyst_down"]}
{"id": 44043626, "time": "2025-02-28 09:45:52", "headline": "Baird Maintains Outperform on Elastic, Raises Price Target to $140", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043626/baird-maintains-outperform-on-elastic-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 44043665, "time": "2025-02-28 09:46:16", "headline": "CrowdStrike Holdings's Options: A Look at What the Big Money is Thinking", "summary": " ", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44043665/crowdstrike-holdingss-options-a-look-at-what-the-big-money-is-thinking", "tags": []}
{"id": 44043710, "time": "2025-02-28 09:46:20", "headline": "$1000 Invested In Williams Companies 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["WMB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44043710/1000-invested-in-williams-companies-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44043735, "time": "2025-02-28 09:46:22", "headline": "Smart Money Is Betting Big In DELL Options", "summary": " ", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44043735/smart-money-is-betting-big-in-dell-options", "tags": []}
{"id": 44043747, "time": "2025-02-28 09:46:27", "headline": "Spotlight on Taiwan Semiconductor: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["TSM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44043747/spotlight-on-taiwan-semiconductor-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 44043776, "time": "2025-02-28 09:46:54", "headline": "HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target", "summary": "", "symbols": ["VIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043776/hc-wainwright-co-reiterates-buy-on-vir-biotechnology-maintains-110-price-target", "tags": ["analyst_other"]}
{"id": 44043792, "time": "2025-02-28 09:47:07", "headline": "Baird Maintains Outperform on Vertex, Lowers Price Target to $45", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44043792/baird-maintains-outperform-on-vertex-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 44044039, "time": "2025-02-28 09:50:45", "headline": "Jefferies Maintains Hold on Nordic American Tankers, Maintains $3 Price Target", "summary": "", "symbols": ["NAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044039/jefferies-maintains-hold-on-nordic-american-tankers-maintains-3-price-target", "tags": ["analyst_other"]}
{"id": 44044103, "time": "2025-02-28 09:52:47", "headline": "Macquarie Maintains Outperform on PENN Entertainment, Maintains $26 Price Target", "summary": "", "symbols": ["PENN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044103/macquarie-maintains-outperform-on-penn-entertainment-maintains-26-price-target", "tags": ["analyst_other"]}
{"id": 44044227, "time": "2025-02-28 09:56:30", "headline": "Macquarie Maintains Outperform on Golden Entertainment, Maintains $40 Price Target", "summary": "", "symbols": ["GDEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044227/macquarie-maintains-outperform-on-golden-entertainment-maintains-40-price-target", "tags": ["analyst_other"]}
{"id": 44044315, "time": "2025-02-28 09:59:12", "headline": "What's Going On With Lucid Stock?", "summary": "Lucid shares are trading lower by 28% this week. The stock has been volatile after the company reported Q4\u00a0financial results.", "symbols": ["LCID"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/02/44044315/whats-going-on-with-lucid-stock-6", "tags": ["why_moving"]}
{"id": 44044364, "time": "2025-02-28 10:00:10", "headline": "Investigating NVIDIA's Standing In Semiconductors &amp; Semiconductor Equipment Industry Compared To Competitors", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44044364/investigating-nvidias-standing-in-semiconductors-amp-semiconductor-equipment-industry-compared-to-c", "tags": []}
{"id": 44044367, "time": "2025-02-28 10:00:18", "headline": "$1000 Invested In Wheaton Precious Metals 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["WPM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44044367/1000-invested-in-wheaton-precious-metals-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44044368, "time": "2025-02-28 10:00:19", "headline": "Performance Comparison: Microsoft And Competitors In Software Industry", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44044368/performance-comparison-microsoft-and-competitors-in-software-industry", "tags": []}
{"id": 44044369, "time": "2025-02-28 10:00:21", "headline": "Macquarie Maintains Outperform on Accel Entertainment, Raises Price Target to $16", "summary": "", "symbols": ["ACEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044369/macquarie-maintains-outperform-on-accel-entertainment-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 44044374, "time": "2025-02-28 10:00:27", "headline": "Understanding Meta Platforms's Position In Interactive Media &amp; Services Industry Compared To Competitors", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44044374/understanding-meta-platformss-position-in-interactive-media-amp-services-industry-compared-to-compe", "tags": []}
{"id": 44044379, "time": "2025-02-28 10:00:37", "headline": "Evaluating Amazon.com Against Peers In Broadline Retail Industry", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44044379/evaluating-amazon-com-against-peers-in-broadline-retail-industry", "tags": []}
{"id": 44044390, "time": "2025-02-28 10:00:46", "headline": "Competitor Analysis: Evaluating Apple And Competitors In Technology Hardware, Storage &amp; Peripherals Industry", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44044390/competitor-analysis-evaluating-apple-and-competitors-in-technology-hardware-storage-amp-peripherals", "tags": []}
{"id": 44044409, "time": "2025-02-28 10:01:01", "headline": "Costco Wholesale Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["COST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44044409/costco-wholesale-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 44044423, "time": "2025-02-28 10:01:13", "headline": "Behind the Scenes of Coinbase Global's Latest Options Trends", "summary": " ", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44044423/behind-the-scenes-of-coinbase-globals-latest-options-trends", "tags": []}
{"id": 44044480, "time": "2025-02-28 10:02:11", "headline": "Solana Rises More Than 6% In 24 hours", "summary": "Solana&#39;s (CRYPTO: SOL) price has increased 6.15% over the past 24 hours to $144.64, which is in the opposite direction of its trend over the past week, where it has experienced a 22.0% loss, moving from $177.46 to its current price.", "symbols": ["SOLUSD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cryptocurrency/25/02/44044480/solana-rises-more-than-6-in-24-hours", "tags": []}
{"id": 44044503, "time": "2025-02-28 10:02:47", "headline": "Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $20", "summary": "", "symbols": ["XRAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044503/barrington-research-maintains-outperform-on-dentsply-sirona-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 44044604, "time": "2025-02-28 10:05:15", "headline": "Healthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares", "summary": "Owens &amp; Minor beat Q4 EPS and revenue estimates, announced a $100M buyback, and provided 2025 guidance, projecting double-digit adjusted EBITDA growth.", "symbols": ["OMI"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/02/44044604/healthcare-logistics-giant-owens-minor-reports-better-than-expected-q4-earnings-and-outlook-to-repurchase-100-million-worth-shares", "tags": ["earnings", "guidance", "buyback"]}
{"id": 44044606, "time": "2025-02-28 10:05:15", "headline": "BWS Financial Maintains Buy on TriMas, Maintains $40 Price Target", "summary": "", "symbols": ["TRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044606/bws-financial-maintains-buy-on-trimas-maintains-40-price-target", "tags": ["analyst_other"]}
{"id": 44044656, "time": "2025-02-28 10:06:45", "headline": "Bitcoin's Sharp Decline Pulls Crypto Market Down; Musk Raises Alarm On FAA Workforce Gaps; Nvidia's Stock Dip Seen As Buying Opportunity \u2013 Top Headlines While The U.S. Slept", "summary": " ", "symbols": ["BTCUSD", "ETHUSD", "SPY"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/02/44044656/bitcoins-sharp-decline-pulls-crypto-market-down-musk-raises-alarm-on-faa-workforce-gaps-nvidias-stock-dip-seen-as-buying-opportunity-top-headlines-while-the-us-slept", "tags": []}
{"id": 44044668, "time": "2025-02-28 10:06:59", "headline": "Comstock Gains $14 Million Investment From Marathon To Enhance Biofuel Operations", "summary": "Comstock Inc. (LODE) shares rise on partnership with Marathon Petroleum (MPC) for $14 million investment in renewable fuel production.", "symbols": ["LODE", "MPC"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/25/02/44044668/comstock-gains-14-million-investment-from-marathon-to-enhance-biofuel-operations", "tags": ["contract"]}
{"id": 44044700, "time": "2025-02-28 10:07:34", "headline": "Macquarie Maintains Outperform on Autodesk, Maintains $360 Price Target", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044700/macquarie-maintains-outperform-on-autodesk-maintains-360-price-target", "tags": ["analyst_other"]}
{"id": 44044817, "time": "2025-02-28 10:09:59", "headline": "BWS Financial Maintains Buy on Arlo Technologies, Maintains $24 Price Target", "summary": "", "symbols": ["ARLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044817/bws-financial-maintains-buy-on-arlo-technologies-maintains-24-price-target", "tags": ["analyst_other"]}
{"id": 44044822, "time": "2025-02-28 10:10:04", "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["NHICU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44044822/trading-halt-halt-status-updated-at-10-10-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 44044872, "time": "2025-02-28 10:11:01", "headline": "Why Tencent Music Entertainment (TME) Stock Is Falling", "summary": "Tencent Music shares are trading lower by 3.3% during Friday&#39;s session. The stock is falling after the company announced board changes.", "symbols": ["TME"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/02/44044872/why-tencent-music-entertainment-tme-stock-is-falling", "tags": ["why_moving"]}
{"id": 44044955, "time": "2025-02-28 10:12:52", "headline": "Wolfe Research Downgrades Skyward Specialty to Peer Perform", "summary": "", "symbols": ["SKWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44044955/wolfe-research-downgrades-skyward-specialty-to-peer-perform", "tags": ["analyst_down"]}
{"id": 44045152, "time": "2025-02-28 10:15:30", "headline": "D. Boral Capital Maintains Buy on Scilex Holding, Maintains $22 Price Target", "summary": "", "symbols": ["SCLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045152/d-boral-capital-maintains-buy-on-scilex-holding-maintains-22-price-target", "tags": ["analyst_other"]}
{"id": 44045167, "time": "2025-02-28 10:15:55", "headline": "What the Options Market Tells Us About MercadoLibre", "summary": " ", "symbols": ["MELI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44045167/what-the-options-market-tells-us-about-mercadolibre", "tags": []}
{"id": 44045172, "time": "2025-02-28 10:16:01", "headline": "Shopify Unusual Options Activity", "summary": " ", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44045172/shopify-unusual-options-activity", "tags": []}
{"id": 44045481, "time": "2025-02-28 10:18:03", "headline": "Chardan Capital Maintains Buy on Intellia Therapeutics, Lowers Price Target to $68", "summary": "", "symbols": ["NTLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045481/chardan-capital-maintains-buy-on-intellia-therapeutics-lowers-price-target-to-68", "tags": ["analyst_other", "price_target_down"]}
{"id": 44045605, "time": "2025-02-28 10:20:00", "headline": "Stephens & Co. Maintains Equal-Weight on Universal Health Servs, Raises Price Target to $223", "summary": "", "symbols": ["UHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045605/stephens-co-maintains-equal-weight-on-universal-health-servs-raises-price-target-to-223", "tags": ["analyst_other", "price_target_up"]}
{"id": 44045623, "time": "2025-02-28 10:20:07", "headline": "Bath & Body Works Beats Q4, Guidance Disappoints: Analyst Says 2025 Performance Vulnerable To China Tariffs", "summary": "Bath &amp; Body Works stock rose slightly after reporting Q4 results. JPMorgan and Telsey maintain buy ratings with price targets of $47 and $43, respectively", "symbols": ["BBW", "BBWI"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/news/earnings/earnings-beats/25/02/44045623/bath-body-works-beats-q4-guidance-disappoints-analyst-says-2025-performance-vulnerable-to-china-tariffs", "tags": ["earnings", "guidance"]}
{"id": 44045708, "time": "2025-02-28 10:20:37", "headline": "Chardan Capital Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $54", "summary": "", "symbols": ["RCKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045708/chardan-capital-maintains-buy-on-rocket-pharmaceuticals-lowers-price-target-to-54", "tags": ["analyst_other", "price_target_down"]}
{"id": 44045774, "time": "2025-02-28 10:21:39", "headline": "Stephens & Co. Upgrades Openlane to Overweight, Raises Price Target to $26", "summary": "", "symbols": ["KAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045774/stephens-co-upgrades-openlane-to-overweight-raises-price-target-to-26", "tags": ["analyst_up", "price_target_up"]}
{"id": 44045824, "time": "2025-02-28 10:22:58", "headline": "Chardan Capital Maintains Buy on Dyne Therapeutics, Maintains $50 Price Target", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045824/chardan-capital-maintains-buy-on-dyne-therapeutics-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 44045864, "time": "2025-02-28 10:24:28", "headline": "CORRECTION: Piper Sandler Maintains Overweight on TechnipFMC, Raises Price Target to $40 (Analyst Name Updated)", "summary": "", "symbols": ["FTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045864/correction-piper-sandler-maintains-overweight-on-technipfmc-raises-price-target-to-40-analyst-name-u", "tags": ["analyst_other", "price_target_up"]}
{"id": 44045920, "time": "2025-02-28 10:25:52", "headline": "Keybanc Maintains Overweight on Rocket Lab USA, Lowers Price Target to $28", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045920/keybanc-maintains-overweight-on-rocket-lab-usa-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 44045967, "time": "2025-02-28 10:27:07", "headline": "Keybanc Maintains Overweight on Acushnet Hldgs, Lowers Price Target to $77", "summary": "", "symbols": ["GOLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44045967/keybanc-maintains-overweight-on-acushnet-hldgs-lowers-price-target-to-77", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046028, "time": "2025-02-28 10:28:29", "headline": "Keybanc Maintains Overweight on Cable One, Lowers Price Target to $650", "summary": "", "symbols": ["CABO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046028/keybanc-maintains-overweight-on-cable-one-lowers-price-target-to-650", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046132, "time": "2025-02-28 10:30:56", "headline": "P/E Ratio Insights for Blackstone", "summary": " ", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44046132/pe-ratio-insights-for-blackstone", "tags": []}
{"id": 44046138, "time": "2025-02-28 10:31:07", "headline": "Keybanc Maintains Overweight on Autodesk, Raises Price Target to $335", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046138/keybanc-maintains-overweight-on-autodesk-raises-price-target-to-335", "tags": ["analyst_other", "price_target_up"]}
{"id": 44046252, "time": "2025-02-28 10:32:58", "headline": "Citizens Capital Markets Maintains Outperform on Golden Entertainment, Raises Price Target to $37", "summary": "", "symbols": ["GDEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046252/citizens-capital-markets-maintains-outperform-on-golden-entertainment-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 44046292, "time": "2025-02-28 10:33:50", "headline": "Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target", "summary": "", "symbols": ["OPK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046292/barrington-research-maintains-outperform-on-opko-health-maintains-2-25-price-target", "tags": ["analyst_other"]}
{"id": 44046315, "time": "2025-02-28 10:34:49", "headline": "Citizens Capital Markets Maintains Outperform on argenx, Raises Price Target to $701", "summary": "", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046315/citizens-capital-markets-maintains-outperform-on-argenx-raises-price-target-to-701", "tags": ["analyst_other", "price_target_up"]}
{"id": 44046332, "time": "2025-02-28 10:35:06", "headline": "Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["FERAU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44046332/trading-halt-halt-status-updated-at-10-35-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 44046333, "time": "2025-02-28 10:35:08", "headline": "Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["LOKVU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44046333/trading-halt-halt-status-updated-at-10-35-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 44044388, "time": "2025-02-28 10:00:36", "headline": "Michael Saylor Says 'Sell A Kidney, But Keep The Bitcoin', But MSTR Is Down 28% Since He Appeared On The Cover Of Forbes", "summary": "Strategy (NASDAQ:MSTR) executive chairman Michael Saylor jokedly advocated for a high-risk strategy to keep Bitcoin (CRYPTO: BTC) investments in light of the ", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44044388/michael-saylor-says-sell-a-kidney-but-keep-the-bitcoin-but-mstr-is-down-28-since-he-appeared-on-the-cover-of-forbes", "tags": []}
{"id": 44046414, "time": "2025-02-28 10:37:07", "headline": "Citizens Capital Markets Maintains Market Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $91", "summary": "", "symbols": ["CRNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046414/citizens-capital-markets-maintains-market-outperform-on-crinetics-pharmaceuticals-lowers-price-targe", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046417, "time": "2025-02-28 10:37:16", "headline": "ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast", "summary": "ANI Pharmaceuticals beat Q4 estimates with strong sales growth and raised its 2025 revenue and EPS outlook, driven by Cortrophin Gel and brand expansion.", "symbols": ["ANIP"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/25/02/44046417/ani-pharmaceuticals-expects-strong-start-to-2025-on-back-of-cortrophin-gel-and-generics-lifts-annual-forecast", "tags": ["earnings", "guidance"]}
{"id": 44046515, "time": "2025-02-28 10:39:26", "headline": "Canaccord Genuity Maintains Buy on Archer Aviation, Raises Price Target to $13.5", "summary": "", "symbols": ["ACHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046515/canaccord-genuity-maintains-buy-on-archer-aviation-raises-price-target-to-13-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 44046550, "time": "2025-02-28 10:40:01", "headline": "Nayax Expands In Brazil With UPPay Acquisition, Taps Into New Payment Points", "summary": "Nayax acquired UPPay, expanding its presence in Brazil&#39;s self-service coffee market with a scalable telemetry solution. The $5.3M deal strengthens Nayax&#39;s position in Brazil and Latin America, offering affordable payment solutions and operational efficiency.", "symbols": ["NYAX"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/02/44046550/nayax-acquires-uppay-in-53m-deal-adding-25000-self-service-points-to-its-brazilian-network", "tags": ["offering", "merger", "contract"]}
{"id": 44046595, "time": "2025-02-28 10:40:45", "headline": "Craig-Hallum Maintains Buy on Globalstar, Lowers Price Target to $45", "summary": "", "symbols": ["GSAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046595/craig-hallum-maintains-buy-on-globalstar-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046628, "time": "2025-02-28 10:41:47", "headline": "Canaccord Genuity Maintains Buy on Ameresco, Lowers Price Target to $27", "summary": "", "symbols": ["AMRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046628/canaccord-genuity-maintains-buy-on-ameresco-lowers-price-target-to-27", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046666, "time": "2025-02-28 10:42:56", "headline": "Craig-Hallum Maintains Buy on Airgain, Lowers Price Target to $9", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046666/craig-hallum-maintains-buy-on-airgain-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046680, "time": "2025-02-28 10:43:34", "headline": "Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $15", "summary": "", "symbols": ["CMPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046680/canaccord-genuity-maintains-buy-on-compass-pathways-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046703, "time": "2025-02-28 10:44:29", "headline": "Canaccord Genuity Maintains Buy on DoubleVerify Hldgs, Lowers Price Target to $26", "summary": "", "symbols": ["DV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046703/canaccord-genuity-maintains-buy-on-doubleverify-hldgs-lowers-price-target-to-26", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046734, "time": "2025-02-28 10:45:13", "headline": "What's Going On With Super Micro Computer Stock Friday?", "summary": "Super Micro shares are moving lower on continued volatility on Friday following the company&#39;s quarterly report filing.", "symbols": ["SMCI"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/02/44046734/whats-going-on-with-super-micro-computer-stock-friday-2", "tags": ["why_moving"]}
{"id": 44046756, "time": "2025-02-28 10:45:16", "headline": "Craig-Hallum Maintains Buy on Life Time Group Hldgs, Raises Price Target to $45", "summary": "", "symbols": ["LTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046756/craig-hallum-maintains-buy-on-life-time-group-hldgs-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 44046761, "time": "2025-02-28 10:45:23", "headline": "Is Interactive Brokers Gr Gaining or Losing Market Support?", "summary": " ", "symbols": ["IBKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44046761/is-interactive-brokers-gr-gaining-or-losing-market-support", "tags": []}
{"id": 44046768, "time": "2025-02-28 10:45:29", "headline": "Peering Into Goldman Sachs Gr's Recent Short Interest", "summary": " ", "symbols": ["GS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44046768/peering-into-goldman-sachs-grs-recent-short-interest", "tags": []}
{"id": 44046774, "time": "2025-02-28 10:45:34", "headline": "Is Herc Holdings Gaining or Losing Market Support?", "summary": " ", "symbols": ["HRI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44046774/is-herc-holdings-gaining-or-losing-market-support", "tags": []}
{"id": 44046880, "time": "2025-02-28 10:46:47", "headline": "Better Choice Company Announces That SRx Health Solutions Was Granted The Final Order Pursuant To The Business Corporations Act By The Ontario Superior Court Of Justice To Proceed With The Acquisition By Better Choice Company", "summary": "", "symbols": ["BTTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44046880/better-choice-company-announces-that-srx-health-solutions-was-granted-the-final-order-pursuant-to-th", "tags": ["legal"]}
{"id": 44046950, "time": "2025-02-28 10:47:54", "headline": "What's Going On With AMC Entertainment Stock?", "summary": "AMC Entertainment shares are trading lower by 6% since Monday&#39;s open. The company this week reported Q4 financial results.", "symbols": ["AMC"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/02/44046950/whats-going-on-with-amc-entertainment-stock-11", "tags": ["why_moving"]}
{"id": 44046969, "time": "2025-02-28 10:48:16", "headline": "Citizens Capital Markets Maintains Market Outperform on Structure Therapeutics, Lowers Price Target to $87", "summary": "", "symbols": ["GPCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44046969/citizens-capital-markets-maintains-market-outperform-on-structure-therapeutics-lowers-price-target-t", "tags": ["analyst_other", "price_target_down"]}
{"id": 44047014, "time": "2025-02-28 10:49:09", "headline": "Canaccord Genuity Maintains Buy on Elastic, Raises Price Target to $135", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047014/canaccord-genuity-maintains-buy-on-elastic-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047021, "time": "2025-02-28 10:49:32", "headline": "Citizens Capital Markets Maintains Market Outperform on HCI Group, Raises Price Target to $165", "summary": "", "symbols": ["HCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047021/citizens-capital-markets-maintains-market-outperform-on-hci-group-raises-price-target-to-165", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047080, "time": "2025-02-28 10:50:35", "headline": "Citizens Capital Markets Maintains Market Outperform on Hamilton Insurance Group, Raises Price Target to $27", "summary": "", "symbols": ["HG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047080/citizens-capital-markets-maintains-market-outperform-on-hamilton-insurance-group-raises-price-target", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047089, "time": "2025-02-28 10:50:48", "headline": "Canaccord Genuity Maintains Buy on Jamf Holding, Lowers Price Target to $19", "summary": "", "symbols": ["JAMF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047089/canaccord-genuity-maintains-buy-on-jamf-holding-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 44047129, "time": "2025-02-28 10:52:26", "headline": "Canaccord Genuity Maintains Buy on Natera, Raises Price Target to $195", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047129/canaccord-genuity-maintains-buy-on-natera-raises-price-target-to-195", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047130, "time": "2025-02-28 10:52:28", "headline": "Citizens Capital Markets Maintains Market Outperform on Jamf Holding, Lowers Price Target to $27", "summary": "", "symbols": ["JAMF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047130/citizens-capital-markets-maintains-market-outperform-on-jamf-holding-lowers-price-target-to-27", "tags": ["analyst_other", "price_target_down"]}
{"id": 44047172, "time": "2025-02-28 10:54:57", "headline": "Citizens Capital Markets Maintains Buy on LeMaitre Vascular, Raises Price Target to $110", "summary": "", "symbols": ["LMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047172/citizens-capital-markets-maintains-buy-on-lemaitre-vascular-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047187, "time": "2025-02-28 10:55:38", "headline": "Canaccord Genuity Maintains Hold on Progyny, Raises Price Target to $23", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047187/canaccord-genuity-maintains-hold-on-progyny-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047246, "time": "2025-02-28 10:56:58", "headline": "Polestar Secures New $450M Financing Deal To Boost Growth", "summary": "Polestar Inc. (NASDAQ: PSNY) secures up to $450 million in a 12-month term facility and renews its \u20ac480 million Green Trade Finance Facility (TFF). This follows the company&#39;s $800 million in funding from December 2024, strengthening its financial position.", "symbols": ["PSNY", "TSLA"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/news/25/02/44047246/polestar-secures-new-450m-financing-deal-to-boost-growth", "tags": ["contract"]}
{"id": 44047261, "time": "2025-02-28 10:57:27", "headline": "Citizens Capital Markets Maintains Market Outperform on BeOne Medicines, Raises Price Target to $348", "summary": "", "symbols": ["ONC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047261/citizens-capital-markets-maintains-market-outperform-on-beone-medicines-raises-price-target-to-348", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047262, "time": "2025-02-28 10:57:28", "headline": "Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $30", "summary": "", "symbols": ["PRVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047262/canaccord-genuity-maintains-buy-on-privia-health-gr-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047295, "time": "2025-02-28 10:58:34", "headline": "CleanSpark Option Alert: Apr 17 $15 Calls At The Ask: 5000 @ $0.15 vs 880 OI; Ref=$8.0514", "summary": "", "symbols": ["CLSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047295/cleanspark-option-alert-apr-17-15-calls-at-the-ask-5000-0-15-vs-880-oi-ref-8-0514", "tags": []}
{"id": 44047309, "time": "2025-02-28 10:59:14", "headline": "Citizens Capital Markets Maintains Market Outperform on Plymouth Industrial REIT, Lowers Price Target to $24", "summary": "", "symbols": ["PLYM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047309/citizens-capital-markets-maintains-market-outperform-on-plymouth-industrial-reit-lowers-price-target", "tags": ["analyst_other", "price_target_down"]}
{"id": 44047360, "time": "2025-02-28 11:00:22", "headline": "Iamgold Option Alert: Jun 20 $6 Calls Sweep (5) Near The Ask: 3500 @ $0.518 vs 1609 OI; Ref=$5.4699", "summary": "", "symbols": ["IAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047360/iamgold-option-alert-jun-20-6-calls-sweep-5-near-the-ask-3500-0-518-vs-1609-oi-ref-5-4699", "tags": []}
{"id": 44047368, "time": "2025-02-28 11:00:24", "headline": "Citizens Capital Markets Maintains Market Outperform on Privia Health Gr, Raises Price Target to $29", "summary": "", "symbols": ["PRVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047368/citizens-capital-markets-maintains-market-outperform-on-privia-health-gr-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047389, "time": "2025-02-28 11:00:33", "headline": "Looking Into Lucid Group's Recent Short Interest", "summary": " ", "symbols": ["LCID"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44047389/looking-into-lucid-groups-recent-short-interest", "tags": []}
{"id": 44047408, "time": "2025-02-28 11:00:39", "headline": "Is the Market Bullish or Bearish on Zimmer Biomet Holdings?", "summary": " ", "symbols": ["ZBH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44047408/is-the-market-bullish-or-bearish-on-zimmer-biomet-holdings", "tags": []}
{"id": 44047423, "time": "2025-02-28 11:00:46", "headline": "Is the Market Bullish or Bearish on Labcorp Hldgs?", "summary": " ", "symbols": ["LH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44047423/is-the-market-bullish-or-bearish-on-labcorp-hldgs", "tags": []}
{"id": 44047519, "time": "2025-02-28 11:01:58", "headline": "Guggenheim Maintains Buy on Nexstar Media Gr, Raises Price Target to $220", "summary": "", "symbols": ["NXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047519/guggenheim-maintains-buy-on-nexstar-media-gr-raises-price-target-to-220", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047547, "time": "2025-02-28 11:03:07", "headline": "Bloom Energy Posts Q4 Beat: Margin Profile Remains Below Industry Average, Analyst Says", "summary": "Bloom Energy (BE) reported Q4 results ahead of expectations. Analyst Mark Strouse raised price target to $18.", "symbols": ["BE"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/news/earnings/earnings-beats/25/02/44047547/bloom-energy-posts-q4-beat-margin-profile-remains-below-industry-average-analyst-says", "tags": ["earnings"]}
{"id": 44047561, "time": "2025-02-28 11:03:17", "headline": "Canaccord Genuity Maintains Buy on Wallbox, Lowers Price Target to $1", "summary": "", "symbols": ["WBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047561/canaccord-genuity-maintains-buy-on-wallbox-lowers-price-target-to-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 44047570, "time": "2025-02-28 11:03:27", "headline": "Guggenheim Maintains Buy on Life Time Group Hldgs, Raises Price Target to $36", "summary": "", "symbols": ["LTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047570/guggenheim-maintains-buy-on-life-time-group-hldgs-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047600, "time": "2025-02-28 11:04:07", "headline": "Benzinga Market Summary: Jan. PCE Price Index Comes In Line With Estimates, NVIDIA Rebounds, 10-Year Falls", "summary": "", "symbols": ["NVDA", "SPY", "VTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44047600/benzinga-market-summary-jan-pce-price-index-comes-in-line-with-estimates-nvidia-r", "tags": []}
{"id": 44047616, "time": "2025-02-28 11:04:35", "headline": "Guggenheim Maintains Buy on FirstEnergy, Lowers Price Target to $45", "summary": "", "symbols": ["FE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047616/guggenheim-maintains-buy-on-firstenergy-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 44047642, "time": "2025-02-28 11:05:25", "headline": "Guggenheim Maintains Buy on Elastic, Raises Price Target to $136", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047642/guggenheim-maintains-buy-on-elastic-raises-price-target-to-136", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047683, "time": "2025-02-28 11:07:27", "headline": "Benchmark Maintains Buy on Rush Street Interactive, Raises Price Target to $14", "summary": "", "symbols": ["RSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047683/benchmark-maintains-buy-on-rush-street-interactive-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047715, "time": "2025-02-28 11:08:57", "headline": "Benchmark Maintains Buy on Nexstar Media Gr, Raises Price Target to $225", "summary": "", "symbols": ["NXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047715/benchmark-maintains-buy-on-nexstar-media-gr-raises-price-target-to-225", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047737, "time": "2025-02-28 11:09:57", "headline": "XRP Down 22% In 7 Days: How Low Will It Go?", "summary": "XRP (CRYPTO: XRP)is down 22% over the past seven days, but traders see signs of a potential relief rally if sentiment around Ripple remains positive.", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44047737/xrp-down-22-in-7-days-how-low-will-it-go", "tags": []}
{"id": 44047739, "time": "2025-02-28 11:10:01", "headline": "Benchmark Maintains Buy on Light & Wonder, Raises Price Target to $130", "summary": "", "symbols": ["LNW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047739/benchmark-maintains-buy-on-light-wonder-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047793, "time": "2025-02-28 11:12:06", "headline": "HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $17 Price Target", "summary": "", "symbols": ["VALN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047793/hc-wainwright-co-reiterates-buy-on-valneva-maintains-17-price-target", "tags": ["analyst_other"]}
{"id": 44047831, "time": "2025-02-28 11:14:19", "headline": "HC Wainwright & Co. Reiterates Buy on 89bio, Lowers Price Target to $21", "summary": "", "symbols": ["ETNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047831/hc-wainwright-co-reiterates-buy-on-89bio-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 44047847, "time": "2025-02-28 11:14:50", "headline": "DA Davidson Maintains Neutral on Autodesk, Raises Price Target to $285", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047847/da-davidson-maintains-neutral-on-autodesk-raises-price-target-to-285", "tags": ["analyst_other", "price_target_up"]}
{"id": 44047877, "time": "2025-02-28 11:15:29", "headline": "Peering Into Okta's Recent Short Interest", "summary": " ", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44047877/peering-into-oktas-recent-short-interest", "tags": []}
{"id": 44047900, "time": "2025-02-28 11:15:34", "headline": "What's Driving the Market Sentiment Around Ingersoll Rand?", "summary": " ", "symbols": ["IR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44047900/whats-driving-the-market-sentiment-around-ingersoll-rand", "tags": []}
{"id": 44047903, "time": "2025-02-28 11:15:40", "headline": "How Is The Market Feeling About Associated Cap Gr?", "summary": " ", "symbols": ["AC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44047903/how-is-the-market-feeling-about-associated-cap-gr", "tags": []}
{"id": 44047915, "time": "2025-02-28 11:15:53", "headline": "DA Davidson Maintains Buy on Installed Building Prods, Lowers Price Target to $225", "summary": "", "symbols": ["IBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44047915/da-davidson-maintains-buy-on-installed-building-prods-lowers-price-target-to-225", "tags": ["analyst_other", "price_target_down"]}
{"id": 44047945, "time": "2025-02-28 11:16:19", "headline": "Duolingo's AI Investments Set The Stage For Long-Term Growth\u2014Analyst Sees Stock Hitting $400", "summary": "Analyst raises Duolingo&#39;s price forecast to $400 while maintaining Buy rating. Company reports mixed Q4 results with strong DAU growth and increased investments for long-term growth.", "symbols": ["DUOL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/02/44047945/duolingos-ai-investments-set-the-stage-for-long-term-growth-analyst-sees-stock-hitting-400", "tags": ["earnings", "guidance"]}
{"id": 44048023, "time": "2025-02-28 11:17:01", "headline": "DA Davidson Maintains Buy on AAON, Lowers Price Target to $125", "summary": "", "symbols": ["AAON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048023/da-davidson-maintains-buy-on-aaon-lowers-price-target-to-125", "tags": ["analyst_other", "price_target_down"]}
{"id": 44048110, "time": "2025-02-28 11:18:04", "headline": "DA Davidson Maintains Buy on Duolingo, Raises Price Target to $400", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048110/da-davidson-maintains-buy-on-duolingo-raises-price-target-to-400", "tags": ["analyst_other", "price_target_up"]}
{"id": 44048148, "time": "2025-02-28 11:19:19", "headline": "DA Davidson Maintains Buy on Vertex, Lowers Price Target to $55", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048148/da-davidson-maintains-buy-on-vertex-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 44048187, "time": "2025-02-28 11:20:13", "headline": "DA Davidson Maintains Buy on SoundHound AI, Raises Price Target to $13", "summary": "", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048187/da-davidson-maintains-buy-on-soundhound-ai-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 44048226, "time": "2025-02-28 11:21:21", "headline": "DA Davidson Maintains Neutral on GitLab, Lowers Price Target to $60", "summary": "", "symbols": ["GTLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048226/da-davidson-maintains-neutral-on-gitlab-lowers-price-target-to-60", "tags": ["analyst_other", "price_target_down"]}
{"id": 44048279, "time": "2025-02-28 11:23:02", "headline": "What's Going On With SoundHound AI Shares Friday?", "summary": "SoundHound AI shares are moving higher on Friday after the company reported better-than-expected fourth-quarter earnings and raised its fiscal-year 2025 guidance on Thursday after the market closed.", "symbols": ["SOUN"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/02/44048279/whats-going-on-with-soundhound-ai-shares-friday-2", "tags": ["earnings", "guidance", "why_moving"]}
{"id": 44048360, "time": "2025-02-28 11:25:18", "headline": "Jefferies Maintains Buy on Vertex, Lowers Price Target to $48", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048360/jefferies-maintains-buy-on-vertex-lowers-price-target-to-48", "tags": ["analyst_other", "price_target_down"]}
{"id": 44048438, "time": "2025-02-28 11:27:26", "headline": "Trump Restaurant In The Metaverse? President's Trademark Shows Fans Could Wear Virtual MAGA Hats There Soon", "summary": "The Trump Organization, which is privately owned by President Donald Trump, recently filed a new trademark for several cryptocurrency and NFT-related items. Here&#39;s a look at what the move means and how Trump could be betting on the future growth of the metaverse.", "symbols": ["BTC", "BTCUSD", "DJT", "ETHUSD", "MATICUSD", "SOLUSD", "TRUMPUSD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/government/regulations/25/02/44048438/trump-restaurant-in-the-metaverse-presidents-trademark-shows-fans-could-wear-virtual-maga-hats-there-soon", "tags": []}
{"id": 44048486, "time": "2025-02-28 11:28:57", "headline": "Bitcoin's 24% Correction 'Mostly Technical' Say Experts", "summary": "A sharp decline in cryptocurrency sentiment, dubbed a \u201cmega nuke\u201d by analysts, has gripped the market as Bitcoin (CRYPTO: BTC) fell below $79,000 on Thursday evening, down 24% from its January peak of $109,590.", "symbols": ["BNBUSD", "BTCUSD", "DOGEUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44048486/bitcoins-24-correction-mostly-technical-say-experts", "tags": []}
{"id": 44048491, "time": "2025-02-28 11:29:18", "headline": "JP Morgan Maintains Neutral on Ormat Technologies, Raises Price Target to $75", "summary": "", "symbols": ["ORA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048491/jp-morgan-maintains-neutral-on-ormat-technologies-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 44048545, "time": "2025-02-28 11:30:31", "headline": "JP Morgan Maintains Neutral on Cars.com, Lowers Price Target to $17", "summary": "", "symbols": ["CARS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048545/jp-morgan-maintains-neutral-on-cars-com-lowers-price-target-to-17", "tags": ["analyst_other", "price_target_down"]}
{"id": 44048554, "time": "2025-02-28 11:30:46", "headline": "Here's How Much $1000 Invested In Jones Lang LaSalle 20 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["JLL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44048554/heres-how-much-1000-invested-in-jones-lang-lasalle-20-years-ago-would-be-worth-today", "tags": []}
{"id": 44048581, "time": "2025-02-28 11:31:18", "headline": "Hims & Hers Health Unusual Options Activity For February 28", "summary": " ", "symbols": ["HIMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44048581/hims-hers-health-unusual-options-activity-for-february-28", "tags": []}
{"id": 44048618, "time": "2025-02-28 11:31:55", "headline": "Warner Bros Discovery Posts Q4 Miss, Gap With Competitors Is Widening: Analyst", "summary": "Warner Bros. revenue growth is likely to be flat, with negative earnings, over the next couple of years, according to Needham.", "symbols": ["WBD"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/news/earnings/earnings-misses/25/02/44048618/warner-bros-discovery-posts-q4-miss-gap-with-competitors-is-widening-analyst", "tags": ["earnings"]}
{"id": 44048659, "time": "2025-02-28 11:32:39", "headline": "JP Morgan Maintains Underweight on Brown-Forman, Lowers Price Target to $34", "summary": "", "symbols": ["BF", "BF/B"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048659/jp-morgan-maintains-underweight-on-brown-forman-lowers-price-target-to-34", "tags": ["analyst_other", "price_target_down"]}
{"id": 44048717, "time": "2025-02-28 11:34:54", "headline": "JP Morgan Maintains Overweight on PTC Therapeutics, Lowers Price Target to $72", "summary": "", "symbols": ["PTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048717/jp-morgan-maintains-overweight-on-ptc-therapeutics-lowers-price-target-to-72", "tags": ["analyst_other", "price_target_down"]}
{"id": 44048758, "time": "2025-02-28 11:35:51", "headline": "JP Morgan Maintains Overweight on CrowdStrike Holdings, Raises Price Target to $450", "summary": "", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048758/jp-morgan-maintains-overweight-on-crowdstrike-holdings-raises-price-target-to-450", "tags": ["analyst_other", "price_target_up"]}
{"id": 44048841, "time": "2025-02-28 11:38:04", "headline": "Reported February 27, 2025: Select Equity Group, L.P. Writes Letter To The Board Of Signet Jewelers", "summary": "", "symbols": ["SIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44048841/reported-february-27-2025-select-equity-group-l-p-writes-letter-to-the-board-of-signet-jewelers", "tags": []}
{"id": 44048684, "time": "2025-02-28 11:33:29", "headline": "Reported February 27, 2025: Signet Jewelers 13D Filing Shows Select Equity Group, L.P. Reported A 9.7% Stake In The Co As Of February 26, 2025", "summary": "", "symbols": ["SIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44048684/reported-february-17-2025-signet-jewelers-13d-filing-shows-select-equity-group-l-p-reported-a-9-7-st", "tags": []}
{"id": 44048921, "time": "2025-02-28 11:39:48", "headline": "President Trump Says We Have Something That Is A Very Fair Deal; It Is A Big Commitment From The U.S.; Spoke To Putin; Had Good Discussions With Russia; We've Started The Confines Of A Deal; Will Sign Minerals Deal Today; Ukrainian President Zelenskiy Says Hopeful This Document Will Be A Step Forward For Ukraine; I Want To Discuss What U.S. Is Ready To Do", "summary": "", "symbols": ["SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44048921/president-trump-says-we-have-something-that-is-a-very-fair-deal-it-is-a-big-commi", "tags": ["contract"]}
{"id": 44049029, "time": "2025-02-28 11:42:54", "headline": "JP Morgan Maintains Overweight on Okta, Raises Price Target to $105", "summary": "", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049029/jp-morgan-maintains-overweight-on-okta-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049050, "time": "2025-02-28 11:43:25", "headline": "President Trump Says We Are Going To Take Rare Earths And Use It For All We Do, Including Ai And Military Weapons", "summary": "", "symbols": ["SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44049050/president-trump-says-we-are-going-to-take-rare-earths-and-use-it-for-all-we-do-in", "tags": []}
{"id": 44047017, "time": "2025-02-28 10:49:19", "headline": "Citigroup Accidentally Sends $81 Trillion To Client, Reverses Error Within Hours (UPDATED)", "summary": "Citigroup Inc (C) made $81 trillion mistake, but no loss of funds occurred, as two officials failed to detect error and a third employee detected it later.", "symbols": ["BRK", "C"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/25/02/44047017/citigroup-accidentally-sends-81-trillion-to-client-reverses-error-within-hours", "tags": []}
{"id": 44049061, "time": "2025-02-28 11:43:42", "headline": "JP Morgan Maintains Overweight on Duolingo, Raises Price Target to $410", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049061/jp-morgan-maintains-overweight-on-duolingo-raises-price-target-to-410", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049102, "time": "2025-02-28 11:44:44", "headline": "JP Morgan Maintains Overweight on NetApp, Lowers Price Target to $153", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049102/jp-morgan-maintains-overweight-on-netapp-lowers-price-target-to-153", "tags": ["analyst_other", "price_target_down"]}
{"id": 44049136, "time": "2025-02-28 11:45:31", "headline": "How Is The Market Feeling About Tradeweb Markets?", "summary": " ", "symbols": ["TW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44049136/how-is-the-market-feeling-about-tradeweb-markets", "tags": []}
{"id": 44049146, "time": "2025-02-28 11:45:36", "headline": "Looking Into Northern Trust's Recent Short Interest", "summary": " ", "symbols": ["NTRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44049146/looking-into-northern-trusts-recent-short-interest", "tags": []}
{"id": 44049151, "time": "2025-02-28 11:45:41", "headline": "Peering Into NetEase's Recent Short Interest", "summary": " ", "symbols": ["NTES"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44049151/peering-into-neteases-recent-short-interest", "tags": []}
{"id": 44049333, "time": "2025-02-28 11:47:57", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Equitable Holdings, Raises Price Target to $66", "summary": "", "symbols": ["EQH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049333/keefe-bruyette-woods-maintains-outperform-on-equitable-holdings-raises-price-target-to-66", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049376, "time": "2025-02-28 11:49:40", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Green Dot, Lowers Price Target to $10", "summary": "", "symbols": ["GDOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049376/keefe-bruyette-woods-maintains-market-perform-on-green-dot-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 44049396, "time": "2025-02-28 11:50:07", "headline": "Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027", "summary": "Perrigo Company shares surged after issuing financial targets for 2025 &amp; 2025-2027 on investor day. Expect sales growth, EPS, and margin expansion. &#39;Three-S&#39; plan will enhance cash flow &amp; shareholder return. Q4 results below estimates.", "symbols": ["PRGO", "SMIG", "XPH"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/02/44049396/perrigo-outlines-2025-growth-plans-projects-sales-boost-and-margin-expansion-by-2027", "tags": ["earnings"]}
{"id": 44049407, "time": "2025-02-28 11:50:18", "headline": "Barclays Maintains Underweight on Alignment Healthcare, Raises Price Target to $9", "summary": "", "symbols": ["ALHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049407/barclays-maintains-underweight-on-alignment-healthcare-raises-price-target-to-9", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049445, "time": "2025-02-28 11:51:25", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Jackson Finl, Raises Price Target to $105", "summary": "", "symbols": ["JXN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049445/keefe-bruyette-woods-maintains-market-perform-on-jackson-finl-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049455, "time": "2025-02-28 11:51:58", "headline": "Barclays Maintains Equal-Weight on Certara, Raises Price Target to $13", "summary": "", "symbols": ["CERT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049455/barclays-maintains-equal-weight-on-certara-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049469, "time": "2025-02-28 11:52:52", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Unum Gr, Raises Price Target to $103", "summary": "", "symbols": ["UNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049469/keefe-bruyette-woods-maintains-outperform-on-unum-gr-raises-price-target-to-103", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049494, "time": "2025-02-28 11:53:36", "headline": "Inventory Stabilizes, But Cars.com Lags Peers: Analyst Flags Profit Pressures", "summary": "JP Morgan analyst cuts Cars.com price forecast to $17 while keeping Neutral rating. Q4 adjusted EPS and revenue miss estimates.", "symbols": ["CARS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/02/44049494/inventory-stabilizes-but-cars-com-lags-peers-analyst-flags-profit-pressures", "tags": ["earnings", "guidance"]}
{"id": 44049522, "time": "2025-02-28 11:54:45", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Payoneer Global, Lowers Price Target to $10", "summary": "", "symbols": ["PAYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049522/keefe-bruyette-woods-maintains-market-perform-on-payoneer-global-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 44049541, "time": "2025-02-28 11:55:22", "headline": "Barclays Downgrades Acadia Healthcare Co to Equal-Weight, Lowers Price Target to $35", "summary": "", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049541/barclays-downgrades-acadia-healthcare-co-to-equal-weight-lowers-price-target-to-35", "tags": ["analyst_down", "price_target_down"]}
{"id": 44049576, "time": "2025-02-28 11:56:37", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Skyward Specialty, Raises Price Target to $62", "summary": "", "symbols": ["SKWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049576/keefe-bruyette-woods-maintains-outperform-on-skyward-specialty-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049599, "time": "2025-02-28 11:57:48", "headline": "Loop Capital Upgrades Nexstar Media Gr to Buy, Raises Price Target to $200", "summary": "", "symbols": ["NXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049599/loop-capital-upgrades-nexstar-media-gr-to-buy-raises-price-target-to-200", "tags": ["analyst_up", "price_target_up"]}
{"id": 44049604, "time": "2025-02-28 11:58:06", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on BlackRock TCP Cap, Lowers Price Target to $8.5", "summary": "", "symbols": ["TCPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049604/keefe-bruyette-woods-maintains-market-perform-on-blackrock-tcp-cap-lowers-price-target-to-8-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44049626, "time": "2025-02-28 11:59:29", "headline": "Key Inflation Measure Falls In January: 'Should Catch The Fed's Attention,' Economist Says", "summary": "The Federal Reserve&#39;s preferred gauge of inflation marked its first decline in four months Friday. Markets and economists are reacting to the latest PCE data.\u00a0", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/25/02/44049626/key-inflation-measure-falls-in-january-should-catch-the-feds-attention-expert-says", "tags": []}
{"id": 44049629, "time": "2025-02-28 11:59:33", "headline": "Lake Street Maintains Buy on LENSAR, Raises Price Target to $16", "summary": "", "symbols": ["LNSR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049629/lake-street-maintains-buy-on-lensar-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049676, "time": "2025-02-28 12:00:33", "headline": "How Do Investors Really Feel About Willis Towers Watson?", "summary": " ", "symbols": ["WTW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44049676/how-do-investors-really-feel-about-willis-towers-watson", "tags": []}
{"id": 44049680, "time": "2025-02-28 12:00:39", "headline": "How Is The Market Feeling About Qualcomm?", "summary": " ", "symbols": ["QCOM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44049680/how-is-the-market-feeling-about-qualcomm", "tags": []}
{"id": 44049685, "time": "2025-02-28 12:00:45", "headline": "What Does the Market Think About Abbott Laboratories?", "summary": " ", "symbols": ["ABT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44049685/what-does-the-market-think-about-abbott-laboratories", "tags": []}
{"id": 44049687, "time": "2025-02-28 12:00:47", "headline": "Lake Street Maintains Buy on PubMatic, Lowers Price Target to $21", "summary": "", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049687/lake-street-maintains-buy-on-pubmatic-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 44049719, "time": "2025-02-28 12:01:35", "headline": "Lake Street Maintains Buy on LeMaitre Vascular, Raises Price Target to $110", "summary": "", "symbols": ["LMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049719/lake-street-maintains-buy-on-lemaitre-vascular-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049746, "time": "2025-02-28 12:01:58", "headline": "Morgan Stanley Maintains Equal-Weight on Aflac, Raises Price Target to $105", "summary": "", "symbols": ["AFL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049746/morgan-stanley-maintains-equal-weight-on-aflac-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049777, "time": "2025-02-28 12:03:00", "headline": "Lake Street Maintains Buy on Expensify, Raises Price Target to $5", "summary": "", "symbols": ["EXFY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049777/lake-street-maintains-buy-on-expensify-raises-price-target-to-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049816, "time": "2025-02-28 12:04:41", "headline": "Morgan Stanley Maintains Equal-Weight on Globe Life, Raises Price Target to $126", "summary": "", "symbols": ["GL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049816/morgan-stanley-maintains-equal-weight-on-globe-life-raises-price-target-to-126", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049861, "time": "2025-02-28 12:06:08", "headline": "Morgan Stanley Maintains Equal-Weight on Lincoln National, Raises Price Target to $42", "summary": "", "symbols": ["LNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049861/morgan-stanley-maintains-equal-weight-on-lincoln-national-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049887, "time": "2025-02-28 12:07:29", "headline": "Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $109", "summary": "", "symbols": ["MET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049887/morgan-stanley-maintains-overweight-on-metlife-raises-price-target-to-109", "tags": ["analyst_other", "price_target_up"]}
{"id": 44049950, "time": "2025-02-28 12:10:01", "headline": "Better-Than-Feared PCE Brings Buying Into Stock Market, Trump's Stroke Of Genius", "summary": " ", "symbols": [], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/markets/equities/25/02/44049950/better-than-feared-pce-brings-buying-into-stock-market-trumps-stroke-of-genius", "tags": []}
{"id": 44049958, "time": "2025-02-28 12:10:18", "headline": "Macquarie Maintains Outperform on BeOne Medicines, Raises Price Target to $313", "summary": "", "symbols": ["ONC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44049958/macquarie-maintains-outperform-on-beone-medicines-raises-price-target-to-313", "tags": ["analyst_other", "price_target_up"]}
{"id": 44050017, "time": "2025-02-28 12:12:13", "headline": "Morgan Stanley Maintains Equal-Weight on Primerica, Lowers Price Target to $304", "summary": "", "symbols": ["PRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050017/morgan-stanley-maintains-equal-weight-on-primerica-lowers-price-target-to-304", "tags": ["analyst_other", "price_target_down"]}
{"id": 44050038, "time": "2025-02-28 12:13:33", "headline": "Citigroup Reinstates Buy on ONEOK, Announces $110 Price Target", "summary": "", "symbols": ["OKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050038/citigroup-reinstates-buy-on-oneok-announces-110-price-target", "tags": []}
{"id": 44050075, "time": "2025-02-28 12:14:39", "headline": "Morgan Stanley Maintains Equal-Weight on Prudential Financial, Lowers Price Target to $128", "summary": "", "symbols": ["PRU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050075/morgan-stanley-maintains-equal-weight-on-prudential-financial-lowers-price-target-to-128", "tags": ["analyst_other", "price_target_down"]}
{"id": 44050128, "time": "2025-02-28 12:16:04", "headline": "Looking At Exxon Mobil's Recent Unusual Options Activity", "summary": " ", "symbols": ["XOM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44050128/looking-at-exxon-mobils-recent-unusual-options-activity", "tags": []}
{"id": 44050221, "time": "2025-02-28 12:17:10", "headline": "Morgan Stanley Maintains Equal-Weight on Unum Gr, Raises Price Target to $84", "summary": "", "symbols": ["UNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050221/morgan-stanley-maintains-equal-weight-on-unum-gr-raises-price-target-to-84", "tags": ["analyst_other", "price_target_up"]}
{"id": 44050314, "time": "2025-02-28 12:18:49", "headline": "Wells Fargo Maintains Equal-Weight on Aris Water Solutions, Raises Price Target to $29", "summary": "", "symbols": ["ARIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050314/wells-fargo-maintains-equal-weight-on-aris-water-solutions-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 44050317, "time": "2025-02-28 12:18:52", "headline": "Dine Brands Lacks Clear Catalysts, Analyst Downgrades Stock And Cuts Price Forecast By 40%", "summary": "Wedbush analyst Nick Setyan downgraded Dine Brands from Outperform to Neutral, slashing the price target from $47 to $28. Despite efforts to boost same-store sales through value-focused strategies, results for Applebee&#39;s and IHOP remain underwhelming.", "symbols": ["DIN"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/02/44050317/dine-brands-lacks-clear-catalysts-analyst-downgrades-stock-and-cuts-price-forecast-by-40", "tags": ["analyst_down", "guidance"]}
{"id": 44050318, "time": "2025-02-28 12:18:53", "headline": "Morgan Stanley Maintains Overweight on Monster Beverage, Raises Price Target to $60", "summary": "", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050318/morgan-stanley-maintains-overweight-on-monster-beverage-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 44050351, "time": "2025-02-28 12:19:30", "headline": "CORRECTION: Shares Of Chinese Stocks Are Lower", "summary": "", "symbols": ["BABA", "BIDU", "IQ", "JD", "LI", "NIO", "PDD", "XPEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050351/correction-shares-of-chinese-stocks-are-lower", "tags": []}
{"id": 44050417, "time": "2025-02-28 12:20:47", "headline": "'Fed's Goolsbee Warns Against Overreliance on Productivity Gains' - Bloomberg News", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44050417/feds-goolsbee-warns-against-overreliance-on-productivity-gains-bloomberg-news", "tags": []}
{"id": 44050421, "time": "2025-02-28 12:20:50", "headline": "Wells Fargo Maintains Overweight on DT Midstream, Lowers Price Target to $108", "summary": "", "symbols": ["DTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050421/wells-fargo-maintains-overweight-on-dt-midstream-lowers-price-target-to-108", "tags": ["analyst_other", "price_target_down"]}
{"id": 44050423, "time": "2025-02-28 12:21:01", "headline": "Morgan Stanley Maintains Overweight on Liberty Formula One Gr, Lowers Price Target to $110", "summary": "", "symbols": ["FWONK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050423/morgan-stanley-maintains-overweight-on-liberty-formula-one-gr-lowers-price-target-to-110", "tags": ["analyst_other", "price_target_down"]}
{"id": 44050433, "time": "2025-02-28 12:21:43", "headline": "Wells Fargo Maintains Overweight on Intellia Therapeutics, Lowers Price Target to $50", "summary": "", "symbols": ["NTLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050433/wells-fargo-maintains-overweight-on-intellia-therapeutics-lowers-price-target-to-50", "tags": ["analyst_other", "price_target_down"]}
{"id": 44050446, "time": "2025-02-28 12:22:44", "headline": "Wells Fargo Maintains Overweight on Xencor, Lowers Price Target to $33", "summary": "", "symbols": ["XNCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050446/wells-fargo-maintains-overweight-on-xencor-lowers-price-target-to-33", "tags": ["analyst_other", "price_target_down"]}
{"id": 44050502, "time": "2025-02-28 12:24:57", "headline": "Wells Fargo Maintains Overweight on argenx, Raises Price Target to $741", "summary": "", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050502/wells-fargo-maintains-overweight-on-argenx-raises-price-target-to-741", "tags": ["analyst_other", "price_target_up"]}
{"id": 44050750, "time": "2025-02-28 12:30:33", "headline": "Is KKR Gaining or Losing Market Support?", "summary": " ", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44050750/is-kkr-gaining-or-losing-market-support", "tags": []}
{"id": 44050751, "time": "2025-02-28 12:30:38", "headline": "What's Driving the Market Sentiment Around Realty Income?", "summary": " ", "symbols": ["O"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44050751/whats-driving-the-market-sentiment-around-realty-income", "tags": []}
{"id": 44050755, "time": "2025-02-28 12:30:43", "headline": "Peering Into Pure Storage's Recent Short Interest", "summary": " ", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44050755/peering-into-pure-storages-recent-short-interest", "tags": []}
{"id": 44050819, "time": "2025-02-28 12:32:15", "headline": "Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang", "summary": "LAVA Therapeutics reviews strategic options amid cost cuts. HC Wainwright downgrades stock, citing uncertainties over LAVA-1266 and possible business shifts.", "symbols": ["JNJ", "LVTX", "PFE"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/02/44050819/analyst-downgrades-lava-therapeutics-sees-pipeline-overhang", "tags": ["analyst_down"]}
{"id": 44050820, "time": "2025-02-28 12:32:18", "headline": "Wells Fargo Maintains Overweight on Verona Pharma, Raises Price Target to $93", "summary": "", "symbols": ["VRNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050820/wells-fargo-maintains-overweight-on-verona-pharma-raises-price-target-to-93", "tags": ["analyst_other", "price_target_up"]}
{"id": 44050870, "time": "2025-02-28 12:33:54", "headline": "Wells Fargo Maintains Equal-Weight on Dentsply Sirona, Lowers Price Target to $19", "summary": "", "symbols": ["XRAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050870/wells-fargo-maintains-equal-weight-on-dentsply-sirona-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 44050871, "time": "2025-02-28 12:33:59", "headline": "Mizuho Maintains Neutral on Array Technologies, Lowers Price Target to $9", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050871/mizuho-maintains-neutral-on-array-technologies-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 44050898, "time": "2025-02-28 12:35:14", "headline": "10 Information Technology Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AAPL", "AI", "AMD", "AVGO", "CLSK", "NVDA", "PLTR", "RGTI", "SMCI", "TSM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44050898/10-information-technology-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 44050901, "time": "2025-02-28 12:35:19", "headline": "10 Consumer Discretionary Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["BABA", "DUOL", "EBAY", "GRPN", "LI", "MBLY", "PDD", "RIVN", "TJX", "TSLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44050901/10-consumer-discretionary-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 44050915, "time": "2025-02-28 12:35:25", "headline": "10 Financials Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["BAC", "C", "COIN", "IBKR", "MS", "NU", "PYPL", "ROOT", "XP", "XYZ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44050915/10-financials-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 44050929, "time": "2025-02-28 12:36:06", "headline": "Tesla's Sharp Drop Sends Shockwaves Through These ETFs", "summary": "Tesla&#39;s stock decline is impacting ETFs with significant exposure to the company. Leveraged ETFs have been hit the hardest, while broad-market and sector ETFs are also experiencing losses.", "symbols": ["NITE", "TESL", "TSLA", "VCR", "XLY"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/sector-etfs/25/02/44050929/teslas-sharp-drop-sends-shockwaves-through-these-etfs", "tags": []}
{"id": 44050949, "time": "2025-02-28 12:36:37", "headline": "Oppenheimer Maintains Outperform on argenx, Raises Price Target to $704", "summary": "", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44050949/oppenheimer-maintains-outperform-on-argenx-raises-price-target-to-704", "tags": ["analyst_other", "price_target_up"]}
{"id": 44050992, "time": "2025-02-28 12:37:45", "headline": "The Real Reason Why Bitcoin Is Down 14% In 7 Days (And May Go Down More)", "summary": "Bitcoin (CRYPTO: BTC) is down 14% over the past seven days, prompting experts to debate about the role receding liquidity is playing in this correction.", "symbols": ["BTCUSD", "ETHUSD", "MSTR", "SOLUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44050992/the-real-reason-why-bitcoin-is-down-14-in-7-days-and-may-go-down-more", "tags": []}
{"id": 44051000, "time": "2025-02-28 12:38:01", "headline": "Oppenheimer Maintains Outperform on Array Technologies, Lowers Price Target to $13", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051000/oppenheimer-maintains-outperform-on-array-technologies-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 44051021, "time": "2025-02-28 12:38:10", "headline": "On CNBC, Kevin Simpson Announced Sold MicroStrategy; Bought More Salesforce", "summary": "", "symbols": ["CRM", "MSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051021/on-cnbc-kevin-simpson-announced-sold-microstrategy-bought-more-salesforce", "tags": []}
{"id": 44051034, "time": "2025-02-28 12:38:26", "headline": "On CNBC, Stephanie Link Announced Bought More Eaton & Quanta Services", "summary": "", "symbols": ["ETN", "PWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051034/on-cnbc-stephanie-link-announced-bought-more-eaton-quanta-services", "tags": []}
{"id": 44051049, "time": "2025-02-28 12:38:41", "headline": "On CNBC, Jim Lebenthal Announced Bought More Nvidia", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051049/on-cnbc-jim-lebenthal-announced-bought-more-nvidia", "tags": []}
{"id": 44051053, "time": "2025-02-28 12:38:43", "headline": "Wells Fargo Maintains Overweight on Hamilton Insurance Group, Raises Price Target to $23", "summary": "", "symbols": ["HG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051053/wells-fargo-maintains-overweight-on-hamilton-insurance-group-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 44051071, "time": "2025-02-28 12:39:38", "headline": "Wells Fargo Maintains Equal-Weight on Norwegian Cruise Line, Raises Price Target to $28", "summary": "", "symbols": ["NCLH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051071/wells-fargo-maintains-equal-weight-on-norwegian-cruise-line-raises-price-target-to-28", "tags": ["analyst_other", "price_target_up"]}
{"id": 44051200, "time": "2025-02-28 12:43:09", "headline": "Wells Fargo Maintains Underweight on Liberty Formula One Gr, Lowers Price Target to $80", "summary": "", "symbols": ["FWONK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051200/wells-fargo-maintains-underweight-on-liberty-formula-one-gr-lowers-price-target-to-80", "tags": ["analyst_other", "price_target_down"]}
{"id": 44051218, "time": "2025-02-28 12:44:01", "headline": "Wells Fargo Maintains Equal-Weight on NetApp, Lowers Price Target to $115", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051218/wells-fargo-maintains-equal-weight-on-netapp-lowers-price-target-to-115", "tags": ["analyst_other", "price_target_down"]}
{"id": 44051236, "time": "2025-02-28 12:44:48", "headline": "Wells Fargo Maintains Equal-Weight on Kinetik Holdings, Lowers Price Target to $58", "summary": "", "symbols": ["KNTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051236/wells-fargo-maintains-equal-weight-on-kinetik-holdings-lowers-price-target-to-58", "tags": ["analyst_other", "price_target_down"]}
{"id": 44051260, "time": "2025-02-28 12:45:21", "headline": "Stifel Maintains Buy on Alignment Healthcare, Raises Price Target to $18", "summary": "", "symbols": ["ALHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051260/stifel-maintains-buy-on-alignment-healthcare-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 44051278, "time": "2025-02-28 12:46:11", "headline": "This Is What Whales Are Betting On Goldman Sachs Gr", "summary": " ", "symbols": ["GS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44051278/this-is-what-whales-are-betting-on-goldman-sachs-gr", "tags": []}
{"id": 44051280, "time": "2025-02-28 12:46:16", "headline": "Decoding Walmart's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44051280/decoding-walmarts-options-activity-whats-the-big-picture", "tags": []}
{"id": 44051282, "time": "2025-02-28 12:46:21", "headline": "Wells Fargo Maintains Overweight on Elastic, Raises Price Target to $150", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051282/wells-fargo-maintains-overweight-on-elastic-raises-price-target-to-150", "tags": ["analyst_other", "price_target_up"]}
{"id": 44051300, "time": "2025-02-28 12:46:37", "headline": "Stifel Maintains Buy on Autodesk, Lowers Price Target to $350", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051300/stifel-maintains-buy-on-autodesk-lowers-price-target-to-350", "tags": ["analyst_other", "price_target_down"]}
{"id": 44051469, "time": "2025-02-28 12:48:00", "headline": "Stifel Maintains Buy on DocGo, Lowers Price Target to $5.5", "summary": "", "symbols": ["DCGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051469/stifel-maintains-buy-on-docgo-lowers-price-target-to-5-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44051518, "time": "2025-02-28 12:49:17", "headline": "Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday?", "summary": "Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday&#39;s losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA) ", "symbols": ["ACHR", "ASTS", "BTCUSD", "CLOV", "DELL", "DIA", "DUOL", "EBS", "EIX", "ETHUSD", "GTLB", "HUT", "IWM", "NOVA", "NVAX", "NVDA", "OKTA", "PLUG", "QQQ", "RILY", "RKLB", "RUN", "SMR", "SOUN", "SPY", "TLN", "TLT", "TSLA", "XLE", "XLY", "XRPUSD"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/market-summary/25/02/44051518/nvidia-tesla-lead-tech-stock-rebound-whats-driving-markets-friday", "tags": []}
{"id": 44051553, "time": "2025-02-28 12:50:08", "headline": "Susquehanna Upgrades Rush Street Interactive to Positive, Announces $14 Price Target", "summary": "", "symbols": ["RSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051553/susquehanna-upgrades-rush-street-interactive-to-positive-announces-14-price-target", "tags": ["analyst_up"]}
{"id": 44051734, "time": "2025-02-28 12:56:26", "headline": "Morgan Stanley Maintains Overweight on Elastic, Raises Price Target to $140", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051734/morgan-stanley-maintains-overweight-on-elastic-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 44051764, "time": "2025-02-28 12:57:16", "headline": "On CNBC, Stephanie Link Announced Bought More UnitedHealth Group", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051764/on-cnbc-stephanie-link-announced-bought-more-unitedhealth-group", "tags": []}
{"id": 44051823, "time": "2025-02-28 12:59:13", "headline": "B. Riley Securities Downgrades Eventbrite to Neutral, Lowers Price Target to $3.5", "summary": "", "symbols": ["EB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051823/b-riley-securities-downgrades-eventbrite-to-neutral-lowers-price-target-to-3-5", "tags": ["analyst_down", "price_target_down"]}
{"id": 44051830, "time": "2025-02-28 12:59:41", "headline": "What's Going On With Nuvve Shares Friday?", "summary": "Nuvve shares are trading higher on Friday after the company was awarded a $400 million contract from the State of New Mexico.", "symbols": ["NVVE"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/02/44051830/whats-going-on-with-nuvve-shares-friday", "tags": ["why_moving", "contract"]}
{"id": 44051876, "time": "2025-02-28 13:00:20", "headline": "Expert Outlook: Voya Financial Through The Eyes Of 17 Analysts", "summary": " ", "symbols": ["VOYA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44051876/expert-outlook-voya-financial-through-the-eyes-of-17-analysts", "tags": ["guidance"]}
{"id": 44051899, "time": "2025-02-28 13:00:28", "headline": "7 Analysts Have This To Say About Vir Biotechnology", "summary": " ", "symbols": ["VIR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44051899/7-analysts-have-this-to-say-about-vir-biotechnology", "tags": []}
{"id": 44051904, "time": "2025-02-28 13:00:37", "headline": "A Glimpse Into The Expert Outlook On NetApp Through 7 Analysts", "summary": " ", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44051904/a-glimpse-into-the-expert-outlook-on-netapp-through-7-analysts", "tags": ["guidance"]}
{"id": 44051914, "time": "2025-02-28 13:00:46", "headline": "Expert Outlook: PENN Entertainment Through The Eyes Of 5 Analysts", "summary": " ", "symbols": ["PENN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44051914/expert-outlook-penn-entertainment-through-the-eyes-of-5-analysts", "tags": ["guidance"]}
{"id": 44051932, "time": "2025-02-28 13:01:15", "headline": "Deep Dive Into Skyward Specialty Stock: Analyst Perspectives (6 Ratings)", "summary": " ", "symbols": ["SKWD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44051932/deep-dive-into-skyward-specialty-stock-analyst-perspectives-6-ratings", "tags": []}
{"id": 44051933, "time": "2025-02-28 13:01:16", "headline": "Market Whales and Their Recent Bets on ACHC Options", "summary": " ", "symbols": ["ACHC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44051933/market-whales-and-their-recent-bets-on-achc-options", "tags": []}
{"id": 44051937, "time": "2025-02-28 13:01:22", "headline": "Check Out What Whales Are Doing With IBM", "summary": " ", "symbols": ["IBM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44051937/check-out-what-whales-are-doing-with-ibm", "tags": []}
{"id": 44051938, "time": "2025-02-28 13:01:25", "headline": "Where Portillos Stands With Analysts", "summary": " ", "symbols": ["PTLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44051938/where-portillos-stands-with-analysts", "tags": []}
{"id": 44051976, "time": "2025-02-28 13:02:18", "headline": "CNBC Halftime Report Final Trades: Salesforce, TripAdvisor, The Walt Disney Company, Diamondback Energy", "summary": "", "symbols": ["CRM", "DIS", "FANG", "TRIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44051976/cnbc-halftime-report-final-trades-salesforce-tripadvisor-the-walt-disney-company-diamondback-energy", "tags": []}
{"id": 44052047, "time": "2025-02-28 13:03:53", "headline": "U.S. Baker Hughes Oil Rig Count 489 Vs 488 Prior; U.S. Baker Hughes Total Rig Count 593 Vs 592 Prior", "summary": "", "symbols": ["SPY", "UNG", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44052047/u-s-baker-hughes-oil-rig-count-489-vs-488-prior-u-s-baker-hughes-total-rig-count-", "tags": []}
{"id": 44052145, "time": "2025-02-28 13:06:22", "headline": "Taiwan Semi Faces Geopolitical Strain Due To US Scrutiny On Huawei's Chip Access", "summary": "US concerns over Huawei&#39;s access to Taiwan Semiconductor&#39;s chips continue due to geopolitical tensions over AI technology. Taiwan promises to boost trade and defense ties to address Trump&#39;s chip concerns.", "symbols": ["NVDA", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/media/25/02/44052145/taiwan-semi-faces-geopolitical-strain-due-to-us-scrutiny-on-huaweis-chip-access", "tags": []}
{"id": 44052316, "time": "2025-02-28 13:09:20", "headline": "J.P. Morgan Flags Overvaluation In Acushnet\u2014EBITDA Outlook Suggests Limited Upside", "summary": "Acushnet Holdings missed revenue expectations in Q4 but saw a 300 basis point improvement in gross margin. J.P. Morgan&#39;s Matthew R. Boss maintains an Underweight rating.", "symbols": ["GOLF"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/02/44052316/j-p-morgan-flags-overvaluation-in-acushnet-ebitda-outlook-suggests-limited-upside", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 44052646, "time": "2025-02-28 13:16:33", "headline": "Aclarion Shares Resume Trade, Stock Now Up 80%", "summary": "", "symbols": ["ACON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/02/44052646/aclarion-shares-resume-trade-stock-now-up-80", "tags": []}
{"id": 44052833, "time": "2025-02-28 13:20:09", "headline": "SoundHound AI's CEO On AI Agents Transforming The World: 'This Is An Inevitable Evolution'", "summary": "SoundHound CEO Keyvan Mohajer spoke with Benzinga about the company&#39;s latest developments and plans for 2025.", "symbols": ["SOUN"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/markets/equities/25/02/44052833/soundhound-ais-ceo-on-ai-agents-transforming-the-world-this-is-an-inevitable-evolution", "tags": ["management"]}
{"id": 44052935, "time": "2025-02-28 13:21:42", "headline": "Intel Delays $28 Billion Ohio Chip Plant Again, Pushing Opening to 2030 Amid Financial Struggles", "summary": "Intel delays chip fabrication plant debut in Ohio until 2030/2031 due to financial troubles. Stock down 43% in past year, new initiatives launched.", "symbols": ["ASML", "INTC", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/media/25/02/44052935/intel-delays-28-billion-ohio-chip-plant-again-pushing-opening-to-2030-amid-financial-struggles", "tags": []}
{"id": 44053021, "time": "2025-02-28 13:24:06", "headline": "President Trump Posts On Truth Social \"... It's amazing what comes out through emotion, and I have determined that President Zelenskyy is not ready for Peace if America is involved....\"", "summary": "", "symbols": ["SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44053021/president-trump-posts-on-truth-social-its-amazing-what-comes-out-through-emotion-", "tags": []}
{"id": 44053066, "time": "2025-02-28 13:25:40", "headline": "Ukraine's Zelenksiy Leaves White House Early After Contentious Meeting With President Trump", "summary": "", "symbols": ["SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44053066/ukraines-zelenksiy-leaves-white-house-early-after-contentious-meeting-with-presid", "tags": []}
{"id": 44053172, "time": "2025-02-28 13:29:51", "headline": "President Trump, Ukraine President Zelenskiy Press Conference Is Canceled", "summary": "", "symbols": ["SPY", "USO", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44053172/president-trump-ukraine-president-zelenskiy-press-conference-is-canceled", "tags": []}
{"id": 44053318, "time": "2025-02-28 13:32:23", "headline": "Nvidia-Backed CoreWeave Eyes $4 Billion IPO: Is This AI's Next Big Test?", "summary": "CoreWeave, backed by Nvidia, prepares to file for an IPO with $4 billion raised at a valuation above $35 billion, in one of the most anticipated debuts of the year.", "symbols": ["MSFT", "NVDA"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/25/02/44053318/nvidia-backed-coreweaves-4b-ipo-the-ai-booms-next-big-test", "tags": []}
{"id": 44053451, "time": "2025-02-28 13:36:02", "headline": "'Amazon Plans Global Expansion For Haul, Its Temu Rival' - The Information", "summary": "", "symbols": ["AMZN", "PDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053451/amazon-plans-global-expansion-for-haul-its-temu-rival-the-information", "tags": []}
{"id": 44053478, "time": "2025-02-28 13:37:13", "headline": "BANK7 Announces Acquisition Of First American Mortgage, Terms Not Disclosed", "summary": "", "symbols": ["BSVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44053478/bank7-announces-acquisition-of-first-american-mortgage-terms-not-disclosed", "tags": []}
{"id": 44053493, "time": "2025-02-28 13:37:42", "headline": "Wells Fargo Maintains Overweight on Dell Technologies, Lowers Price Target to $150", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053493/wells-fargo-maintains-overweight-on-dell-technologies-lowers-price-target-to-150", "tags": ["analyst_other", "price_target_down"]}
{"id": 44053497, "time": "2025-02-28 13:37:45", "headline": "Six Flags' Stock Reflects Best-Case Scenario\u2014Analyst Warns Of Growth & Cost Risks", "summary": "J.P. Morgan analyst Matthew R. Boss reiterated an Underweight rating on Six Flags Entertainment with a price target of $46. FUN&#39;s Q4 EBITDA fell 30% short of estimates, driven by revenue and cost discrepancies. Attendance grew 6.2%, slightly missing the Street&#39;s forecast. ", "symbols": ["FUN"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/general/entertainment/25/02/44053497/six-flags-stock-reflects-best-case-scenario-analyst-warns-of-growth-cost-risks", "tags": ["earnings", "guidance"]}
{"id": 44053552, "time": "2025-02-28 13:38:55", "headline": "Wells Fargo Maintains Equal-Weight on FirstEnergy, Lowers Price Target to $41", "summary": "", "symbols": ["FE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053552/wells-fargo-maintains-equal-weight-on-firstenergy-lowers-price-target-to-41", "tags": ["analyst_other", "price_target_down"]}
{"id": 44053592, "time": "2025-02-28 13:40:32", "headline": "White House Meeting Turns Tense As Trump Warns Zelenskyy: 'You're Gambling With World War III'", "summary": "Trump and Vance clash with Zelenskyy during a White House meeting over Ukraine&#39;s diplomatic strategies.", "symbols": ["PLTR"], "source": "benzinga", "author": "Michael Cohen", "url": "https://www.benzinga.com/news/global/25/02/44053592/white-house-meeting-turns-tense-as-trump-warns-zelenskyy-youre-gambling-with-world-war-iii", "tags": []}
{"id": 44053620, "time": "2025-02-28 13:40:46", "headline": "Wells Fargo Maintains Equal-Weight on Teleflex, Lowers Price Target to $146", "summary": "", "symbols": ["TFX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053620/wells-fargo-maintains-equal-weight-on-teleflex-lowers-price-target-to-146", "tags": ["analyst_other", "price_target_down"]}
{"id": 44053650, "time": "2025-02-28 13:41:51", "headline": "Wells Fargo Maintains Overweight on GoodRx Holdings, Lowers Price Target to $8", "summary": "", "symbols": ["GDRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053650/wells-fargo-maintains-overweight-on-goodrx-holdings-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 44053681, "time": "2025-02-28 13:43:08", "headline": "Wells Fargo Maintains Underweight on BlackRock TCP Cap, Lowers Price Target to $7.5", "summary": "", "symbols": ["TCPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053681/wells-fargo-maintains-underweight-on-blackrock-tcp-cap-lowers-price-target-to-7-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44053713, "time": "2025-02-28 13:43:54", "headline": "Wells Fargo Maintains Underweight on Trinity Cap, Raises Price Target to $14", "summary": "", "symbols": ["TRIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053713/wells-fargo-maintains-underweight-on-trinity-cap-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 44053744, "time": "2025-02-28 13:45:05", "headline": "Wells Fargo Maintains Overweight on Edison Intl, Lowers Price Target to $75", "summary": "", "symbols": ["EIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053744/wells-fargo-maintains-overweight-on-edison-intl-lowers-price-target-to-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 44053760, "time": "2025-02-28 13:45:33", "headline": "Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet", "summary": "The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week. Here&#39;s the list and some potential catalysts.", "symbols": ["BX", "FWONA", "FWONK", "IONQ", "KDP", "SFM", "SUI"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/trading-ideas/25/02/44053760/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-55", "tags": []}
{"id": 44053788, "time": "2025-02-28 13:46:20", "headline": "Alkami Growth Accelerates With MANTL Deal, Boosts Digital Banking And Cross-Sell Potential: Analyst", "summary": "Alkami Technology stock gained Friday after Wall Street analysts rerated it after its fourth-quarter report on Thursday.", "symbols": ["ALKT"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/02/44053788/alkami-growth-accelerates-with-mantl-deal-boosting-digital-banking-and-cross-sell-potential-analyst-says", "tags": ["contract"]}
{"id": 44053789, "time": "2025-02-28 13:46:23", "headline": "Moderna Unusual Options Activity", "summary": " ", "symbols": ["MRNA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44053789/moderna-unusual-options-activity", "tags": []}
{"id": 44053790, "time": "2025-02-28 13:46:27", "headline": "Wells Fargo Maintains Equal-Weight on Solventum, Raises Price Target to $75", "summary": "", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053790/wells-fargo-maintains-equal-weight-on-solventum-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 44053938, "time": "2025-02-28 13:48:17", "headline": "Wells Fargo Maintains Underweight on Cable One, Lowers Price Target to $240", "summary": "", "symbols": ["CABO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053938/wells-fargo-maintains-underweight-on-cable-one-lowers-price-target-to-240", "tags": ["analyst_other", "price_target_down"]}
{"id": 44053972, "time": "2025-02-28 13:49:21", "headline": "Wells Fargo Maintains Equal-Weight on SJW Gr, Raises Price Target to $57", "summary": "", "symbols": ["SJW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44053972/wells-fargo-maintains-equal-weight-on-sjw-gr-raises-price-target-to-57", "tags": ["analyst_other", "price_target_up"]}
{"id": 44053985, "time": "2025-02-28 13:49:57", "headline": "Senior White House Official Says Press Conference With Zelenskiy Canceled; No Deal Signed; Says \"It's Up To Ukrainians If It Can Be Rescheduled While Zelenskiy Still In Country\"", "summary": "", "symbols": ["REMX", "SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44053985/senior-white-house-official-says-press-conference-with-zelenskiy-canceled-no-deal", "tags": ["contract"]}
{"id": 44054044, "time": "2025-02-28 13:51:09", "headline": "UBS Maintains Buy on Kontoor Brands, Lowers Price Target to $96", "summary": "", "symbols": ["KTB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054044/ubs-maintains-buy-on-kontoor-brands-lowers-price-target-to-96", "tags": ["analyst_other", "price_target_down"]}
{"id": 44054087, "time": "2025-02-28 13:52:26", "headline": "UBS Maintains Sell on Dillard's, Raises Price Target to $202", "summary": "", "symbols": ["DDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054087/ubs-maintains-sell-on-dillards-raises-price-target-to-202", "tags": ["analyst_other", "price_target_up"]}
{"id": 44054134, "time": "2025-02-28 13:53:41", "headline": "UBS Maintains Buy on Dell Technologies, Lowers Price Target to $150", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054134/ubs-maintains-buy-on-dell-technologies-lowers-price-target-to-150", "tags": ["analyst_other", "price_target_down"]}
{"id": 44054159, "time": "2025-02-28 13:54:59", "headline": "UBS Maintains Buy on Elastic, Raises Price Target to $148", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054159/ubs-maintains-buy-on-elastic-raises-price-target-to-148", "tags": ["analyst_other", "price_target_up"]}
{"id": 44054180, "time": "2025-02-28 13:56:06", "headline": "UBS Maintains Neutral on Warby Parker, Raises Price Target to $23", "summary": "", "symbols": ["WRBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054180/ubs-maintains-neutral-on-warby-parker-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 44054207, "time": "2025-02-28 13:57:15", "headline": "QVC Group Q4 EPS $(3.25), Sales $2.94B Down From $3.14B YoY", "summary": "", "symbols": ["QVCGA", "QVCGB", "QVCGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44054207/qvc-group-q4-eps-3-25-sales-2-94b-down-from-3-14b-yoy", "tags": ["earnings"]}
{"id": 44054211, "time": "2025-02-28 13:57:21", "headline": "UBS Maintains Buy on Autodesk, Raises Price Target to $370", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054211/ubs-maintains-buy-on-autodesk-raises-price-target-to-370", "tags": ["analyst_other", "price_target_up"]}
{"id": 44054240, "time": "2025-02-28 13:58:17", "headline": "UBS Maintains Neutral on Blend Labs, Lowers Price Target to $3.5", "summary": "", "symbols": ["BLND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054240/ubs-maintains-neutral-on-blend-labs-lowers-price-target-to-3-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44054266, "time": "2025-02-28 13:59:23", "headline": "Top 2 Tech And Telecom Stocks That May Implode In Q1", "summary": " ", "symbols": ["NOK", "T", "ZI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/02/44054266/top-2-tech-and-telecom-stocks-that-may-implode-in-q1", "tags": []}
{"id": 44054282, "time": "2025-02-28 13:59:43", "headline": "Shiba Inu Down 5% But Could An ETF Be In The Works?", "summary": "Shiba Inu (CRYPTO: SHIB) is going through a strong correction, leading traders to watch for potential support levels and bullish reversal catalysts.", "symbols": ["DOGEUSD", "PEPEUSD", "SHIBUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44054282/shiba-inu-down-5-but-could-an-etf-be-in-the-works", "tags": []}
{"id": 44054285, "time": "2025-02-28 13:59:59", "headline": "Okta's Growth in Identity Security Drives Bullish Outlook, Analyst Sees Upside", "summary": "WestPark Capital analyst reaffirms Buy rating on Okta with $140 price target. Q4 and FY25 results to be reported on March 3. RPO growth and expansion into new markets to drive sustained growth.", "symbols": ["OKTA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/02/44054285/oktas-growth-in-identity-security-drives-bullish-outlook-analyst-sees-upside", "tags": ["guidance"]}
{"id": 44054323, "time": "2025-02-28 14:00:24", "headline": "PubMatic Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44054323/pubmatic-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 44054330, "time": "2025-02-28 14:00:35", "headline": "Demystifying GitLab: Insights From 22 Analyst Reviews", "summary": " ", "symbols": ["GTLB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44054330/demystifying-gitlab-insights-from-22-analyst-reviews", "tags": []}
{"id": 44054333, "time": "2025-02-28 14:00:42", "headline": "Expert Outlook: Progyny Through The Eyes Of 4 Analysts", "summary": " ", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44054333/expert-outlook-progyny-through-the-eyes-of-4-analysts", "tags": ["guidance"]}
{"id": 44054335, "time": "2025-02-28 14:00:49", "headline": "This Is What Whales Are Betting On Freeport-McMoRan", "summary": " ", "symbols": ["FCX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44054335/this-is-what-whales-are-betting-on-freeport-mcmoran", "tags": []}
{"id": 44054336, "time": "2025-02-28 14:00:50", "headline": "Hamilton Insurance Group Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["HG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44054336/hamilton-insurance-group-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 44054338, "time": "2025-02-28 14:00:55", "headline": "What the Options Market Tells Us About Walt Disney", "summary": " ", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44054338/what-the-options-market-tells-us-about-walt-disney", "tags": []}
{"id": 44054339, "time": "2025-02-28 14:00:58", "headline": "Demystifying Norwegian Cruise Line: Insights From 7 Analyst Reviews", "summary": " ", "symbols": ["NCLH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44054339/demystifying-norwegian-cruise-line-insights-from-7-analyst-reviews", "tags": []}
{"id": 44054349, "time": "2025-02-28 14:01:06", "headline": "The Analyst Verdict: GoodRx Holdings In The Eyes Of 4 Experts", "summary": " ", "symbols": ["GDRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44054349/the-analyst-verdict-goodrx-holdings-in-the-eyes-of-4-experts", "tags": []}
{"id": 44054383, "time": "2025-02-28 14:01:55", "headline": "Citigroup Maintains Neutral on Opendoor Technologies, Lowers Price Target to $1.4", "summary": "", "symbols": ["OPEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054383/citigroup-maintains-neutral-on-opendoor-technologies-lowers-price-target-to-1-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 44054480, "time": "2025-02-28 14:03:48", "headline": "Archer Aviation's Stellantis Deal, Launch Program Strengthen Growth Prospects, FAA Certification Looms", "summary": "Archer Aviation&#39;s stock rose after Wall Street analysts rerated it following Q4 report. Loss of $1.42 per share missed estimates.", "symbols": ["ACHR", "JOBY", "STLA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/02/44054480/archer-aviations-stellantis-deal-launch-program-strengthen-growth-prospects-faa-certification-looms", "tags": ["contract"]}
{"id": 44054628, "time": "2025-02-28 14:07:17", "headline": "Citigroup Maintains Buy on Rocket Lab USA, Lowers Price Target to $33", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054628/citigroup-maintains-buy-on-rocket-lab-usa-lowers-price-target-to-33", "tags": ["analyst_other", "price_target_down"]}
{"id": 44054695, "time": "2025-02-28 14:09:56", "headline": "Citigroup Maintains Neutral on Outbrain, Lowers Price Target to $5.9", "summary": "", "symbols": ["OB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054695/citigroup-maintains-neutral-on-outbrain-lowers-price-target-to-5-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 44054714, "time": "2025-02-28 14:10:41", "headline": "Citigroup Maintains Neutral on Intellia Therapeutics, Raises Price Target to $14", "summary": "", "symbols": ["NTLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054714/citigroup-maintains-neutral-on-intellia-therapeutics-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 44054723, "time": "2025-02-28 14:11:00", "headline": "First Trust's New Small-Cap ETF Aims To Combine Growth With Income", "summary": "First Trust launches actively managed FTKI ETF, using buy-write strategy for steady income and small-cap exposure. Expense ratio is 0.85%.", "symbols": ["FTAIM", "FTKI", "INSM", "NGX"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/25/02/44054723/first-trusts-new-small-cap-etf-combines-growth-with-income", "tags": []}
{"id": 44054765, "time": "2025-02-28 14:12:53", "headline": "Citigroup Maintains Neutral on Salesforce, Lowers Price Target to $335", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054765/citigroup-maintains-neutral-on-salesforce-lowers-price-target-to-335", "tags": ["analyst_other", "price_target_down"]}
{"id": 44054807, "time": "2025-02-28 14:14:04", "headline": "Citigroup Maintains Buy on Monster Beverage, Raises Price Target to $64", "summary": "", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054807/citigroup-maintains-buy-on-monster-beverage-raises-price-target-to-64", "tags": ["analyst_other", "price_target_up"]}
{"id": 44054831, "time": "2025-02-28 14:15:18", "headline": "Citigroup Maintains Buy on First Horizon, Raises Price Target to $25", "summary": "", "symbols": ["FHN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054831/citigroup-maintains-buy-on-first-horizon-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 44054841, "time": "2025-02-28 14:15:52", "headline": "Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds", "summary": "Amphastar&#39;s Q4 sales grew 20% to $186.5M, missing estimates. Primatene MIST surpassed $100M in annual sales, while Baqsimi saw strong growth.", "symbols": ["AMPH"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/25/02/44054841/specialty-pharma-amphastar-stock-falls-on-lower-than-expected-q4-earnings-analyst-sees-competitive-headwinds", "tags": ["earnings"]}
{"id": 44054869, "time": "2025-02-28 14:16:33", "headline": "Citigroup Maintains Buy on Norwegian Cruise Line, Raises Price Target to $34", "summary": "", "symbols": ["NCLH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054869/citigroup-maintains-buy-on-norwegian-cruise-line-raises-price-target-to-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 44054921, "time": "2025-02-28 14:17:06", "headline": "L3Harris Announces Quarterly Dividend Increase From $1.16 To $1.20 Per Share", "summary": "", "symbols": ["LHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44054921/l3harris-announces-quarterly-dividend-increase-from-1-16-to-1-20-per-share", "tags": ["dividend"]}
{"id": 44055017, "time": "2025-02-28 14:20:09", "headline": "Stock Of The Day: Why The Viatris Meltdown Ended Where It Did", "summary": "Random Walk Theory is wrong. If price were random, there would not be support or resistance levels. The Viatris (VTRS) shows there are.", "symbols": [], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/25/02/44055017/stock-of-the-day-why-the-viatris-meltdown-ended-where-it-did", "tags": []}
{"id": 44054783, "time": "2025-02-28 14:13:32", "headline": "New ETF PRIV Bridges Private And Public Credit, Draws Investor Interest And SEC Concerns", "summary": "EFT PRIV by State Street &amp; Apollo offers steady returns &amp; income, allocating 80% to investment-grade debt &amp; 20% to high-yield bonds. SEC raises concerns.", "symbols": ["PRIV"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/new-etfs/25/02/44054783/new-etf-priv-bridges-private-and-public-credit-draws-investor-interest-and-sec-concerns", "tags": []}
{"id": 44055158, "time": "2025-02-28 14:25:10", "headline": "Ukraine's Volodymyr Zelenskyy Posts On X \"Thank you America, thank you for your support, thank you for this visit. Thank you @POTUS, Congress, and the American people. Ukraine needs just and lasting peace, and we are working exactly for that.\"", "summary": "", "symbols": ["SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44055158/ukraines-volodymyr-zelenskyy-posts-on-x-thank-you-america-thank-you-for-your-supp", "tags": []}
{"id": 44055229, "time": "2025-02-28 14:27:12", "headline": "Why Bitcoin Cash Is Volatile Today", "summary": "Bitcoin Cash (CRYPTO: BCH), a fork of Bitcoin designed for faster and cheaper transactions, is trading higher by 6.15% to $315.12 during Friday\u2019s session.", "symbols": ["BCHUSD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/02/44055229/why-bitcoin-cash-is-volatile-today", "tags": []}
{"id": 44055256, "time": "2025-02-28 14:27:48", "headline": "'Mexico Open To New Tariffs On China To Avoid Trump Duties; Mexico's Potential China Tariffs Would Focus On Cars And Auto Parts; Could Also Include Finished Goods' - Bloomberg News", "summary": "", "symbols": ["EWW", "FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44055256/mexico-open-to-new-tariffs-on-china-to-avoid-trump-duties-mexicos-potential-china", "tags": []}
{"id": 44055315, "time": "2025-02-28 14:30:29", "headline": "Is XPeng Gaining or Losing Market Support?", "summary": " ", "symbols": ["XPEV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44055315/is-xpeng-gaining-or-losing-market-support", "tags": []}
{"id": 44055324, "time": "2025-02-28 14:30:35", "headline": "How Do Investors Really Feel About AMETEK?", "summary": " ", "symbols": ["AME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44055324/how-do-investors-really-feel-about-ametek", "tags": []}
{"id": 44055326, "time": "2025-02-28 14:30:41", "headline": "Is Dillard's Gaining or Losing Market Support?", "summary": " ", "symbols": ["DDS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44055326/is-dillards-gaining-or-losing-market-support", "tags": []}
{"id": 44054669, "time": "2025-02-28 14:08:38", "headline": "This Walgreens Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday", "summary": " ", "symbols": ["ARRY", "ICFI", "LOGI", "PLTK", "WBA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/downgrades/25/02/44054669/this-walgreens-analyst-turns-bearish-here-are-top-5-downgrades-for-friday", "tags": ["analyst_down"]}
{"id": 44055454, "time": "2025-02-28 14:33:24", "headline": "This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday", "summary": " ", "symbols": ["ALT", "AVTX", "CSGP", "MDWD", "SMMT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/02/44055454/this-costar-group-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday", "tags": ["analyst_init"]}
{"id": 44055469, "time": "2025-02-28 14:34:04", "headline": "JLens Launches TOV ETF, Merging Jewish Advocacy With Market Investing", "summary": "A new ETF, TOV, allows investors to align financial goals with Jewish values. It excludes unethical industries and backs advocacy principles.", "symbols": ["AAPL", "BRK", "GOOG", "GOOGL", "TOV"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/specialty-etfs/25/02/44055469/jlens-launches-tov-etf-merging-jewish-advocacy-with-market-investing", "tags": []}
{"id": 44055605, "time": "2025-02-28 14:39:35", "headline": "This Li Auto Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday", "summary": " ", "symbols": ["BBWI", "CAVA", "LI", "NXST", "VOYA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/02/44055605/this-li-auto-analyst-turns-bullish-here-are-top-5-upgrades-for-friday", "tags": ["analyst_up"]}
{"id": 44055730, "time": "2025-02-28 14:45:10", "headline": "Options Corner: Traders May Price In A Reality Check For Rocket Lab USA", "summary": "Although Rocket Lab posted strong Q4 sales, its lackluster Q1 guidance raised alarm about valuation risks for RKLB stock.", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44055730/rklb-stock-hot-premium-earnings-reality-check", "tags": ["guidance"]}
{"id": 44055752, "time": "2025-02-28 14:45:53", "headline": "Apollo Global Management's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44055752/apollo-global-managements-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 44055933, "time": "2025-02-28 14:48:14", "headline": "Investor Bearishness Surges, Yet Historical Data Suggests Potential Market Gains Ahead", "summary": "Markets cooled in Feb with historic low investor sentiment. However, past bearishness has led to higher future returns. Rosier outlook on Wall Street.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/news/econ-s/25/02/44055933/investor-bearishness-surges-yet-historical-data-suggests-potential-market-gains-ahead", "tags": ["guidance"]}
{"id": 44056291, "time": "2025-02-28 15:00:17", "headline": "Forecasting The Future: 13 Analyst Projections For Equitable Holdings", "summary": " ", "symbols": ["EQH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44056291/forecasting-the-future-13-analyst-projections-for-equitable-holdings", "tags": []}
{"id": 44056299, "time": "2025-02-28 15:00:28", "headline": "Deep Dive Into Natera Stock: Analyst Perspectives (9 Ratings)", "summary": " ", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44056299/deep-dive-into-natera-stock-analyst-perspectives-9-ratings", "tags": []}
{"id": 44056305, "time": "2025-02-28 15:00:36", "headline": "What Analysts Are Saying About Vertex Stock", "summary": " ", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44056305/what-analysts-are-saying-about-vertex-stock", "tags": []}
{"id": 44056308, "time": "2025-02-28 15:00:44", "headline": "Looking At Axon Enterprise's Recent Unusual Options Activity", "summary": " ", "symbols": ["AXON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44056308/looking-at-axon-enterprises-recent-unusual-options-activity", "tags": []}
{"id": 44056309, "time": "2025-02-28 15:00:45", "headline": "Forecasting The Future: 4 Analyst Projections For Iovance Biotherapeutics", "summary": " ", "symbols": ["IOVA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44056309/forecasting-the-future-4-analyst-projections-for-iovance-biotherapeutics", "tags": []}
{"id": 44056312, "time": "2025-02-28 15:00:49", "headline": "Here's How Much $1000 Invested In Fluor 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["FLR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44056312/heres-how-much-1000-invested-in-fluor-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44056313, "time": "2025-02-28 15:00:50", "headline": "Decoding Intuitive Machines's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["LUNR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44056313/decoding-intuitive-machiness-options-activity-whats-the-big-picture", "tags": []}
{"id": 44056315, "time": "2025-02-28 15:00:52", "headline": "A Glimpse Into The Expert Outlook On Lincoln National Through 8 Analysts", "summary": " ", "symbols": ["LNC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44056315/a-glimpse-into-the-expert-outlook-on-lincoln-national-through-8-analysts", "tags": ["guidance"]}
{"id": 44056317, "time": "2025-02-28 15:00:59", "headline": "11 Analysts Have This To Say About Aflac", "summary": " ", "symbols": ["AFL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44056317/11-analysts-have-this-to-say-about-aflac", "tags": []}
{"id": 44046215, "time": "2025-02-28 10:32:10", "headline": "BitVM Integration Unlocks Bitcoin's $1.9 Trillion Liquidity Across Five Major Blockchains", "summary": "Bitlayer, a Bitcoin (CRYPTO: BTC) Layer-2 developer, has partnered with five blockchains\u2014Base, Starknet (CRYPTO: STRK), Arbitrum (CRYPTO: ARB&lt;/", "symbols": ["AAVEUSD", "AEROUSD", "ARBUSD", "BTCUSD", "STRKUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44046215/bitvm-integration-unlocks-bitcoins-1-9-trillion-liquidity-across-five-major-blockchains", "tags": []}
{"id": 44056569, "time": "2025-02-28 15:07:43", "headline": "How I Saw This Tech Crash Coming a Mile Away \u2013 And You Could Have Too", "summary": "Learn how to identify the BBP level, a proprietary indicator from Benzinga Option School, to know when to take profits, hedge against downside, and trade bullish or bearish for tickers like PLTR, SCMI, and TSLA.", "symbols": ["PLTR", "SMCI", "TSLA"], "source": "benzinga", "author": "Benzinga Research Team", "url": "https://www.benzinga.com/25/02/44056569/how-i-saw-this-tech-crash-coming-a-mile-away-and-you-could-have-too", "tags": []}
{"id": 44056821, "time": "2025-02-28 15:15:36", "headline": "A Look Into Fidelity National Info Inc's Price Over Earnings", "summary": " ", "symbols": ["FIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44056821/a-look-into-fidelity-national-info-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 44056840, "time": "2025-02-28 15:15:54", "headline": "$1000 Invested In Valero Energy 15 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["VLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44056840/1000-invested-in-valero-energy-15-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44056857, "time": "2025-02-28 15:16:06", "headline": "Stablecoins Are Future Of Commerce, Says Base's Tom Vieira", "summary": "Stablecoins are the future of commerce, according to Tom Vieira, Head of Product for Base, Coinbase&#39;s (NASDAQ:COIN) Ethereum (CRYPTO: ETH) Layer-2 network.", "symbols": ["COIN", "ETHUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44056857/stablecoins-are-future-of-commerce-says-bases-tom-vieira", "tags": []}
{"id": 44057033, "time": "2025-02-28 15:18:28", "headline": "'This Is Something That President Trump Does Over And Over Again,' Geopolitical Strategist Says About Failed Rare Minerals Deal With Ukraine President Zelenskyy", "summary": "Ukraine President Volodymyr Zelenskyy met with U.S. President Donald Trump and Vice President JD Vance on Friday but left the White House without signing an agreement for rare minerals.", "symbols": [], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/news/global/25/02/44057033/this-is-something-that-president-trump-does-over-and-over-again-geopolitical-strategist-says-about-failed-rare-minerals-deal-with-ukraine-president-zelenskyy", "tags": ["contract"]}
{"id": 44057085, "time": "2025-02-28 15:19:28", "headline": "Bitcoin, Ethereum, XRP, Dogecoin Rebound From The Brink: Here Are The Key Levels To Watch", "summary": "Cryptocurrency markets are rebounding from an overnight dip that saw Bitcoin go as low as $78,300.", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "HBARUSD", "SHIBUSD", "SOLUSD", "TIAUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44057085/bitcoin-ethereum-xrp-dogecoin-rebound-from-the-brink-here-are-the-key-levels-to-watch", "tags": []}
{"id": 44057422, "time": "2025-02-28 15:29:28", "headline": "Bitcoin, Magnificent 7 Lose Safe-Haven Status In 2025 As China ETFs, Dow Stocks Outperform", "summary": "Many of the top-performing stocks and assets in recent years have stumbled at the start of 2025, with Bitcoin (CRYPTO: BTC) dropping to a three-month low.", "symbols": ["AAPL", "AMGN", "AMZN", "BABA", "BRK", "BTCUSD", "DIA", "FXI", "GOOG", "GOOGL", "IBM", "JNJ", "KO", "KWEB", "MCHI", "META", "MMM", "MSFT", "NVDA", "QQQ", "SPY", "TSLA", "V", "XPEV"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/tech/25/02/44057422/bitcoin-magnificent-7-lose-safe-haven-status-in-2025-as-china-etfs-dow-stocks-outperform", "tags": []}
{"id": 44057466, "time": "2025-02-28 15:30:28", "headline": "What's Driving the Market Sentiment Around Insulet?", "summary": " ", "symbols": ["PODD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44057466/whats-driving-the-market-sentiment-around-insulet", "tags": []}
{"id": 44057469, "time": "2025-02-28 15:30:34", "headline": "What Does the Market Think About Ally Financial?", "summary": " ", "symbols": ["ALLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44057469/what-does-the-market-think-about-ally-financial", "tags": []}
{"id": 44057471, "time": "2025-02-28 15:30:38", "headline": "What Does the Market Think About Entergy?", "summary": " ", "symbols": ["ETR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/02/44057471/what-does-the-market-think-about-entergy", "tags": []}
{"id": 44057484, "time": "2025-02-28 15:30:55", "headline": "Here's How Much $100 Invested In Canadian Natural Res 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["CNQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44057484/heres-how-much-100-invested-in-canadian-natural-res-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44057579, "time": "2025-02-28 15:33:53", "headline": "JP Morgan CEO Jamie Dimon Says We Have 450 Use Cases For AI Now, It Could Go Up To 1,000 Use Cases By Next Year", "summary": "", "symbols": ["JPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44057579/jp-morgan-ceo-jamie-dimon-says-we-have-450-use-cases-for-ai-now-it-could-go-up-to-1-000-use-cases-by", "tags": ["management"]}
{"id": 44057916, "time": "2025-02-28 15:45:18", "headline": "Deal Dispatch: Boeing Done With Drones? Plus BP To Sell Lubricants, 7-Eleven Parent Nixes $58 Billion Bid", "summary": "From Walgreens&#39; breakup to Forever 21&#39;s pending bankruptcy, M&amp;A and drama unfold in this week&#39;s edition of Deal Dispatch.", "symbols": ["BA", "BP", "CTLP", "EDR", "TKO", "TYO:3382", "WBA"], "source": "benzinga", "author": "Anthony Noto", "url": "https://www.benzinga.com/news/asset-sales/25/02/44057916/deal-dispatch-boeing-done-with-drones-plus-bp-to-sell-lubricants-7-eleven-parent-nixes-58-billion-bid", "tags": ["contract"]}
{"id": 44057994, "time": "2025-02-28 15:46:50", "headline": "Check Out What Whales Are Doing With RCL", "summary": " ", "symbols": ["RCL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/02/44057994/check-out-what-whales-are-doing-with-rcl", "tags": []}
{"id": 44058135, "time": "2025-02-28 15:48:39", "headline": "Energy Markets Volatile As Trump, Vance Clash with Zelenskyy Over Ukraine Aid", "summary": "A White House clash between Trump, Vance and Zelenskyy over Ukraine aid sparked energy market gains. Rising geopolitical tensions pushed oil prices and energy stocks higher.", "symbols": ["USO", "XLE"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/02/44058135/energy-markets-pop-as-trump-vance-clash-with-zelenskyy-over-ukraine-aid", "tags": []}
{"id": 44058205, "time": "2025-02-28 15:51:27", "headline": "Plus Therapeutics Granted FDA Orphan Designation For BMEDA-Chelated Rhenium-186 Nanoliposomes For The Treatment Of Lung Cancer With Leptomeningeal Metastases", "summary": "", "symbols": ["PSTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44058205/plus-therapeutics-granted-fda-orphan-designation-for-bmeda-chelated-rhenium-186-nanoliposomes-for", "tags": ["fda"]}
{"id": 44058520, "time": "2025-02-28 16:00:22", "headline": "Where Universal Health Servs Stands With Analysts", "summary": " ", "symbols": ["UHS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44058520/where-universal-health-servs-stands-with-analysts", "tags": []}
{"id": 44058524, "time": "2025-02-28 16:00:28", "headline": "Here's How Much $1000 Invested In ConocoPhillips 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["COP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44058524/heres-how-much-1000-invested-in-conocophillips-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44058525, "time": "2025-02-28 16:00:31", "headline": "6 Analysts Have This To Say About Aris Water Solutions", "summary": " ", "symbols": ["ARIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44058525/6-analysts-have-this-to-say-about-aris-water-solutions", "tags": []}
{"id": 44058537, "time": "2025-02-28 16:00:37", "headline": "Trading Halt: Halted at 4:00:10 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["VINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44058537/trading-halt-halted-at-4-00-10-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44058538, "time": "2025-02-28 16:00:37", "headline": "Trading Halt: Halted at 4:00:10 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44058538/trading-halt-halted-at-4-00-10-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44058551, "time": "2025-02-28 16:00:50", "headline": "Beyond The Numbers: 5 Analysts Discuss Golden Entertainment Stock", "summary": " ", "symbols": ["GDEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44058551/beyond-the-numbers-5-analysts-discuss-golden-entertainment-stock", "tags": []}
{"id": 44058558, "time": "2025-02-28 16:00:57", "headline": "What Analysts Are Saying About Kontoor Brands Stock", "summary": " ", "symbols": ["KTB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44058558/what-analysts-are-saying-about-kontoor-brands-stock", "tags": []}
{"id": 44058573, "time": "2025-02-28 16:01:05", "headline": "5 Analysts Assess Standex International: What You Need To Know", "summary": " ", "symbols": ["SXI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44058573/5-analysts-assess-standex-international-what-you-need-to-know", "tags": []}
{"id": 44058589, "time": "2025-02-28 16:01:16", "headline": "Beyond The Numbers: 5 Analysts Discuss SoundHound AI Stock", "summary": " ", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44058589/beyond-the-numbers-5-analysts-discuss-soundhound-ai-stock", "tags": []}
{"id": 44058686, "time": "2025-02-28 16:02:42", "headline": "Tariffs Shock Hit Stocks, Cryptos, While Nvidia Fails To Come To The Rescue: This Week In Markets", "summary": "Risk assets tumbled as a wave of bearish sentiment gripped markets, with escalating trade tensions, disappointing earnings and signs of economic fragility weighing on investor confidence.", "symbols": ["BTC", "BTCUSD", "ETHUSD", "GM", "NVDA"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44058686/tariffs-shock-hit-stocks-cryptos-while-nvidia-fails-to-come-to-the-rescue-this-week-in-markets", "tags": ["earnings"]}
{"id": 44058750, "time": "2025-02-28 16:03:36", "headline": "Apogee Therapeutics To Host Conference Call To Report Interim Results From The Phase 1 Healthy Volunteer Trial For APG990 And Provide Combination Strategy Update On March 3, 2025 At 8:30am ET", "summary": "", "symbols": ["APGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/02/44058750/apogee-therapeutics-to-host-conference-call-to-report-interim-results-from-the-phase-1-healthy-vo", "tags": ["fda"]}
{"id": 44058855, "time": "2025-02-28 16:05:04", "headline": "'Synopsys Preparing Around $10B Bond Deal for Next Week' - Bloomberg News", "summary": "", "symbols": ["SNPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44058855/synopsys-preparing-around-10b-bond-deal-for-next-week-bloomberg-news", "tags": ["contract"]}
{"id": 44059013, "time": "2025-02-28 16:07:36", "headline": "Bumble Appoints Ronald J. Fior Appointed Interim CFO, Effective March 15, 2025", "summary": "", "symbols": ["BMBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059013/bumble-appoints-ronald-j-fior-appointed-interim-cfo-effective-march-15-2025", "tags": ["management"]}
{"id": 44059031, "time": "2025-02-28 16:07:58", "headline": "Supermicro Announces Plans For Third Silicon Valley Campus", "summary": "", "symbols": ["SMCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059031/supermicro-announces-plans-for-third-silicon-valley-campus", "tags": []}
{"id": 44059058, "time": "2025-02-28 16:09:05", "headline": "Longeveron FY 2024 GAAP EPS $(2.62) Beats $(3.53) Estimate, Sales $2.392M Beat $2.143M Estimate", "summary": "", "symbols": ["LGVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44059058/longeveron-fy-2024-gaap-eps-2-62-beats-3-53-estimate-sales-2-392m-beat-2-143m-estimate", "tags": ["earnings"]}
{"id": 44059059, "time": "2025-02-28 16:09:11", "headline": "Applied Optoelectronics Entered Equity Distribution Agreement With, May Issue And Sell Up To $100M Through Raymond James", "summary": "", "symbols": ["AAOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/25/02/44059059/applied-optoelectronics-entered-equity-distribution-agreement-with-may-issue-and-sell-up-to-100m-thr", "tags": ["contract"]}
{"id": 44059063, "time": "2025-02-28 16:09:56", "headline": "Syros Announces Voluntary Delisting From Nasdaq And SEC Deregistration, Delisting Is Expected To Become Effective On Or About March 20, 2025.", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059063/syros-announces-voluntary-delisting-from-nasdaq-and-sec-deregistration-delisting-is-expected-to-beco", "tags": []}
{"id": 44059076, "time": "2025-02-28 16:10:12", "headline": "Vincerx Pharma Announces Termination Of Term Sheet Between Vincerx, Oqory And Vivasor For Reverse Merger Transaction", "summary": "", "symbols": ["VINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44059076/vincerx-pharma-announces-termination-of-term-sheet-between-vincerx-oqory-and-vivasor-for-reverse-mer", "tags": ["merger"]}
{"id": 44059103, "time": "2025-02-28 16:10:59", "headline": "Vincerx Pharma Board To Reassess Strategic Alternatives Including Out-Licensing, Merger And Acquisition Opportunities, The Sale Of Assets And Technologies And Winding Down Operations Among Other Potential Transactions", "summary": "", "symbols": ["VINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059103/vincerx-pharma-board-to-reassess-strategic-alternatives-including-out-licensing-merger-and-acquisiti", "tags": ["merger"]}
{"id": 44059114, "time": "2025-02-28 16:11:09", "headline": "4D Molecular Therapeutics FY 2024 GAAP EPS $(2.98) Misses $(2.92) Estimate, Sales $37.000K", "summary": "", "symbols": ["FDMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44059114/4d-molecular-therapeutics-fy-2024-gaap-eps-2-98-misses-2-92-estimate-sales-37-000k", "tags": ["earnings"]}
{"id": 44059156, "time": "2025-02-28 16:11:42", "headline": "AT&T Files For Mixed Shelf; Size Not Disclosed", "summary": "", "symbols": ["T"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059156/at-t-files-for-mixed-shelf-size-not-disclosed", "tags": []}
{"id": 44059180, "time": "2025-02-28 16:11:59", "headline": "CJS Securities Upgrades AAON to Market Outperform, Announces $110 Price Target", "summary": "", "symbols": ["AAON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059180/cjs-securities-upgrades-aaon-to-market-outperform-announces-110-price-target", "tags": ["analyst_up"]}
{"id": 44059230, "time": "2025-02-28 16:12:41", "headline": "Biomea Fusion CFO Franco Valle Resigns, Effective Mar. 7", "summary": "", "symbols": ["BMEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059230/biomea-fusion-cfo-franco-valle-resigns-effective-mar-7", "tags": ["management"]}
{"id": 44059244, "time": "2025-02-28 16:13:10", "headline": "Casella Waste Systems Announces $25M Vermont Revenue Bonds Offering To Fund Capital Projects", "summary": "", "symbols": ["CWST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059244/casella-waste-systems-announces-25m-vermont-revenue-bonds-offering-to-fund-capital-projects", "tags": ["earnings", "offering"]}
{"id": 44059266, "time": "2025-02-28 16:13:34", "headline": "Fathom Holdings Says On Feb 26, Joanne Zach Separates From Fathom Holdings As CFO; Marco Fregenal To Serve As Principal Financial Officer", "summary": "", "symbols": ["FTHM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059266/fathom-holdings-says-on-feb-26-joanne-zach-separates-from-fathom-holdings-as-cfo-marco-fregenal-to-s", "tags": ["management"]}
{"id": 44059279, "time": "2025-02-28 16:13:56", "headline": "LAVA Therapeutics Receives Nasdaq Non-Compliance Notice For Minimum Bid Price", "summary": "", "symbols": ["LVTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059279/lava-therapeutics-receives-nasdaq-non-compliance-notice-for-minimum-bid-price", "tags": []}
{"id": 44059288, "time": "2025-02-28 16:14:14", "headline": "MP Materials Files For Mixed Shelf, Size Not Disclosed", "summary": "", "symbols": ["MP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059288/mp-materials-files-for-mixed-shelf-size-not-disclosed", "tags": []}
{"id": 43911321, "time": "2025-02-28 16:14:29", "headline": "The Future Of Money Market Fund Tokens", "summary": "Tokenized access to money market funds addresses a growing demand from institutional investors for regulated, digital-first financial products.", "symbols": [], "source": "benzinga", "author": "skrady@gmail.com", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/43911321/the-future-of-money-market-fund-tokens", "tags": []}
{"id": 44059360, "time": "2025-02-28 16:16:08", "headline": "Range Resources Increases Quarterly Dividend From $0.08 to $0.09/Share", "summary": "", "symbols": ["RRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059360/range-resources-increases-quarterly-dividend-from-0-08-to-0-09share", "tags": ["dividend"]}
{"id": 44059367, "time": "2025-02-28 16:16:18", "headline": "Here's How Much You Would Have Made Owning Lattice Semiconductor Stock In The Last 15 Years", "summary": " ", "symbols": ["LSCC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44059367/heres-how-much-you-would-have-made-owning-lattice-semiconductor-stock-in-the-last-15-years", "tags": []}
{"id": 44059450, "time": "2025-02-28 16:17:45", "headline": "American Assets Trust, Inc. Acquires Genesee Park Apartments Property For $67.9M", "summary": "", "symbols": ["AAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44059450/american-assets-trust-inc-acquires-genesee-park-apartments-property-for-67-9m", "tags": ["merger"]}
{"id": 44059486, "time": "2025-02-28 16:18:02", "headline": "Jefferies Maintains Buy on Fox Factory Hldg, Lowers Price Target to $38", "summary": "", "symbols": ["FOXF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059486/jefferies-maintains-buy-on-fox-factory-hldg-lowers-price-target-to-38", "tags": ["analyst_other", "price_target_down"]}
{"id": 44059517, "time": "2025-02-28 16:18:54", "headline": "Affirm Holdings Files For Mixed Shelf Offering; Size Not Disclosed", "summary": "", "symbols": ["AFRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059517/affirm-holdings-files-for-mixed-shelf-offering-size-not-disclosed", "tags": ["offering"]}
{"id": 44059526, "time": "2025-02-28 16:19:13", "headline": "MasTec Files For Mixed Shelf, Size Not Disclosed", "summary": "", "symbols": ["MTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059526/mastec-files-for-mixed-shelf-size-not-disclosed", "tags": []}
{"id": 44059532, "time": "2025-02-28 16:19:22", "headline": "Somnigroup International Files Prospectus Relates To Proposed Resale From Time To Time Of Up To 34.2M Common Shares By Selling Stockholders", "summary": "", "symbols": ["SGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059532/somnigroup-international-files-prospectus-relates-to-proposed-resale-from-time-to-time-of-up-to-34-2", "tags": []}
{"id": 44059609, "time": "2025-02-28 16:21:36", "headline": "Mersana Therapeutics Receives Nasdaq Non-Compliance Notice", "summary": "", "symbols": ["MRSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059609/mersana-therapeutics-receives-nasdaq-non-compliance-notice", "tags": []}
{"id": 44059626, "time": "2025-02-28 16:22:15", "headline": "Century Therapeutics Receives Nasdaq Notice For Bid Price Deficiency", "summary": "", "symbols": ["IPSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059626/century-therapeutics-receives-nasdaq-notice-for-bid-price-deficiency", "tags": []}
{"id": 44059641, "time": "2025-02-28 16:22:34", "headline": "Spirit AeroSystems Hldgs Q4 2024 Adj. EPS $(4.22), Sales $1.651B Miss $1.676B Estimate", "summary": "", "symbols": ["SPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44059641/spirit-aerosystems-hldgs-q4-2024-adj-eps-4-22-sales-1-651b-miss-1-676b-estimate", "tags": ["earnings"]}
{"id": 44059652, "time": "2025-02-28 16:22:47", "headline": "JP Morgan Initiates Coverage On ACM Research with Overweight Rating, Announces Price Target of $36", "summary": "", "symbols": ["ACMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059652/jp-morgan-initiates-coverage-on-acm-research-with-overweight-rating-announces-price-target-of-36", "tags": ["analyst_init"]}
{"id": 44059664, "time": "2025-02-28 16:23:05", "headline": "TXNM Energy Files For Mixed Shelf Offering; Size Not Disclosed", "summary": "", "symbols": ["TXNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059664/txnm-energy-files-for-mixed-shelf-offering-size-not-disclosed", "tags": ["offering"]}
{"id": 44059680, "time": "2025-02-28 16:23:43", "headline": "Cactus Files For Mixed Shelf; Size Not Disclosed", "summary": "", "symbols": ["WHD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059680/cactus-files-for-mixed-shelf-size-not-disclosed", "tags": []}
{"id": 44059696, "time": "2025-02-28 16:24:23", "headline": "Spirit Aerosystems Says Overall Deliveries Increased During  Q4 Of 2024 Compared To The Same Period Of 2023, Including Higher Boeing 737 Deliveries.", "summary": "", "symbols": ["BA", "SPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059696/spirit-aerosystems-says-overall-deliveries-increased-during-q4-of-2024-compared-to-the-same-period-o", "tags": []}
{"id": 44059760, "time": "2025-02-28 16:27:14", "headline": "Comcast Corp Files For Mixed Shelf; Size Not Disclosed", "summary": "", "symbols": ["CMCSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059760/comcast-corp-files-for-mixed-shelf-size-not-disclosed", "tags": []}
{"id": 44059763, "time": "2025-02-28 16:27:26", "headline": "RFK Jr Applauds This Restaurant Chain's Move: 'Fries Will Be RFK'D'", "summary": "Steak &#39;n Shake restaurants in Ohio, Colorado, Florida, Texas and Oklahoma are cooking fries with beef tallow instead of oil.", "symbols": ["BH"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/restaurants/25/02/44059763/rfk-jr-applauds-this-restaurant-chains-move-fries-will-be-rfkd", "tags": []}
{"id": 44059777, "time": "2025-02-28 16:27:34", "headline": "Spirit AeroSystems Says In Light Of Merger Agreement With Boeing, Will Not Provide Guidance", "summary": "", "symbols": ["BA", "SPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059777/spirit-aerosystems-says-in-light-of-merger-agreement-with-boeing-will-not-provide-guidance", "tags": ["guidance", "merger", "contract"]}
{"id": 44059761, "time": "2025-02-28 16:27:15", "headline": "Secretary of State Makes Determination Approving Possible Foreign Military Sale To Israel Of Caterpillar D9 Bulldozers And Related Equipment For Est. $295M", "summary": "", "symbols": ["CAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059761/secretary-of-state-makes-determination-approving-possible-foreign-military-sale-to-israel-of-caterpi", "tags": []}
{"id": 44059808, "time": "2025-02-28 16:28:33", "headline": "Atlantic International Terminates Merger Agreement With Staffing 360 Solutions; No Material Termination Penalties Incurred By Atlantic International", "summary": "", "symbols": ["ATLN", "STAF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44059808/atlantic-international-terminates-merger-agreement-with-staffing-360-solutions-no-material-terminati", "tags": ["merger", "contract"]}
{"id": 44059834, "time": "2025-02-28 16:29:35", "headline": "Italy PM Meloni Says We Need Immediate Summit Between The United States, European States And Allies To Talk About Present Challenges, Starting With Ukraine; Every Division Of The West Makes Us All Weaker And Favors Those Who Would Like To See The Decline Of Our Civilization", "summary": "", "symbols": ["EWI", "SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44059834/italy-pm-meloni-says-we-need-immediate-summit-between-the-united-states-european-", "tags": []}
{"id": 44059865, "time": "2025-02-28 16:30:09", "headline": "Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["VINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44059865/trading-halt-halt-status-updated-at-4-30-00-pm-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 44059919, "time": "2025-02-28 16:30:56", "headline": "Alaska Airlines Attendants Represented By Association of Flight Attendants Ratify New Three-Year Contract", "summary": "", "symbols": ["ALK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44059919/alaska-airlines-attendants-represented-by-association-of-flight-attendants-ratify-new-three-year-con", "tags": ["contract"]}
{"id": 44059997, "time": "2025-02-28 16:32:34", "headline": "BIT Mining Q4 2024 Adj. EPS $(0.16) Up From $(0.39) YoY, Sales $8.793M Miss $12.400M Estimate", "summary": "", "symbols": ["BTCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44059997/bit-mining-q4-2024-adj-eps-0-16-up-from-0-39-yoy-sales-8-793m-miss-12-400m-estimate", "tags": ["earnings"]}
{"id": 44060003, "time": "2025-02-28 16:32:45", "headline": "Leerink Partners Maintains Market Perform on Recursion Pharmaceuticals, Lowers Price Target to $6", "summary": "", "symbols": ["RXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060003/leerink-partners-maintains-market-perform-on-recursion-pharmaceuticals-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 44060013, "time": "2025-02-28 16:33:04", "headline": "Home Bancshares Inc Announces Tracy M. French To Retire As Chairman And Director On April 17, 2025", "summary": "", "symbols": ["HOMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060013/home-bancshares-inc-announces-tracy-m-french-to-retire-as-chairman-and-director-on-april-17-2025", "tags": []}
{"id": 44060062, "time": "2025-02-28 16:34:45", "headline": "U.S. State Dept Approves Potential Sale Of Munitions And Munitions Support To Israel For An Estimated $2.04B", "summary": "", "symbols": ["BA", "EIS", "GD", "ISRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44060062/u-s-state-dept-approves-potential-sale-of-munitions-and-munitions-support-to-isra", "tags": []}
{"id": 44060079, "time": "2025-02-28 16:35:32", "headline": "Network-1 2024 Revenue $100,000, EPS $(0.13)", "summary": "", "symbols": ["NTIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44060079/network-1-2024-revenue-100-000-eps-0-13", "tags": ["earnings"]}
{"id": 44060084, "time": "2025-02-28 16:35:43", "headline": "Goldman Sachs Form 4 Filing Shows CEO David M Solomon Reports Open Market Sale Of 2,415 Shares Of Co's Common Stock At Average Price Of $622.15/share On Feb 26", "summary": "", "symbols": ["GS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060084/goldman-sachs-form-4-filing-shows-ceo-david-m-solomon-reports-open-market-sale-of-2-415-shares-of-co", "tags": ["insider", "management"]}
{"id": 44060113, "time": "2025-02-28 16:36:39", "headline": "Fed's Goolsbee Says Inflation Data Is Still Higher Than We'd Like; Still Appear On A Path Back To 2% Inflation; Everything Keeps Us Up At Night; We Should Start Working Through Scenarios Of Trump Economic Agenda; Don't Have Enough Clarity To Forecast Off Trump Agenda Yet", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44060113/feds-goolsbee-says-inflation-data-is-still-higher-than-wed-like-still-appear-on-a", "tags": ["guidance"]}
{"id": 44060217, "time": "2025-02-28 16:40:28", "headline": "Vast Renewables H1 2025 Revenue $6.6M, Consisting Of Grant Revenue", "summary": "", "symbols": ["VSTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44060217/vast-renewables-h1-2025-revenue-6-6m-consisting-of-grant-revenue", "tags": ["earnings"]}
{"id": 44060245, "time": "2025-02-28 16:41:25", "headline": "Fed's Goolsbee Says Will Have To See What Exactly Happens With Tariffs; Tariffs Can Take A Long Time To Impact Economy; Rise In Productivity Appears Real But Still Unsure How Long It Will Last", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/02/44060245/feds-goolsbee-says-will-have-to-see-what-exactly-happens-with-tariffs-tariffs-can", "tags": []}
{"id": 44060271, "time": "2025-02-28 16:41:56", "headline": "Associated Capital Group's Douglas R. Jamieson To Retire As CEO, Effective March 17; Patrick Huvane To Become Interim CEO", "summary": "", "symbols": ["AC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060271/associated-capital-groups-douglas-r-jamieson-to-retire-as-ceo-effective-march-17-patrick-huvane-to-b", "tags": ["management"]}
{"id": 44060296, "time": "2025-02-28 16:42:36", "headline": "Huntington Bancshares Files For Mixed Shelf ; Size Not Disclosed", "summary": "", "symbols": ["HBAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060296/huntington-bancshares-files-for-mixed-shelf-size-not-disclosed", "tags": []}
{"id": 44060336, "time": "2025-02-28 16:43:36", "headline": "Senior Senate Democrat Cantwell Says Elon Musk Comments On FAA's $2.4B Contract To Verizon Raise \"Serious Red Flags\"", "summary": "", "symbols": ["SPY", "VZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060336/senior-senate-democrat-cantwell-says-elon-musk-comments-on-faas-2-4b-contract-to-verizon-raise-serio", "tags": ["contract"]}
{"id": 44060358, "time": "2025-02-28 16:44:00", "headline": "Revvity Files For Mixed Shelf Offering; Size Not Disclosed", "summary": "", "symbols": ["RVTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060358/revvity-files-for-mixed-shelf-offering-size-not-disclosed", "tags": ["offering"]}
{"id": 44060361, "time": "2025-02-28 16:44:04", "headline": "Barclays Maintains Equal-Weight on Jamf Holding, Lowers Price Target to $16", "summary": "", "symbols": ["JAMF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060361/barclays-maintains-equal-weight-on-jamf-holding-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 44060382, "time": "2025-02-28 16:44:59", "headline": "Motorsport Games Says On Feb 26, U.S. District Court For District Of Delaware Granted Summary Judgment Motion Filed By Co And Other Defendants; Court Rules In Favor Of Motorsport Games On All Counts", "summary": "", "symbols": ["MSGM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060382/motorsport-games-says-on-feb-26-u-s-district-court-for-district-of-delaware-granted-summary-judgment", "tags": ["legal"]}
{"id": 44060421, "time": "2025-02-28 16:46:15", "headline": "Middlesex Water Q4 2024 GAAP EPS $0.49 Beats $0.36 Estimate, Sales $47.107M Beat $43.000M Estimate", "summary": "", "symbols": ["MSEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/02/44060421/middlesex-water-q4-2024-gaap-eps-0-49-beats-0-36-estimate-sales-47-107m-beat-43-000m-estimate", "tags": ["earnings"]}
{"id": 44060483, "time": "2025-02-28 16:47:03", "headline": "Barclays Maintains Overweight on Marriott Vacations, Lowers Price Target to $97", "summary": "", "symbols": ["VAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060483/barclays-maintains-overweight-on-marriott-vacations-lowers-price-target-to-97", "tags": ["analyst_other", "price_target_down"]}
{"id": 44060529, "time": "2025-02-28 16:47:23", "headline": "Alphabet Stock Enters Oversold Territory \u2014 Is It A Buying Opportunity?", "summary": "Alphabet stock is down more than 13% since the end of January and has now entered oversold territory.\u00a0", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/large-cap/25/02/44060529/alphabet-stock-enters-oversold-territory-is-it-a-buying-opportunity", "tags": []}
{"id": 44060683, "time": "2025-02-28 16:49:13", "headline": "Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction", "summary": "", "symbols": ["CCRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/02/44060683/cross-country-healthcare-stockholders-approve-aya-healthcare-transaction", "tags": []}
{"id": 44060704, "time": "2025-02-28 16:49:58", "headline": "Silynxcom Files For Stock Shelf Of Up To $50M", "summary": "", "symbols": ["SYNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060704/silynxcom-files-for-stock-shelf-of-up-to-50m", "tags": []}
{"id": 44060821, "time": "2025-02-28 16:54:27", "headline": "Barclays Maintains Overweight on Vir Biotechnology, Raises Price Target to $31", "summary": "", "symbols": ["VIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44060821/barclays-maintains-overweight-on-vir-biotechnology-raises-price-target-to-31", "tags": ["analyst_other", "price_target_up"]}
{"id": 44060944, "time": "2025-02-28 17:00:24", "headline": "Demystifying Payoneer Global: Insights From 6 Analyst Reviews", "summary": " ", "symbols": ["PAYO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44060944/demystifying-payoneer-global-insights-from-6-analyst-reviews", "tags": []}
{"id": 44060959, "time": "2025-02-28 17:00:42", "headline": "Array Technologies Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)", "summary": " ", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44060959/array-technologies-stock-a-deep-dive-into-analyst-perspectives-6-ratings", "tags": []}
{"id": 44060968, "time": "2025-02-28 17:00:53", "headline": "A Glimpse Into The Expert Outlook On MetLife Through 8 Analysts", "summary": " ", "symbols": ["MET"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44060968/a-glimpse-into-the-expert-outlook-on-metlife-through-8-analysts", "tags": ["guidance"]}
{"id": 44060972, "time": "2025-02-28 17:01:01", "headline": "Expert Outlook: Prudential Financial Through The Eyes Of 13 Analysts", "summary": " ", "symbols": ["PRU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44060972/expert-outlook-prudential-financial-through-the-eyes-of-13-analysts", "tags": ["guidance"]}
{"id": 44060984, "time": "2025-02-28 17:01:07", "headline": "11 Analysts Have This To Say About First Horizon", "summary": " ", "symbols": ["FHN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44060984/11-analysts-have-this-to-say-about-first-horizon", "tags": []}
{"id": 44060987, "time": "2025-02-28 17:01:16", "headline": "What Analysts Are Saying About Solventum Stock", "summary": " ", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/02/44060987/what-analysts-are-saying-about-solventum-stock", "tags": []}
{"id": 44061022, "time": "2025-02-28 17:02:33", "headline": "Barclays Maintains Overweight on Autodesk, Raises Price Target to $365", "summary": "", "symbols": ["ADSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44061022/barclays-maintains-overweight-on-autodesk-raises-price-target-to-365", "tags": ["analyst_other", "price_target_up"]}
{"id": 44061024, "time": "2025-02-28 17:02:39", "headline": "BlackRock Stock up Over 3% After This Trading Signal", "summary": "A significant trading signal occurred for BlackRock, Inc. (BLK) as it demonstrated a Power Inflow at a price of $948.95.", "symbols": [], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/markets/equities/25/02/44061024/blackrock-stock-up-over-3-after-this-trading-signal", "tags": []}
{"id": 44061110, "time": "2025-02-28 17:05:37", "headline": "Barclays Maintains Overweight on Avidity Biosciences, Lowers Price Target to $57", "summary": "", "symbols": ["RNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44061110/barclays-maintains-overweight-on-avidity-biosciences-lowers-price-target-to-57", "tags": ["analyst_other", "price_target_down"]}
{"id": 44061190, "time": "2025-02-28 17:10:39", "headline": "Barclays Maintains Overweight on Brown-Forman, Lowers Price Target to $40", "summary": "", "symbols": ["BF", "BF/B"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44061190/barclays-maintains-overweight-on-brown-forman-lowers-price-target-to-40", "tags": ["analyst_other", "price_target_down"]}
{"id": 44061588, "time": "2025-02-28 17:20:48", "headline": "Barclays Maintains Equal-Weight on Duolingo, Raises Price Target to $330", "summary": "", "symbols": ["DUOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44061588/barclays-maintains-equal-weight-on-duolingo-raises-price-target-to-330", "tags": ["analyst_other", "price_target_up"]}
{"id": 44061736, "time": "2025-02-28 17:30:29", "headline": "Here's How Much $100 Invested In MARA Holdings 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/02/44061736/heres-how-much-100-invested-in-mara-holdings-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44061897, "time": "2025-02-28 17:33:19", "headline": "Barclays Maintains Overweight on First Solar, Lowers Price Target to $236", "summary": "", "symbols": ["FSLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44061897/barclays-maintains-overweight-on-first-solar-lowers-price-target-to-236", "tags": ["analyst_other", "price_target_down"]}
{"id": 44046653, "time": "2025-02-28 17:05:43", "headline": "Do No-Fault Laws Drive Up Your Car Insurance Premiums?", "summary": "Are No-Fault Laws Inflating Your Car Insurance Premiums? Insights from a lawyer with over 20 years of no-fault litigation experience.", "symbols": [], "source": "benzinga", "author": "jtnylawmake@gmail.com", "url": "https://www.benzinga.com/news/legal/25/02/44046653/do-no-fault-laws-drive-up-your-car-insurance-premiums", "tags": []}
{"id": 44061952, "time": "2025-02-28 17:40:53", "headline": "Barclays Maintains Equal-Weight on HP, Raises Price Target to $36", "summary": "", "symbols": ["HPQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44061952/barclays-maintains-equal-weight-on-hp-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 44061966, "time": "2025-02-28 17:43:00", "headline": "Barclays Maintains Overweight on JD.com, Raises Price Target to $55", "summary": "", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44061966/barclays-maintains-overweight-on-jd-com-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 44061979, "time": "2025-02-28 17:44:38", "headline": "Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $16", "summary": "", "symbols": ["SHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44061979/barclays-maintains-overweight-on-sotera-health-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062074, "time": "2025-02-28 17:50:08", "headline": "Barclays Maintains Underweight on Toronto-Dominion Bank, Raises Price Target to C$81", "summary": "", "symbols": ["TSX:TD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062074/barclays-maintains-underweight-on-toronto-dominion-bank-raises-price-target-to-c-81", "tags": ["analyst_other", "price_target_up"]}
{"id": 44062082, "time": "2025-02-28 17:52:47", "headline": "Barclays Maintains Overweight on Urban Outfitters, Raises Price Target to $68", "summary": "", "symbols": ["URBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062082/barclays-maintains-overweight-on-urban-outfitters-raises-price-target-to-68", "tags": ["analyst_other", "price_target_up"]}
{"id": 44062100, "time": "2025-02-28 17:56:38", "headline": "Barclays Maintains Underweight on Viatris, Lowers Price Target to $9", "summary": "", "symbols": ["VTRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062100/barclays-maintains-underweight-on-viatris-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062121, "time": "2025-02-28 17:59:57", "headline": "Barclays Maintains Equal-Weight on Warner Bros. Discovery, Raises Price Target to $12", "summary": "", "symbols": ["WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062121/barclays-maintains-equal-weight-on-warner-bros-discovery-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 44062198, "time": "2025-02-28 18:06:10", "headline": "Barclays Maintains Equal-Weight on NetApp, Lowers Price Target to $115", "summary": "", "symbols": ["NTAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062198/barclays-maintains-equal-weight-on-netapp-lowers-price-target-to-115", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062212, "time": "2025-02-28 18:08:12", "headline": "Barclays Maintains Overweight on Pacira BioSciences, Raises Price Target to $24", "summary": "", "symbols": ["PCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062212/barclays-maintains-overweight-on-pacira-biosciences-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 44062219, "time": "2025-02-28 18:11:35", "headline": "Scotiabank Maintains Sector Perform on Armada Hoffler Properties, Lowers Price Target to $10", "summary": "", "symbols": ["AHH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062219/scotiabank-maintains-sector-perform-on-armada-hoffler-properties-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062221, "time": "2025-02-28 18:11:51", "headline": "Trump May Stop All Military Aid To Ukraine After Tense Exchange With Zelenskyy: Report", "summary": "The Trump administration may stop all shipments of military aid to Ukraine following a tense exchange between President Donald Trump and Ukrainian President Vladymyr Zelenskyy in the Oval Office Friday.\u00a0", "symbols": ["ITA", "LMT", "PPA", "RTX"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/25/02/44062221/trump-may-stop-all-military-aid-to-ukraine-after-tense-exchange-with-zelenskyy-report", "tags": []}
{"id": 44062239, "time": "2025-02-28 18:13:48", "headline": "Scotiabank Maintains Sector Outperform on Brixmor Property Group, Lowers Price Target to $30", "summary": "", "symbols": ["BRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062239/scotiabank-maintains-sector-outperform-on-brixmor-property-group-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062258, "time": "2025-02-28 18:17:14", "headline": "Scotiabank Maintains Sector Perform on BXP, Lowers Price Target to $83", "summary": "", "symbols": ["BXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062258/scotiabank-maintains-sector-perform-on-bxp-lowers-price-target-to-83", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062320, "time": "2025-02-28 18:19:42", "headline": "Scotiabank Maintains Sector Outperform on Healthpeak Properties, Lowers Price Target to $23", "summary": "", "symbols": ["DOC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062320/scotiabank-maintains-sector-outperform-on-healthpeak-properties-lowers-price-target-to-23", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062327, "time": "2025-02-28 18:21:17", "headline": "Scotiabank Maintains Sector Perform on Essential Properties, Lowers Price Target to $32", "summary": "", "symbols": ["EPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062327/scotiabank-maintains-sector-perform-on-essential-properties-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062330, "time": "2025-02-28 18:23:50", "headline": "Scotiabank Maintains Sector Outperform on Federal Realty Investment, Lowers Price Target to $117", "summary": "", "symbols": ["FRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062330/scotiabank-maintains-sector-outperform-on-federal-realty-investment-lowers-price-target-to-117", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062348, "time": "2025-02-28 18:27:02", "headline": "Scotiabank Maintains Sector Perform on Realty Income, Lowers Price Target to $57", "summary": "", "symbols": ["O"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062348/scotiabank-maintains-sector-perform-on-realty-income-lowers-price-target-to-57", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062383, "time": "2025-02-28 18:32:36", "headline": "Scotiabank Maintains Sector Outperform on FirstEnergy, Lowers Price Target to $44", "summary": "", "symbols": ["FE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062383/scotiabank-maintains-sector-outperform-on-firstenergy-lowers-price-target-to-44", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062388, "time": "2025-02-28 18:33:56", "headline": "Scotiabank Maintains Sector Perform on PubMatic, Lowers Price Target to $15", "summary": "", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062388/scotiabank-maintains-sector-perform-on-pubmatic-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062392, "time": "2025-02-28 18:35:12", "headline": "Scotiabank Maintains Sector Outperform on Millicom Intl Cellular, Raises Price Target to $37.9", "summary": "", "symbols": ["TIGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062392/scotiabank-maintains-sector-outperform-on-millicom-intl-cellular-raises-price-target-to-37-9", "tags": ["analyst_other", "price_target_up"]}
{"id": 44062396, "time": "2025-02-28 18:36:38", "headline": "Scotiabank Maintains Sector Perform on Janux Therapeutics, Lowers Price Target to $41", "summary": "", "symbols": ["JANX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062396/scotiabank-maintains-sector-perform-on-janux-therapeutics-lowers-price-target-to-41", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062401, "time": "2025-02-28 18:38:36", "headline": "Scotiabank Maintains Sector Outperform on Elastic, Raises Price Target to $140", "summary": "", "symbols": ["ESTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062401/scotiabank-maintains-sector-outperform-on-elastic-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 44062473, "time": "2025-02-28 18:49:49", "headline": "Scotiabank Maintains Sector Perform on SL Green Realty, Lowers Price Target to $75", "summary": "", "symbols": ["SLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062473/scotiabank-maintains-sector-perform-on-sl-green-realty-lowers-price-target-to-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062494, "time": "2025-02-28 18:57:51", "headline": "Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $5.25", "summary": "", "symbols": ["BLND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062494/canaccord-genuity-maintains-buy-on-blend-labs-lowers-price-target-to-5-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062504, "time": "2025-02-28 19:00:02", "headline": "Macquarie Maintains Neutral on Playtika Holding, Lowers Price Target to $6", "summary": "", "symbols": ["PLTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062504/macquarie-maintains-neutral-on-playtika-holding-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 44062568, "time": "2025-02-28 19:02:05", "headline": "BWS Financial Maintains Buy on Ecovyst, Maintains $12 Price Target", "summary": "", "symbols": ["ECVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/02/44062568/bws-financial-maintains-buy-on-ecovyst-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 44063030, "time": "2025-02-28 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["LICN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44063030/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44063031, "time": "2025-02-28 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["CLEU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44063031/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44063032, "time": "2025-02-28 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["EDBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44063032/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44063033, "time": "2025-02-28 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["EDBLW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44063033/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44063034, "time": "2025-02-28 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["STBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/02/44063034/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 44063764, "time": "2025-02-28 21:22:00", "headline": "Crypto's Trump-Era Honeymoon Fades As Regulatory Reality Sets In", "summary": "Experts say Trump&#39;s pro-crypto promises have yet to materialize, but SEC&#39;s approach signal progress. Global competition and challenges remain.", "symbols": [], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/44063764/cryptos-trump-era-honeymoon-fades-as-regulatory-reality-sets-in", "tags": []}
{"id": 44063884, "time": "2025-02-28 22:00:38", "headline": "After FSD Rollout In China, Musk Says Rollout In Europe Delayed Owing To Lack Of Approvals", "summary": "Elon Musk said on Friday that it is still awaiting regulatory clearance to roll out its FSD driver assistance technology in Europe.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/25/02/44063884/after-fsd-rollout-in-china-musk-says-rollout-in-europe-delayed-owing-to-lack-of-approvals", "tags": []}
